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Abstract
Recent advances in fluorescent probes, microscopy, and imaging platforms have revolutionized biology and
medicine, generating multi-dimensional image datasets at unprecedented scales. Traditional, low-throughput
methods of image analysis are inadequate to handle the increased “volume, velocity, and variety” that
characterize the realm of big data. Thus, biomedical imaging requires a new set of tools, which include
advanced computer vision and machine learning algorithms. In this work, we develop computational image
analysis solutions to biological questions at the level of single-molecules, cells, and tissues. At the molecular
level, we dissect the regulation of dynein-dynactin transport initiation using in vitro reconstitution, single-
particle tracking, super-resolution microscopy, live-cell imaging in neurons, and computational modeling. We
show that at least two mechanisms regulate dynein transport initiation neurons: (1) cytoplasmic linker
proteins, which are regulated by phosphorylation, increase the capture radius around the microtubule, thus
reducing the time cargo spends in a diffusive search; and (2) a spatial gradient of tyrosinated alpha-tubulin
enriched in the distal axon increases the affinity of dynein-dynactin for microtubules. Together, these
mechanisms support a multi-modal recruitment model where interacting layers of regulation provide efficient,
robust, and spatiotemporal control of transport initiation. At the cellular level, we develop and train deep
residual convolutional neural networks on a large and diverse set of cellular microscopy images. Then, we
apply networks trained for one task as deep feature extractors for unsupervised phenotypic profiling in a
different task. We show that neural networks trained on one dataset encode robust image phenotypes that are
sufficient to cluster subcellular structures by type and separate drug compounds by the mechanism of action,
without additional training, supporting the strength and flexibility of this approach. Future applications
include phenotypic profiling in image-based screens, where clustering genetic or drug treatments by image
phenotypes may reveal novel relationships among genetic or pharmacologic pathways. Finally, at the tissue
level, we apply deep learning pipelines in digital pathology to segment cardiac tissue and classify clinical heart
failure using whole-slide images of cardiac histopathology. Together, these results demonstrate the power and
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Recent advances in fluorescent probes, microscopy, and imaging platforms have revolutionized 
biology and medicine, generating multi-dimensional image datasets at unprecedented scales. 
Traditional, low-throughput methods of image analysis are inadequate to handle the increased 
“volume, velocity, and variety” that characterize the realm of big data. Thus, biomedical imaging 
requires a new set of tools, which include advanced computer vision and machine learning 
algorithms. In this work, we develop computational image analysis solutions to biological 
questions at the level of single-molecules, cells, and tissues. At the molecular level, we dissect 
the regulation of dynein-dynactin transport initiation using in vitro reconstitution, single-particle 
tracking, super-resolution microscopy, live-cell imaging in neurons, and computational modeling. 
We show that at least two mechanisms regulate dynein transport initiation neurons:  
(1) cytoplasmic linker proteins, which are regulated by phosphorylation, increase the capture 
radius around the microtubule, thus reducing the time cargo spends in a diffusive search; and 
(2) a spatial gradient of tyrosinated alpha-tubulin enriched in the distal axon increases the affinity 
of dynein-dynactin for microtubules. Together, these mechanisms support a multi-modal 
recruitment model where interacting layers of regulation provide efficient, robust, and 
spatiotemporal control of transport initiation. At the cellular level, we develop and train deep 
residual convolutional neural networks on a large and diverse set of cellular microscopy images. 
Then, we apply networks trained for one task as deep feature extractors for unsupervised 
vii 
phenotypic profiling in a different task. We show that neural networks trained on one dataset 
encode robust image phenotypes that are sufficient to cluster subcellular structures by type and 
separate drug compounds by the mechanism of action, without additional training, supporting the 
strength and flexibility of this approach. Future applications include phenotypic profiling in image-
based screens, where clustering genetic or drug treatments by image phenotypes may reveal 
novel relationships among genetic or pharmacologic pathways. Finally, at the tissue level, we 
apply deep learning pipelines in digital pathology to segment cardiac tissue and classify clinical 
heart failure using whole-slide images of cardiac histopathology. Together, these results 
demonstrate the power and promise of computational image analysis, computer vision, and  
deep learning in biological image analysis. 
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This body of work represents research conducted under the supervision of Professor 
Erika L. F. Holzbaur. I have also included research performed as part of the University of 
Pennsylvania M.D. / Ph.D. Clinical Connections Program, under the supervision of 
Professors Michael D. Feldman and Anant Madabhushi, because this work follows the 
paradigm of applying computational image analysis to biomedical images. In addition, 
this work was critical training for me to develop my own neural network toolbox for 
cellular microscopy images in Chapter 4, one of my final thesis projects. 
 
When I joined the Erika’s lab in 2013, I had no idea that computational image analysis 
would be a central theme in my graduate research. Rather, it emerged organically 
through a synthesis of my own interests and strengths as well as the biological questions 
we were investigating. The trajectory is obvious in hindsight, as it usually is, and the 
story began for me prior to graduate school. 
 
As an undergraduate at the University of Iowa I worked with Dr. Chun-Fang Wu on a 
team to develop software to automatically track Drosophila locomotion and behavior 
from movies. During my graduate school rotation in the Holzbaur lab, I created a 
package for semi-automated kymograph analysis of axonal transport. Then, I went on to 
take a course in computational image analysis at the Marine Biological Laboratory 
in Woods Hole, MA. 
  
xvii 
I continued to develop these interests throughout my graduate career. I created image 
analysis pipelines for single-particle tracking in order to extract more information from my 
single-molecule TIRF data. I explored the limits of optical imaging by applying recent 
advances in super-resolution microscopy. I also paid attention to advances in computer 
vision and machine learning, applying them to my research whenever possible. Finally, 
my love for microscopy and image analysis made pathology an attractive future career 
prospect. I was sold after learning about digital pathology and image informatics from 
Drs. Feldman and Madabhushi. 
 
I have structured this dissertation according to the scale of investigation, which ranges 
from single-molecules to cells and tissues. However, the organization also reflects my 
career development. My dissertation begins with axonal transport, mechanistic neuronal 
cell biology and image analysis, as my training began. My dissertation concludes with 
image analysis applied to digital pathology images, representing the trajectory for my 
next phase in training, a residency in pathology. Together, these experiences have 
refined the mission I envision for my future lab; I plan to synthesize mechanistic, 
experimental cell biology with my clinical work in neuropathology as I investigate 
neurodegenerative diseases at the molecular, cellular, and tissue-level. As with my 
Ph.D. training, the common theme will be applying computational image analysis in 
order to better understand the cellular and molecular basis of disease. 
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1. CHAPTER 1: Introduction1 
  
                                                
1 This chapter contains sections that were adapted from: 
Nirschl JJ*, Ghiretti AE*, & Holzbaur ELF. (2017). The impact of cytoskeletal 
organization on the local regulation of neuronal transport. Nature Reviews 
Neuroscience, 18(10), 585–597. http://doi.org/10.1038/nrn.2017.100 
*Denotes equal contribution 
 
Nirschl JJ, Janowczyk A, Peyster EG, Frank, R, Margulies, K, Feldman M, and 
Madabhushi A. (2017). Deep Learning Tissue Segmentation in Cardiac 
Histopathology Images. In S. K. Zhou, H. Greenspan, & D. Shen (Eds.), Deep 
Learning for Medical Image Analysis. Cambridge, MA: Elsevier Academic Press. 
2 
Technology plays a pivotal role in cell biology and medicine, driving discovery and 
deepening our understanding of physiology and disease. In early cell biology, advances 
in microscopy and staining reactions were critical to observe and describe the cellular 
organization of fixed tissues. Phase, polarization, fluorescence, and video-enhanced 
microscopy enabled scientists to visualize and record processes in living cells. These 
techniques were augmented by advances in image processing and computer-based 
analyses, which improved image quality and allowed image quantification. For each 
example, new technology supplied tools that were critical to extend our perception and in 
the process provided new ways to think about, visualize, or interrogate biology. 
 
Recent advances in fluorescent probes, optical microscopy, and automated imaging 
platforms have once again revolutionized biomedical imaging, generating large, multi-
dimensional image datasets on an unprecedented scale. Traditional, low-throughput 
methods of image analysis are inadequate to handle the increased “volume, velocity, 
and variety” that characterize the realm of “big data” (Laney 2001). Thus, biomedical 
imaging requires a new set of tools, which includes advanced computer vision and 
machine learning algorithms. A challenge for cell biology and medicine in the 21st 
century will be incorporating new tools into existing paradigms and leveraging the 
strengths of low and high-throughput approaches in new and creative ways. 
  
3 
The increased size of biomedical image datasets along with new developments in 
computer vision and machine learning has brought new interest in the field of bioimage 
informatics or computational image analysis. Bioimage informatics is the cross-
disciplinary field of biology and bioinformatics concerned with the extraction of 
quantitative information from biomedical images using computer vision, machine 
learning, or applied mathematics and statistics (Meijering et al. 2016). It requires domain 
expertise of the underlying biology as well as the ability to design and implement 
creative computational solutions to address biological questions. One advantage of 
computational image analysis is that it allows biologists to analyze the image data for 
what matters, as opposed to what is convenient or traditional to measure. Fine-grained 
analyses of cellular processes can be coupled to mathematical models of the underlying 
molecular processes (Danuser 2011). They may also reveal phenotypes that were not 
initially apparent to the human observer, sometimes referred to as “sub-visual features” 
(Madabhushi and Lee 2016), which are features revealed through computational 
analysis and are reproducibly associated with a biological phenomenon. 
 
1.1. Thesis aims and organization 
In this thesis, I examine biological questions that are at the level of single molecules, 
cells, and tissues. For each biological problem, I develop and apply computational 
approaches that leverage recent advances in computer vision, machine learning, or 
microscopy to gain new insight into the underlying biology. The following subsections 
present an introduction to the significant contributions of each chapter. The remainder of 
the chapter provides a focused review of the relevant topics covered in this dissertation.  
4 
1.1.1. Retrograde axonal transport 
The axon terminal is the most distal subcellular region in the neuron, innervating targets 
at distances up to 20,000-fold greater than the diameter of the soma. Cytoplasmic 
dynein is the primary motor driving long-distance retrograde transport from the axon 
terminal, and efficient retrograde transport initiation is critical to recycle cellular 
components and transmit retrograde signals (Maday et al. 2014). Defects in the proteins 
involved in retrograde transport initiation are sufficient to cause Perry syndrome, a fatal 
neurodegenerative disease (Farrer et al. 2009; Lloyd et al. 2012; Moughamian and 
Holzbaur 2012). Thus, understanding how this process is regulated is essential to 
understand the disease mechanism as well as develop potential therapeutic strategies. 
 
Chapter two presents a method for live-cell imaging and analysis of axonal transport. 
Chapter three investigates the mechanisms that regulate retrograde axonal transport 
initiation in neurons using a combination of approaches, including in vitro reconstitution 
with Total Internal Reflection Fluorescence (TIRF) microscopy, single-particle tracking, 
live-cell microscopy in primary neurons, super-resolution microscopy, and computational 
image analysis. We show that at least two mechanisms regulate dynein retrograde 
transport initiation in neurons: (1) cytoplasmic linker proteins, which are regulated by 
phosphorylation, increase the capture radius around the microtubule, thus reducing the 
time cargo spends in a diffusive search; (2) a spatial gradient of tyrosinated alpha-tubulin 
enriched in the distal axon increases the local microtubule affinity of dynein-dynactin 
associated cargo. Together, these mechanisms favor a multi-modal recruitment model 
where interacting layers of regulation promote efficient, robust, and regulated transport.  
5 
1.1.2. Phenotypic profiling 
Advances in automated microscopy have exponentially increased image data size and 
complexity in biology. Large image datasets benefit from automated tools that leverage 
computer vision and machine learning, including convolutional neural networks (CNNs). 
However, there are few tools that allow biologists to leverage deep learning without 
requiring significant computational and programming experience. To this end, we 
developed the Cell DEep learning COmputational DEscriptoR (Cell DECODER) toolbox. 
Cell DECODER is an open-source neural network toolbox, implemented in Python, built 
on the Microsoft Cognitive Toolkit (CNTK) (Seide and Agarwal 2016). It is designed to 
allow rapid exploration of large cellular microscopy datasets for 1) quality control, 2) 
grouping images by phenotype, and 3) exploring relationships among image phenotypes 
in different experimental conditions. The goal of exploratory image analysis with Cell 
DECODER is to assist the identification of specific image phenotypes or features for in-
depth quantification and hypothesis testing. 
 
In chapter four, we train deep residual networks on a large, diverse set of cellular 
microscopy images from The Human Protein Atlas. We use the Cell DECODER toolbox 
to apply neural networks as feature extractors on new images, without training. We show 
that pre-trained networks encode robust “deep features” that cluster cellular structures 
by type and differentiate drug compounds by the mechanism of action, even though they 
were not trained for these tasks. Future applications include phenotypic profiling in 
microscopy screens, where clustering genetic or small molecule treatments by image 
phenotypes may reveal novel relationships between genetic or pharmacologic pathways.  
6 
1.1.3. Digital pathology 
Cardiac histopathology can be useful to evaluate and grade heart disease in particular 
clinical conditions (Cooper et al. 2007). However, manual interpretation of cardiac 
histopathology is associated with poor inter-observer agreement (Angelini et al. 2011). 
Further, the lack of quantitative metrics in cardiac histopathology precludes the 
development of predictive models in heart failure. This contrasts with other fields, such 
as cancer, where advanced image analytics, including deep learning convolutional 
neural networks (CNNs), have been shown to improve diagnosis and prognosis (Beck et 
al. 2011; Bhargava and Madabhushi 2016; Esteva et al. 2017; Gulshan et al. 2016; 
Litjens et al. 2016; Wang et al. 2017; Xu et al. 2016a; Yu et al. 2016). 
 
One pathological feature of heart disease is the expansion of acellular stroma tissue, 
known as fibrosis, which disrupts cardiac contraction. In chapter five, we present a 
method for the automated segmentation of myocyte and stromal tissue using 
convolutional neural networks (CNNs). In chapter six, we develop a CNN classifier to 
detect clinical heart failure directly from H&E stained whole-slide images in a large 
cohort of 209 patients. We show that the CNN gives a state-of-the-art performance, 99% 
sensitivity, and 94% specificity, and outperforms conventional feature-engineering 
approaches. Importantly, the CNN outperformed two expert pathologists by nearly 20%. 
Our results suggest that deep learning analytics of cardiac histopathology can be used 
to provide decision support, in the form of a second-reader, improving reproducibility in 
cardiac histopathology. It may also be used to assist pathologists in developing models 
to predict cardiovascular function or to detect and predict heart transplant rejection. 
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In the remainder of this chapter, we review background material for the thesis chapters. 
 
1.2. Microscopy 
This section provides a historical introduction to the role of microscopy and imaging 
technology in cell biology. We introduce the microscopy techniques used in this thesis –
light microscopy, live-cell imaging, Total Internal Reflection Fluorescence (TIRF) 
microscopy, and super-resolution microscopy. 
 
1.2.1. Historical introduction 
The development of the first microscope allowed Robert Hooke to visualize and describe 
biological specimens, including the “cells” of cork sections in his famous work, 
Micrografia (Hooke 1665). Antoni van Leeuwenhoek, inspired by Hooke, used his hand-
crafted lenses and microscopes to describe “little animalcules,” which we now know to 
be protozoa and bacteria (Sharp 1921). However, cells were not visible in most 
biological tissue until improved microscope lenses and staining methods were developed 
in the 19th century (Sharp 1921). The ability to stain and visualize cells in more biological 
samples were critical for Schleiden and Schwann to formulate the “cell theory”; that cells 
are the fundamental units that make up organisms (Sharp 1921). 
 
Similarly, nervous tissue could not be adequately visualized until Camillo Golgi 
developed the famous silver nitrate “black reaction,” staining neurons and their arbors in 
their entirety (Golgi 1873; Pannese 1999). The Golgi stain was elegantly applied by 
neuroanatomist Santiago Ramón y Cajal to describe the organization of the nervous 
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system in great detail and formulate the neuron doctrine theory (Ramón y Cajal 1888; 
1894), which provided the foundation for modern cellular neuroscience. Traditional light 
microscopy and histological stains were essential to early cell biologists and 
neuroanatomists, but these tools have limits. One critical drawback is that many of these 
techniques require fixation and staining protocols that kill the sample, making it difficult 
to study life in motion. 
 
1.2.2. Live-cell imaging to probe dynamic processes 
Most living biological samples are transparent in conventional light microscopes, which 
is why histological stains were crucial in the early development of cell biology as a field. 
Overcoming the limits of traditional light microscopy and staining would require either a 
new microscope or a new visualization method. The first answer came in the 1940’s and 
1950’s with the development of phase (Zernike 1942) and differential interference 
contrast (Nomarski 1955; 1960) microscopy, along with the refinement and application of 
polarization microscopy to cell biology, reviewed in Kam (1987). These tools allowed 
stain-free imaging of processes in live cells, such as the mitotic spindle and 
chromosome segregation during mitosis (Inoue 1953), before the development of 
recombinant fluorescent proteins (discussed in section 1.2.4). 
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1.2.3. Image processing in microscopy 
Shinya Inoue, a pioneer in polarization microscopy, later went on to develop video 
microscopy with image processing for enhanced contrast in live-cell imaging; the 
technique was also independently developed by Allen and colleagues (Allen et al. 1981; 
Inoue 1981). Video-enhanced microscopy improved sensitivity and led to the first direct 
visualization of organelle motility in the squid axon (Allen et al. 1982). This was rapidly 
followed by the discovery and in vitro reconstitution of the microtubule motor kinesin-1 
(Vale et al. 1985a; Vale et al. 1985c) and cytoplasmic dynein (MAP1C) (Paschal and 
Vallee 1987) using differential interference contrast, and video-enhanced microscopy. 
 
1.2.4. Fluorescence microscopy 
Fluorescence microscopy was a second answer for overcoming the limits of transmitted 
light microscopy. The earliest comprehensive scientific characterization of the 
phenomenon of fluorescence dates back to George Gabriel Stokes in 1852 (Stokes 
1852), though it wasn’t widely used in biological research until the 1950’s when its utility 
was demonstrated via the use of fluorescently conjugated antibodies (Coons et al. 1941; 
Weller and Coons 1954). Over the next several decades, the improved fluorescent 
microscopes, fluorescent labels, and dye-conjugates were critical to visualize subcellular 
structures subcellular organelles by immunofluorescence (Kam 1987). However, robust 
fluorescence imaging of proteins in live cells had to wait until fluorescent proteins, such 
as the Aeqorea victoria green fluorescent protein (GFP), were discovered (Shimomura et 
al. 1962) and cloned for use as recombinant proteins (Chalfie et al. 1994; Heim et al. 
1994; Prasher et al. 1992).  
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1.2.5. Single molecule and super-resolution microscopy 
Fluorescence microscopy can provide excellent specificity for labeling biological 
structures. However, visualizing single molecules in early biophysics and cell biology 
was difficult because of poor sensitivity and high background, due to fluorescence 
emission of out-of-focus molecules in solution. The phenomenon of total internal 
reflection was applied in the 1980s to reduce background fluorescence and increase the 
signal-to-noise ratio (SNR) in Total Internal Reflection Fluorescence (TIRF) microscopy 
(Axelrod 1981; 2001). The principle involves positioning light sources at highly inclined 
angles, larger than the critical angle, relative to the coverslip interface. This causes the 
original light wave to be reflected entirely and creates an evanescent wave at the 
coverslip-medium interface. The evanescent wave propagates with exponentially 
decreasing intensity into the medium or biological sample. Fluorescence excitation is 
limited to within ~150nm of the coverslip, thus reducing background, as shown in Figure 
1.1, reprinted from Yildiz and Vale (2015). For a detailed review of TIRF microscopy, we 
refer the reader to Axelrod (2001) or Yildiz and Vale (2015). 
 
TIRF microscopy is useful for high SNR imaging of events near the coverslip such as 
endocytosis in cells or in vitro reconstitution of single molecules. TIRF microscopy has 
been instrumental to many advances in cell biology and biophysics including: visualizing 
ATP turnover with single myosin (Funatsu et al. 1995), the stepping of myosin V (Yildiz 
et al. 2003), single molecule kinesin motility (Vale et al. 1996; Yildiz et al. 2004), yeast 
and mammalian dynein motility (Lippert et al. 2017; Reck-Peterson et al. 2006; Ross et 
al. 2006), and multi-motor cargo transport (Hendricks et al. 2010; McIntosh et al. 2015). 
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Figure 1.1 Schematic of Total Internal Reflection Fluorescence (TIRF) microscopy. 
The angle of the incident light above the critical angle is totally internally reflected back 
from the coverslip surface. The reflected beam generates an evanescent field that 
decays exponentially into the sample. TIR illuminates molecules near (∼100 nm) the 
glass surface. In live cell imaging, TIR only excites molecules in or near the cell 
membrane and significantly reduces background fluorescence. Reprinted with 
permission from Cold Spring Harbor Laboratory Press (Yildiz and Vale 2015),  
copyright (2015). 
 
Advances in single-molecule microscopy were complemented by new image processing 
and single-molecule localization algorithms. The emitted fluorescence of a single 
molecule is diffracted in space by the point spread function (PSF) to appear nearly 
Gaussian in the lateral plane (Figure 1.2); though Bessel functions can give a more 
accurate representation (Hopkins 1955; Small and Stahlheber 2014). Thus, two 
molecules that are closer together than the diffraction due to the PSF cannot be resolved 
and will appear as one object. This fundamental limit of resolution in microscopy, which 
depends on the wavelength of light, is known as Abbe diffraction limit (Abbe 1873). 
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Although the conventional resolution limit of fluorescence microscopy is ~250 nm, the 
PSF can be approximated by a two dimensional Gaussian and the center can be 
localized with a much higher precision, and the localization precision is proportional to 
the inverse square root of the photons collected (Thompson et al. 2002). These 
properties were elegantly applied in the Fluorescence Imaging with One Nanometer 
Accuracy (FIONA) method, which enabled single-particle tracking with high accuracy 
(Yildiz et al. 2003). Single-molecule localization algorithms were also crucial for the 
development and application of single-molecule localization microscopy. The general 
principle is that the PSF center of blinking fluorophores (Dickson et al. 1997) can be 
localized with high precision, given the description above. The stochastically blinking 
particles can be imaged over time and molecules in each frame can be precisely 
localized in order to build a reconstruction of biological structures with resolution below 
the Abbe diffraction limit (Betzig 1995; Betzig et al. 2006). For a detailed review of super-




Figure 1.2 Simulated Point Spread Function of an ideal point source. 
A point light source will be diffracted by the PSF, which depends on the imaging system 
and the wave properties, to produce an “Airy pattern” of concentric rings. The central 
disk is referred to as the “Airy disc.” This PSF was generated in Icy (de Chaumont et al. 
2012) and the intensity was transformed by the square root to visualize the pattern 
better.  
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1.3. Image analysis in biomedical research 
The development and application of video microscopy to biomedical images directly 
paved the way for algorithms and computer-based image analysis. In this section, we 
review the history of image analysis in biology and medicine, highlighting the role of 
algorithms and computing in biomedical research.  
 
1.3.1. Historical introduction 
Although much attention has been given to the recent application of computer image 
analysis algorithms to biomedical images, it would be mistaken to assume that image 
analysis is new to biology or medicine. In fact, the field has a rich history dating back as 
early as the 1950’s where video microscopy and image processing systems were being 
developed to automatically count red blood cell number and size (Taylor 1954), detect 
and classify chromosomes for karyotyping (Gilbert 1966; Ledley 1964), extract cellular 
features (e.g. nuclear/cytoplasmic area, optical density etc.) to classify subtypes of white 
blood cells (Prewitt and Mendelsohn 1966), and even detect lesions in mammograms 
(Macy et al. 1969). Early applications in cell biology included counting or tracking cells 
(Lewandowska et al. 1979), measuring shape changes (Verschueren and Van Larebeke 
1984), and enhancing image contrast or acquisition sensitivity and speed (Allen et al. 
1981; Inoue 1981). Later work developed systems that could track multiple cells in a 
field, measure shape properties, and output up to 30 parameters (Soll et al. 1988), which 
was remarkable given the computing power of the time. 
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1.3.2. Feature extraction 
Traditionally, the first step in developing a computer image analysis workflow, in any 
discipline, is to measure relevant properties of an image in a process known as feature 
extraction. Feature extraction refers to the process of 1) detecting relevant properties of 
an image (e.g., edges or biological structures) and 2) assigning quantitative 
measurements to the attribute (Bishop 2006; Gonzalez and Woods 2018). Feature 
extraction is critical to obtain useful representations for computational analysis including 
the segmentation of objects or measuring differences between groups. 
 
Images contain multiple different types of information including intensity, the type and 
number of objects in a field of view, as well as the spatial arrangement of intensity or 
objects, among other examples. Thus, one can design many different features to 
describe an image. The number of features used to describe an image is referred to as 
the measured dimensionality of the image. The mean pixel intensity of an image is a 
one-dimensional image description, though it is a very limited representation. An image 
can also be described by the individual intensity of each pixel, so a 1000x1000 image 
would have one million dimensions. This is not a useful representation either. Thus, 
image features must be well-crafted in order to provide useful representations to 
discriminate among experimental conditions and quantify image phenotypes. 
 
Two important questions, though, are how do we know which features to measure and 
how do we program a computer to measure these features? Historically, this required 
engineers to work with domain experts such as biologists or pathologists. Domain 
experts would highlight relevant parts of an image and the engineers would develop 
transforms to detect and quantify these features. For example, to detect linear filaments, 
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such as actin or microtubules, one may apply the Prewitt filter to compute the spatial 
derivative of the intensity and highlight vertical or horizontal edges (Prewitt 1970). 
Circular objects can be detected using the Gaussian or Laplace of Gaussian transforms, 
and so on. Thus, advances in image processing allowed scientists to quantify image 
features in biology and medicine. For a thorough text on digital image processing and 
image feature extraction, we refer the reader to Gonzalez and Woods (2018). 
 
1.3.3. High throughput microscopy and phenotypic profiling 
The development of automated microscopy systems allowed image-based assays to 
quantify phenotypes in large-scale RNAi, CRISPR, or pharmacology screens (Caie et al. 
2010; Fuchs et al. 2010; McKinley and Cheeseman 2017; Moffat et al. 2006; Neumann 
et al. 2010; Perlman et al. 2004). However, a small set of simple image features is 
inadequate to describe complex phenotypes in a large dataset. The field responded by 
engineering improved features and automated software to capture the rich information 
contained in images including fluorescent protein expression and distribution, cellular 
morphology, and responses at the population and single-cell level (Carpenter et al. 
2006; Rajaram et al. 2012). The concept of describing phenotypes using a diverse set of 
features is known as phenotypic profiling and is common in genetics and proteomics, but 
image-based phenotypic profiling is relatively new in cell biology (Ljosa et al. 2013). 
  
17 
At the same time, a similar process was happening in digital pathology. The advent of 
whole-slide imaging (WSI) has increased the digitization of pathology slides, which is 
generating large, information-rich datasets where modern computer vision and machine 
learning methods thrive (Bhargava and Madabhushi 2016; Ghaznavi et al. 2013; 
Madabhushi and Lee 2016). Traditional approaches for image analysis in digital 
pathology have involved manually engineering image features to use in a machine 
learning classifier (Bhargava and Madabhushi 2016). These features generally involve 
pixel intensity statistics, texture descriptors, and image decompositions, as well as task-
specific features. Importantly, this can reveal sub-visual image features that were not 
initially apparent, but reproducibly and quantitatively discriminate phenotypes. An 
example of sub-visual image features that may be difficult to appreciate or quantify 
without computational analysis includes the network pattern and arrangement of nuclei 
or the local spatial variance in an image signal (e.g., texture), as shown in Figure 1.3 
(Bhargava and Madabhushi 2016). 
 
Despite the success of traditional feature extraction, there are limitations. First, the 
process of identifying, engineering, and testing new features requires significant time 
and technical expertise. Even if the process is successful, many features tend to be 
domain-specific, meaning that they may not work in a different dataset or system. 
Further, there may be relevant but yet unknown image features that we cannot measure. 
Finally, it is often difficult to translate what humans see into machine vision. An expert 
can readily appreciate the difference between a healthy and unhealthy cell, but this can 
be difficult to express as an image transform or multi-parametric phenotypic profile.  
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Figure 1.3 Feature extraction can reveal or enhance hidden structure in images. 
A routine hematoxylin and eosin tissue image (left) can be converted into a histo-
morphometric representation comprising nuclear architecture (middle) and textural 
measurements (right). Reprinted with permission from Annual Reviews (Bhargava and 
Madabhushi 2016), copyright (2016). 
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1.3.4. Learning algorithms 
Machine learning refers to the process of applying mathematical, statistical, or 
computational techniques to data in order to model or “learn” the underlying patterns 
without explicit programming (Bishop 2006). The field has a long history, rooted in 
classical statistical inference, but has gained attention recently due to the increased 
amount of data available as well as advances in algorithms and computing resources. 
Traditional machine learning involves feature extraction followed by the use of statistical 
pattern recognition algorithms to discover structure in the data. For a text on machine 
learning or applied statistics, we refer the reader to Bishop (2006) or Efron and Hastie 
(2016). 
 
For the reasons described in section 1.3.3, traditional feature extraction methods are 
sometimes inefficient or unable to capture the necessary image information. A different 
approach is known as representation learning, which includes neural networks and 
“deep learning,” where an artificial system learns useful features or representations 
directly from data. Neural networks have made significant advances in computer vision 
and are becoming increasingly common in biomedical imaging (Bhargava and 
Madabhushi 2016; LeCun et al. 2015; Peng et al. 2016). Deep learning has many 
potential applications in biomedical imaging because it excels at tasks with large and 
complex training data sets, such as high-throughput microscopy screens or WSI.  
In addition, since deep learning workflows do not carry domain-specific information, a 
deep learning pipeline can be rapidly applied to problems across different domains. 
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Deep learning differs from conventional approaches in that features are not specified by 
human experts, but are instead learned directly from the data. In general, deep neural 
networks work by arranging nodes or artificial “neurons” in successive, convolutional, 
max-pooling, and fully connected layers, reviewed in Bengio (2009); Schmidhuber 
(2015). The connections between neurons are known as “weights” or parameters. 
During training, the weights are iteratively adjusted to approximate complex functions 
from data in a way that minimizes the error on the training set. The error, in supervised 
learning, is typically defined as the difference between the machine prediction and a 
human-defined label or true value, which is known as the ground truth. After training, the 
neurons and connections among the neurons in the network contain hierarchical 
features that map the input image into abstract feature vectors that capture complex and 
nonlinear relationships in the data. For a comprehensive text on neural networks, we 
refer the reader to Goodfellow et al. (2016). 
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1.4. Axonal transport in the distal axon 
In this final section, we provide a focused review of microtubules, dynein, dynactin, and 
axon transport in the distal axon, which are the subject of investigation in chapters two 
and three. We refer the reader to the following resources for a general review of: axonal 
transport (Maday et al. 2014), axonal cargo sorting (Bentley and Banker 2016), axonal 
transport in neurodegenerative disease (Millecamps and Julien 2013), the kinesin 
superfamily (Hirokawa et al. 2009), microtubule plus-end binding proteins (+TIPS) 
(Akhmanova and Steinmetz 2008; Galjart 2005), the neuronal cytoskeleton (Kapitein and 
Hoogenraad 2015), or the local regulation of trafficking (Nirschl et al. 2017a). 
 
1.4.1. Microtubules 
Microtubules are biological polymers assembled from α and β tubulin, an obligate 
heterodimer. The α-β tubulin heterodimer polymerize in a head-to-tail fashion to form 
protofilaments, and approximately 13 protofilaments associate laterally to form a hollow 
tube roughly 25 nm in diameter (Nogales 2000). The structural asymmetry of the α-β 
tubulin heterodimer, as well as the mechanism of and rates of assembly at each end, 
give microtubules an intrinsic polarity with the fast-growing, highly dynamic end 
designated the microtubule plus-end and the opposing, slow-growing end designated the 
microtubule minus-end. Microtubule motors can recognize this polarity and tend to move 
in one direction along the microtubule track. Kinesin motors were the first to be identified  
and move toward the microtubule plus-end (Vale et al. 1985b) whereas cytoplasmic 
dynein moves toward the microtubule minus-end (Paschal and Vallee 1987).  
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The intrinsic microtubule polarity and the directional preference of motors give rise to 
polarized trafficking that depends on the cytoskeletal architecture. In neurons, 
microtubules are organized radially in the soma; in the axon, microtubules are arranged 
in a unipolar, tiled array with their plus-ends directed outwards (Baas et al. 1988). There 
are many kinesin isoforms, and thus different kinesins can have overlapping functions or 
specialize for a specific type of transport (Hirokawa et al. 2009). However, cytoplasmic 
dynein is the only motor driving long-distance retrograde axonal transport, which makes 
defects in dynein or retrograde transport prone to cause neurological disorders and 
neurodegenerative diseases (Millecamps and Julien 2013; Perlson et al. 2010). 
 
1.4.2. Dynein 
There are two classes of dynein: axonemal dynein, which provides the force to beat cilia 
and flagella, and cytoplasmic dynein, which is responsible for intracellular transport and 
mitosis, among other cellular functions. Improved fixation reagents in electron 
microscopy were critical for the early description of we now know as axonemal dynein. 
Afzelius developed an osmium tetroxide fixative with improved contrast in electron 
micrographs of sperm flagella, which revealed arms bridging the outer microtubule 
doublets (Afzelius 1959). Afzelius hypothesized that the arms might play a role in the 
motile properties of cilia, but it was not until cilia were isolated and characterized 
biochemically (Gibbons 1963) and via electron microscopy that these arms were shown 
to correlate with ATPase activity (Gibbons and Rowe 1965). Later work went on to show 
that ATP promotes the weak binding state and microtubule release (Porter and Johnson 
1983), and that axonemal dynein directly translocates microtubules in an ATP-
dependent manner (Brokaw 1989; Summers and Gibbons 1971).  
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Cytoplasmic dynein was initially identified as a microtubule-associated protein (MAP1C), 
enriched in brain tissue and  potentially related to axonemal dynein, with microtubule 
translocation and nucleotide-hydrolysis properties (Paschal et al. 1987). The direction of 
microtubule translocation was found to be opposite of the anterograde motor kinesin, 
and thus dynein was a likely candidate for retrograde organelle transport (Paschal and 
Vallee 1987). Electron microscopy went on to confirm that cytoplasmic dynein  was 
structurally similar to axonemal dynein (Vallee et al. 1988) although the cytoplasmic 
dynein heavy chain is encoded by a separate gene (Mikami et al. 1993; Zhang et al. 
1993). 
 
In vitro studies of cytoplasmic dynein showed robust microtubule translocation (Paschal 
et al. 1987; Paschal and Vallee 1987). However, purified cytoplasmic dynein exhibited 
little organelle motility without the addition of unknown activating factors in the cytosol 
(Schnapp and Reese 1989; Schroer et al. 1989). These dynein activating factors would 
later be identified as dynactin, discussed in section 1.4.3, which we now know is a multi-
subunit complex and required co-factor for motility and most essential functions of 
cytoplasmic dynein. 
 
Further studies revealed that cytoplasmic dynein complex is a large ~1.5 MDa complex 
composed of two heavy chains and at least three classes of associated subunits 
including intermediate chains, light intermediate chains, and light chains (reviewed in 
Allan (2011)). In cells, it is the primary minus-end directed motor for organelle transport 
(reviewed in Allan (2011)). Cytoplasmic dynein is unique compared to motors like kinesin 
or myosin in that it takes a broad range of step sizes toward the minus-end (Mallik et al. 
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2004; Toba et al. 2006), which can include reversing or sidestepping (Ross et al. 2006). 
In contrast, kinesin-1 takes regular, processive forward steps of 8 nm with few 
exceptions (Asbury et al. 2003; Yildiz et al. 2008; Yildiz et al. 2004). Dynein also requires 
many adaptors to function. In addition to the dynactin complex, many other dynein 
adaptors have been recently characterized including: BicD2, Spindly, and Hook family 
proteins, among others (Hoogenraad et al. 2003; McKenney et al. 2014; Olenick et al. 
2016; Redwine et al. 2017; Schlager et al. 2014; Splinter et al. 2012). Dynein adaptors 
are reviewed in Hoogenraad and Akhmanova (2016); Kardon and Vale (2009). 
 
1.4.3. Dynactin 
The dynactin complex was identified as a set of soluble factors that co-purified with 
dynein and stimulated dynein motility (Gill et al. 1991; Schroer and Sheetz 1991). 
The largest subunit of the complex was a 150 kDa subunit with sequence homology to 
the Drosophila Glued gene (Gill et al. 1991; Holzbaur et al. 1991; 1992) and was named 
p150Glued as it is both the structural and functional mammalian homolog of Glued 
(Holzbaur et al. 1991; 1992; Waterman-Storer and Holzbaur 1996). 
 
Structural and biochemical analysis of the dynactin complex revealed a 37 nm filament 
composed of the actin-related protein 1 (Arp1), named the Arp1 rod, and possibly trace 
levels of β-actin (Schafer et al. 1994a). Early studies yielded conflicting evidence for  
β-actin in the dynactin complex (Holleran et al. 1996; Schafer et al. 1994a), but recent 
Cryo-EM structures conclusively show evidence for β-actin in the dynactin complex at an 
8:1 stoichiometry of Arp1: β-actin (Urnavicius et al. 2015).  
25 
The barbed end of the Arp1 rod is capped by a conventional actin capping protein, CapZ 
(Schafer et al. 1994a; Schafer et al. 1994b) and the nearby shoulder element is 
composed of the subunits p150Glued, p50, and p22/p24 (Echeverri et al. 1996; Eckley et 
al. 1999; Karki et al. 1998). The stoichiometry of the p50 subunit is essential for the 
integrity of the complex because overexpression disrupts the dynein-dynactin complex 
and impairs dynein function (Burkhardt et al. 1997; Echeverri et al. 1996). However, 
transgenic mice expressing low levels of p50-GFP can be used to label the endogenous 
dynein-dynactin complex for in vitro reconstitution of dynein and organelle motility 
(Hendricks et al. 2010; Nirschl et al. 2016; Ross et al. 2006). Finally, the pointed end of 
the Arp1 rod is capped by Arp11, p25, p27, and p62; together the 11 subunits described 
in the previous two paragraphs make up the ~1.2 MDa dynactin complex, reviewed in 
Schroer (2004). 
 
The p150Glued subunit has many domains, as shown in Figure 1.4, which confer critical 
functions to the complex including: binding to microtubules and the Arp1 filament 
(Waterman-Storer et al. 1995) and interacting with the dynein intermediate chain (Karki 
and Holzbaur 1995; King et al. 2003; Vaughan and Vallee 1995). The N-terminal 
Cytoskeletal Associated Protein-Glycine Rich (CAP-Gly) domain (Riehemann and Sorg 
1993) allows binding to microtubules as well as microtubule plus-end binding proteins 
(+TIPS), reviewed in Akhmanova and Steinmetz (2008). The interactions among 
p150Glued, cytoplasmic linker protein 170 kDa (CLIP-170), and end-binding proteins 1 or 
3 (EB1 or 3) during the process of retrograde transport initiation are discussed in 
section 1.4.4.2.  
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Figure 1.4 Schematic of the p150Glued subunit of the dynactin complex 
A) Schematic of p150Glued (DCTN1) showing the point mutations in the CAP-Gly domain 
associated with motor neuron disease HMN7B (Puls et al. 2003) in red or the genetic 
parkinsonism known as Perry syndrome (Farrer et al. 2009; Wider and Wszolek 2008; 
Wszolek and Konno 2016) in blue. B) Schematic showing the microtubule binding 
domains, which include the CAP-Gly and basic (+) domains as well as the dynein 
interacting regions in the first coiled-coil domain. The regions of DCTN1 that have been 
mapped to interact with the adaptor proteins Sec23a, JIP1,3,4, and RLIP, SNX6, and 




There are multiple splice isoforms of p150Glued, which have different functions in vitro and 
in cells (Tokito and Holzbaur 1998; Tokito et al. 1996). The full-length p150Glued isoform 
is expressed all cells and contains two globular CAP-Gly domains at the N-terminus; 
neurons also express a 135 kDa isoform, named p135, lacking most of the N-terminal 
microtubule binding domains (Dixit et al. 2008; Tokito et al. 1996). Why neurons express 
the p135 isoform in addition to full-length p150Glued is an intriguing question. One 
hypothesis is that p135 and p150Glued may have unique, specialized functions in 
neurons. Perhaps the absence of the CAP-Gly domain allows p135 to localize to regions 
away from microtubule plus-ends or +TIPS and fulfill other cellular functions, but this has 
not been tested. However, we do know that the tandem CAP-Gly and basic domains are 
necessary to regulate microtubule dynamics in neurons, thus representing a unique 
function for full-length p150Glued (Lazarus et al. 2013). 
 
Dynactin was initially identified as an activator of dynein motility (Gill et al. 1991; Schroer 
and Sheetz 1991). Later studies showed that antibodies to p150Glued that disrupt dynein-
dynactin interaction reduce organelle transport (Waterman-Storer et al. 1997). In vitro, 
dynactin increases dynein run length and motor processivity while not affecting dynein 
velocity (Kardon et al. 2009; King and Schroer 2000; Ross et al. 2006). The CAP-Gly 
domain of p150Glued is not required for dynein motility in vitro (Kardon et al. 2009) or in 
nonpolarized cells (Moore et al. 2009). However, the microtubule binding of purified 
dynein-dynactin complexes and dynein-dynactin bound vesicles in vitro does depend on 
the CAP-Gly domain, as antibodies specific to the p150Glued CAP-Gly domain reduce 
microtubule binding (Hendricks et al. 2010; Ross et al. 2006). 
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Human mutations in the p150Glued (DCTN1) subunit provided insight into the role of the 
CAP-Gly domain in axonal transport. Figure 1.4 shows point mutations identified to 
cause distal hereditary motor neuropathy 7B (HMN7B) (Puls et al. 2003) or the 
autosomal dominant parkinsonism, Perry syndrome (Farrer et al. 2009; Wider and 
Wszolek 2008; Wszolek and Konno 2016). Detailed cell biological studies in primary 
mammalian neurons and in Drosophila showed that HMN7B mutations globally disrupt 
mid and distal transport whereas Perry syndrome mutations cause a specific defect in 
dynein-dynactin retrograde transport initiation from the distal axon (Lloyd et al. 2012; 
Moughamian and Holzbaur 2012). Later work showed that EB1 and CLIP-170 are also 
required for efficient retrograde transport initiation in the distal axon (Moughamian et al. 
2013), as we discuss in section 1.4.4.2. 
 
1.4.4. The distal axon 
The axon terminal is the most distal subcellular region, innervating targets at distances 
up to 20,000-fold greater than the diameter of the soma (Maday et al. 2014). The 
extreme separation between the axon terminal and the soma defines the needs and 
constraints of this region. Efficient anterograde and retrograde microtubule-based 
transport are required to ensure a continuous supply of new cellular resources and 
appropriate recycling or retrograde signaling. The microtubule cytoskeleton in this region 
is sparse and highly dynamic, with mechanisms adapted for efficient transport delivery 
and initiation Figure 1.5A. We focus our discussion below on constitutive transport in the 
distal axon. However, the distal cytoskeleton and MAPs also have essential roles in 
development and injury (Bearce et al. 2015; Bradke et al. 2012; Voelzmann et al. 2016)  
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Figure 1.5 The cytoskeletal organization of the distal axon terminal. 
a) The cytoskeleton of the distal axon terminal is characterized by a dense actin network 
and sparse microtubule array. Although the morphology of a neuronal growth cone is 
depicted here, these features are also found in mature axon terminals. The organization 
of growth cones and such terminals contrasts with the dense, tiled array of more stable 
microtubules found in the mid-axon. Anterograde cargoes are delivered by kinesin 
motors, primarily belonging to the kinesin-1, kinesin-2 and kinesin-3 families. Actin and 
myosin coordinate the delivery, retention, and release of presynaptic cargoes. 
Retrograde cargo transport is driven by the dynein-dynactin complex. b) Multiple 
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mechanisms regulate the loading of retrograde cargo onto microtubule plus ends. These 
regulatory proteins include microtubule plus-end tracking proteins (+TIPs) such as end-
binding protein 3 (EB3), cytoplasmic linker protein 170 (CLIP170), the dynactin complex 
and lissencephaly-1 protein (LIS1; not shown). Initiation is tuned by the phosphorylation 
(P) state of CLIP170, which assumes an open conformation when dephosphorylated and 
then binds to the plus ends of microtubules in order to enhance the recruitment of the 
dynein-dynactin complex (left panel). The local enrichment of tyrosinated microtubules 
also enhances the recruitment of the dynein-dynactin complex to initiate retrograde 
transport (right panel). PPase, phosphatase. Reprinted by permission from Macmillan 
Publishers Ltd: Nature Reviews Neuroscience (Nirschl et al. 2017a), copyright (2017). 
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1.4.4.1. Anterograde trafficking and the delivery of distal cargo 
The bulk of new axonal proteins and organelles is synthesized in the soma and 
transported to the axon (Maday et al. 2014). As motors move cargo from the mid-axon to 
the terminal, they encounter a sparse microtubule cytoskeleton that is also highly 
dynamic. Recent work in C. elegans elegantly shows that in contrast to the dense, 
stable, overlapping microtubules found along the axon shaft, microtubules are sparser in 
the distal axon, with fewer overlaps between adjacent polymers and increased gaps 
between microtubule ends (Yogev et al. 2016). Distal microtubules are also highly 
dynamic, as demonstrated by the presence of increased EB3 dynamics and therefore 
are enriched in tyrosinated α-tubulin (Moughamian et al. 2013; Nirschl et al. 2016). 
 
Materials transported to the distal axon are usually distributed among multiple axonal 
branches and terminals, with the distance-dependent distribution of resources 
dependent on the cargo. For example, in vivo imaging of mitochondria in zebrafish 
sensory neurons found that mitochondrial density decreased in a distance-dependent 
manner along the axon (Plucinska et al. 2012). Furthermore, flux density decreased with 
axon branching by a factor of two per axonal branch (Plucinska et al. 2012), consistent 
with distributed delivery.  
 
The mechanisms regulating the release of anterograde cargo from microtubules in the 
axon terminal are not yet clear. The best studied of these mechanisms has been the 
delivery of synaptic cargoes to distal presynaptic terminals, a subset of terminals among 
the many en passant synapses along the axon shaft. The simplest model posits that 
cargo dissociates from the ends of the microtubules once they reach the axon terminal; 
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however, this explanation is not sufficient to account for selective cargo delivery to one 
out of many terminals (Rizzoli 2014). Instead, the regulated disengagement or 
inactivation of kinesins in the target terminal probably contributes to localized delivery. At 
least four models for presynaptic cargo delivery have been proposed, although further 
studies are required to establish the underlying mechanisms: kinesin dissociation via 
RAB3 nucleotide exchange; phosphorylation-dependent release of motors from cargoes; 
phosphorylation-dependent inhibition of retrograde transport, promoting distal 
enrichment; and distal delivery followed by continuous anterograde–retrograde cycling 
along synapses (Gibbs et al. 2015; Rizzoli 2014). 
 
1.4.4.2. Retrograde transport initiation 
Many cargoes initiate retrograde transport in the axon terminal, including 
autophagosomes, and neurotrophic-factor-associated signaling endosomes, (Maday et 
al. 2014). For example, autophagosomes are preferentially generated in the axon 
terminal (Maday and Holzbaur 2014; Neisch et al. 2017), and efficient retrograde 
transport of these organelles from the axon terminal toward the soma is crucial for 
autophagosome maturation and function (Fu et al. 2014). Rates of retrograde flux also 
affect the long-distance signaling of neurotrophic factors from axon terminal to soma 
(Wang et al. 2016b). 
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One key barrier to the efficiency of retrograde transport is the sparse and dynamic 
nature of microtubules at the axon terminal. Electron microscopy has consistently shown 
a low and variable number of microtubules at terminals (Bodaleo and Gonzalez-Billault 
2016; Yogev et al. 2016). More recent super-resolution studies also demonstrate a lower 
density of more highly dynamic microtubules (Nirschl et al. 2016). 
 
At least two primary mechanisms have been shown to contribute to the robust 
attachment of retrograde cargos with microtubule tracks (Figure 1.5B). First, both dynein 
and dynactin are distally enriched at the axon terminal. A direct interaction between 
kinesin-1 and cytoplasmic dynein maintains a distal pool of dynein, driven by slow 
axonal transport (Twelvetrees et al. 2016). Dynactin, as well as microtubule plus-end 
tracking proteins (+TIPs) including EB3, cytoplasmic linker protein 170 (CLIP-170; also 
known as CLIP1), and LIS1, are also enriched in the axon terminal, where they are 
required for retrograde transport initiation (Moughamian and Holzbaur 2012; 
Moughamian et al. 2013; Voelzmann et al. 2016). EB3 recruits +TIPs via interactions 
with cytoskeleton-associated protein glycine-rich (CAP-Gly) domains, found in both 
CLIP-170 and p150Glued, the largest subunit of the dynactin complex (Bieling et al. 2008; 
Nirschl et al. 2016; Peris et al. 2006; Weisbrich et al. 2007). Constitutive retrograde 
transport initiation in neurons requires both of these proteins, as well as EB3 or EB1 and 
LIS1 (Lloyd et al. 2012; Moughamian and Holzbaur 2012; Moughamian et al. 2013). 
Specifically, the CAP-Gly domain of p150Glued interacts with EB3 and CLIP-170 
(Moughamian and Holzbaur 2012). EB3 binds to the growing end of dynamic 
microtubules and can recruit CLIP-170, and dynein–dynactin-bound cargoes are 
recruited to the microtubule via the EB3–CLIP-170 complex (Moughamian et al. 2013; 
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Nirschl et al. 2016). This pathway is regulated by phosphorylation, as CLIP-170 
assumes an autoinhibited, inactive conformation when it is phosphorylated in its third 
serine-rich domain (Lee et al. 2010). Thus, local dephosphorylation of CLIP-170 may 
allow temporal control of initiation. The dephosphorylated, active form of CLIP-170 forms 
an extended 135 nm linker that effectively increases the search radius for cargo capture, 
allowing efficient initiation despite the sparse microtubule cytoskeleton in the distal axon 
(Nirschl et al. 2016). 
 
If this were the sole mechanism of enhanced transport initiation, most retrograde 
transport initiation would be confined to the distal 1–2 μm of dynamic microtubules. An 
additional, non-exclusive pathway takes advantage of the spatial enrichment of 
tyrosinated α-tubulin in the distal axon (Nirschl et al. 2016). The C-terminal EEY motif of 
tyrosinated α-tubulin binds CAP-Gly-domain proteins such as p150Glued and CLIP-170 
with high affinity (Bieling et al. 2008; Peris et al. 2006; Weisbrich et al. 2007). Thus, 
dynactin can bind directly and robustly to the tyrosinated microtubule lattice (McKenney 
et al. 2016; Nirschl et al. 2016). CLIP-170 also binds preferentially to tyrosinated 
microtubules (Bieling et al. 2008; Nirschl et al. 2016), further enhancing the robust 
association of the retrograde cargo with the microtubule. Together, these mechanisms 
combine to provide robust and spatially specific regulation of transport initiation in the 
distal axon terminal. 
  
35 
1.4.4.3. Actin and myosin in the axon terminal 
The axon terminal is rich in a dynamic population of actin that is most often studied in 
the context of the developing growth cone and the mature presynaptic terminal. 
Interestingly, a recent study found that this population of distal actin is resistant to actin 
depolymerization by cytochalasin D and latrunculin B, as all conditions showed dense F-
actin patches in approximately half of hippocampal neurites (Chia et al. 2016). Actin is 
also concentrated in the presynaptic terminal of mature neurons, where it acts as a 
scaffold to dock vesicles (Sankaranarayanan et al. 2003) and coordinates 
neurotransmitter release and recycling (Cingolani and Goda 2008). Myosin II is 
implicated in neurotransmitter release at presynaptic terminals, whereas myosin VI and 
PDZ domain-containing protein GIPC1 may coordinate synaptic vesicle recycling and 
endocytosis (Kneussel and Wagner 2013). Additional studies are required to elucidate 
how actin and myosin regulate trafficking in the axon terminal as well as how actin-
based transport interfaces with microtubule-based transport. The transition between 
microtubule- and actin-based transport is likely to be critical for retrograde transport, as 
discussed above, as actin depolymerization is required for the retrograde flux of 
neurotrophic factor signaling endosomes (Harrington et al. 2011). 
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2. CHAPTER 2: Live-cell imaging of retrograde transport 
initiation in primary neurons2 
 
                                                
2 This chapter is adapted from: 
Nirschl, J. J., & Holzbaur, E. L. F. (2016). Live-cell imaging of retrograde 
transport initiation in primary neurons. In K. K. Pfister (Ed.), The Neuronal 




Axonal transport is an essential function in neurons, as mutations in either motor 
proteins or their adaptors cause neurodegeneration. While some mutations cause a 
complete block in axonal transport, other mutations affect transport more subtly. This is 
especially true of mutations identified in human patients, which impair but do not block 
motor function in the cell.  Dissecting the pathogenic mechanisms of these more subtle 
mutations requires assays that can tease apart the distinct phases of axonal transport, 
including transport initiation, sustained/ regulated motility, and cargo-specific sorting or 
delivery. Here, we describe a live-cell photobleaching assay to assess retrograde flux 
from the distal axon tip, a measure for distal transport initiation. We have previously 
used this method to show that the CAP-Gly domain of DCTN1 is required for efficient 
retrograde transport initiation in the distal axon, but it is not required to maintain 
retrograde flux along the mid-axon.  This approach has allowed us to examine the 
effects of disease-causing mutations in the axonal transport machinery, and in 
combination with other assays, will be useful in determining the mechanisms and 




The development of video-enhanced microscopy (Allen et al. 1981; Inoue 1981) allowed 
the first direct visualization of organelle motility in squid axons (Allen et al. 1982) and 
extruded squid axoplasm (Brady et al. 1982). This was followed by the discovery of the 
microtubule motors kinesin-1 (Vale et al. 1985a) and cytoplasmic dynein (Paschal and 
Vallee 1987), which were later identified as the motors driving anterograde (Hirokawa et 
al. 1991) and retrograde (Hirokawa et al. 1990) transport, respectively. Since then, live-
cell imaging and neuron culture have continued to play a critical role in our 
understanding of axonal transport. Here, we will focus on cytoplasmic dynein and the 
dynactin complex, which form the primary motor complex responsible for long-distance 
retrograde axonal transport. 
 
Cellular studies examining the mechanisms of dynein-mediated retrograde transport 
have been complemented by genetic approaches, which have identified mutations in 
dynein/ dynactin and other adaptors or cytoskeleton associated proteins in a number of 
neurodevelopmental and neurodegenerative diseases, reviewed in (Maday et al. 2014; 
Perlson et al. 2010). Approaches to study the effects of these mutations at the cellular 
level have involved overexpressing wild type or mutant protein and visualizing the axonal 
transport of fluorescently labeled proteins/ vesicles. These approaches have been 
successful in identifying mutations that cause gross disruption of axonal transport. 
However, since dynein and many other cytoskeletal proteins have essential functions in 
all cells (e.g. the essential role of dynein/ dynactin in mitosis), mutations that cause 
complete loss of function are embryonic lethal. Thus, mutations that persist into 
adulthood and cause late-onset neurodegenerative diseases likely cause subtle defects 
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or target specific phases of axonal transport, such as transport initiation, sustained/ 
regulated motility, or cargo-specific sorting or delivery. 
 
Here, we describe an assay to measure retrograde flux from the distal axon. Using this 
assay, we confirm that the N-terminal Cytoskeletal-associated Protein Glycine-rich 
(CAP-Gly) domain of dynactin is required for retrograde transport initiation, but is not 
required for mid-axonal transport maintenance (Lloyd et al. 2012; Moughamian and 
Holzbaur 2012). This assay, and the development of additional novel assays that are 
sensitive to distinct phases of axonal transport will be useful in determining the 
pathogenic mechanisms of subtle, novel mutations in motor proteins, adaptors, or their 
associated cytoskeletal components. 
 
2.3. Methods 
2.3.1. Primary neuron culture 
Imaging organelle and vesicle dynamics in primary neuron cultures is a well-established 
method to probe the molecular mechanisms of axonal transport. We use mouse dorsal 
root ganglion sensory neurons as a robust system to examine the effects of mutations in 
motor proteins or their adaptors on axonal transport. Results from DRG neurons have 
been corroborated in other neuronal subtypes using the photobleaching approach. Here 
we focus on the photobleaching assay and analysis of transport initiation. For more 
information on neuron isolation, enrichment, and culture please refer to any of the recent 
protocols on the topic (Kaech and Banker 2006; Malin et al. 2007; Skaper 2012).  
40 
2.3.2. Live-cell imaging 
2.3.2.1. Materials 
• Neurons transfected with fluorescently-tagged proteins of interest, cultured in glass-
bottomed dishes. 
• Glass bottomed dish for live-cell imaging. We use 35mm Fluorodish (FD35-100) or 
Mat-Tek (P35G-1.5-20-C) glass bottomed dishes. 
• Inverted microscope. 
• Spinning disk confocal equipped with a photobleaching module. 
• Controller software: Volocity (PerkinElmer), MetaMorph (Molecular Devices), or 
µManager. 
• Hibernate A low fluorescence medium (BrainBits) 
• B27 Supplement (Gibco 17504-44) 
• GlutaMAX supplement (Invitrogen 35050061) 
 
2.3.2.2. General considerations for photobleaching assays 
• It is important to calibrate the photobleaching module prior to each imaging 
session, especially if multiple users are using the same microscope or if the 
photobleaching module has not been used recently. To calibrate the system, take 
a uniformly fluorescent test slide or sample and select a region of interest (ROI) 
using your integrated microscope manager software. Bleach the test slide/ 
sample and compare the area of photobleaching with your ROI. If the system is 
calibrated, the ROI and bleached region should completely overlap with minimal 
bleaching outside your ROI. If not, re-calibrate the photobleaching module 
according to your system’s User Manual. 
• Prior to starting the experiment, perform test experiments to determine: 
o the minimal laser power and photobleaching cycles required to bleach a 
region of axon. 
o the frame rate required to capture the dynamics of your labeled protein. 
o the image acquisition settings (exposure, gain, sensitivity, laser power) 
and duration of time-lapse imaging. 
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2.3.2.3. Setup of photobleaching and image acquisition 
• In your microscope manager software, set up a new image acquisition protocol in 
the photobleaching module. Set the desired number of photobleaching cycles, 
laser power, and frame rate (frames per second or fps). When using LAMP-1-
RFP, a marker of late endosomes/ lysosomes, we use 25 photobleaching cycles 
at 100% laser power and a frame rate of 3fps post-bleaching. 
• Set the camera to acquire time-lapse series pre-bleach and another series post-
bleach. For LAMP-1-RFP vesicles, which exhibit rapid, bidirectional transport, we 
use at least 5- 10 seconds pre-bleach and 120 seconds post-bleach. These 
settings will depend on the fluorescently labeled protein. 
• Next, prepare your transfected neurons for imaging. Gently remove the neuron 
culture media and replace with 37°C, low fluorescence imaging media pre-
equilibrated in CO2 (Hibernate A + 2% B27 supplement + 2mM Glutamax). 
• Transfer the live-cell dish onto the stage and get the coverslip into focus. 
• Next, find the cell body or axon of a healthy, low expressing neuron. Manually set 
the contrast to a window where the relative level of fluorescent protein 
expression is easily visualized. Avoid cells that appear saturated due to very high 
expression of fluorescent protein. 
•  Trace the axon to the distal axon terminal, adjusting the Z focus to follow the 
axon as it moves over/ under non-transfected neurons. After identifying the distal 
axon, capture a static image. Next, use the “measure” tool to trace 10 µm 
proximal to the distal axon tip and draw an ROI to photobleach. When we image 
at 100X, we draw an ROI beginning 10 µm proximal to the distal axon and 
extending retrograde 40 µm toward the cell body. We find that photobleaching is 
much faster with small, thin, rectangular ROIs than with freehand ROIs. 
• Acquire images using the protocol described above. 
• In the same neuron, move at least 100 -150 µm proximal from the distal axon tip 
and acquire a time-lapse movie from the mid-axon. We recommend imaging 
paired distal and mid-axons to compare distal transport initiation with mid-axonal 
retrograde flux within the same neuron. Record the neuron and the orientation of 




Figure 2.1 Schematic overview of the approach used in the photobleaching assay. 
(A) Primary neuron culture. (B) Live cell photobleaching assay in paired distal and mid-
axon segments. Red circles represent fluorescently labeled LAMP-1-RFP vesicles. (C) 
Kymograph analysis: representative kymographs from the distal axon of wild type DRG 
neurons shows the tracks of vesicles that recently initiated retrograde transport from the 
axon tip. The arrowhead and dotted line in the schematic indicate the pre-defined 
distance threshold for analyzing retrograde flux. Only retrograde-moving vesicles were 
traced. 
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2.4. Data Analysis 
We use manual kymograph analysis to measure retrograde flux in this assay. A 
kymograph is a 1 dimensional projection of the fluorescent intensity along the long axis 
of the axon over time. The X-axis is the distance along the axon and the Y-axis is the 
time elapsed. The primary output of this analysis is the vesicles per minute that have 
moved retrograde into the bleached region a specified distance (retrograde flux). In the 
distal axon, just before the axon tip or growth cone, this provides a measure of the 
number of vesicles starting transport and moving retrograde. 
 
2.4.1. Materials 
• ImageJ (NIH) or other image processing software (e.g. Volocity, MetaMorph) 
• Open source kymograph analysis tools: 
o Icy (http://icy.bioimageanalysis.org/) 
o KYMOMAKER (http://www.pharm.hokudai.ac.jp/shinkei/Kymomaker.html) 
o KymographDirect (https://www.nat.vu.nl/~erwinp/downloads.html) 
 
2.4.1.1. Kymograph analysis of retrograde flux 
• Draw a 1 pixel wide segmented line along the axon beginning with the distal 
region of the bleached ROI and extending proximally toward the soma. Save the 
ROI line selection or take an RGB reference image indicating where the line was 
drawn. 
• Generate a kymograph with time displayed on the Y-axis. In ImageJ, use the 
‘MultipleKymograph’ plugin. 
• Determine the point at which you will measure retrograde flux. In our analysis, we 
make a line ~50 pixels (3-4 microns with a 100x objective) retrograde from the 
distal end of the ROI. 
• Trace the cargo trajectories using automated kymograph tracing tools such as 
Icy (de Chaumont et al. 2012), KYMOMAKER (Chiba et al. 2014), or 
KymographDirect (Mangeol et al. 2016) or manual tracing. Kymographs with low 
signal to noise ratios or high cargo density may require manual tracing. Then, 
count the total number of vesicles crossing this distance threshold vertical line. 
This represents the Retrograde Flux (vesicles·min-1) in an axonal region. In the 
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distal axon, this measurement represents the number of vesicles initiating from 
the distal axon. 
• Repeat the process for the mid-axon and compare whether there is selective 
disruption of distal retrograde flux vs. mid axonal flux. 
 
2.5. Conclusions 
Here we describe a photobleaching assay to analyze retrograde flux in the distal axon, 
as a measure of retrograde transport initiation. We have previously used this approach 
to show that the CAP-Gly domain of dynactin is required for efficient retrograde transport 
initiation from the distal axon (Moughamian and Holzbaur 2012; Moughamian et al. 
2013). This assay may be applied to study the role of dynein, dynactin, or other 
microtubule plus-end binding in retrograde transport initiation and to investigate how 
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45 
3. CHAPTER 3: Alpha-tubulin tyrosination and CLIP-170 phosphorylation 
regulate the initiation of dynein-driven transport in neurons3 
 
                                                
3 This chapter is adapted from: 
Nirschl JJ, Magiera MM, Lazarus JE, Janke C, Holzbaur ELF. α-Tubulin 
Tyrosination and CLIP-170 Phosphorylation Regulate the Initiation of Dynein-




JJN and ELFH designed experiments. JJN performed experiments and analyzed 
data. All authors reviewed and analyzed data. MMM purified tubulin from HeLa 
cells. JEL purified recombinant proteins. JJN and ELFH wrote the paper, with 
contributions from all authors. 
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3.1. Abstract 
Motor-cargo recruitment to microtubules is often the rate-limiting step of intracellular 
transport, and defects in this recruitment can cause neurodegenerative disease. Here, 
we use in vitro reconstitution assays with single molecule resolution, live-cell transport 
assays in primary neurons, computational image analysis and computer simulations to 
investigate the factors regulating retrograde transport initiation in the distal axon. We find 
that phosphorylation of the cytoskeletal-organelle linker protein CLIP-170 and post-
translational modifications of the microtubule track combine to precisely control the 
initiation of retrograde transport. Computer simulations of organelle dynamics in the 
distal axon indicate that while CLIP-170 primarily regulates the time to microtubule 
encounter, the tyrosination state of the microtubule lattice regulates the likelihood of 
binding. These mechanisms interact to control transport initiation in the axon in a 




Microtubule-based transport by molecular motors is essential in most eukaryotic cells. 
One of the first steps in transport is to recruit motor-cargo complexes to microtubules. 
This process can be regulated at multiple levels, including the motor, motor adaptors, 
microtubule associated proteins (MAPs), or the microtubule track itself. How the cell 
integrates these multiple layers of regulation to allow precise spatial and temporal 
control of transport initiation is not yet understood. 
 
The specialized morphology of neurons renders these cells particularly dependent on 
the precise regulation of transport initiation. Due to the uniform plus-end out orientation 
of microtubules in the axon, the dynein-dynactin complex is the primary motor driving 
retrograde transport from the distal axon toward the cell soma. Efficient loading of 
dynein-dynactin-bound cargos is crucial for neuronal survival, as mutations in dynein or 
dynactin cause neurodegeneration in mice and humans (Maday et al. 2014). More 
specifically, mutations in the highly conserved cytoskeleton-associated protein glycine-
rich (CAP-Gly) domain of the p150Glued subunit of dynactin cause a significant reduction 
of retrograde transport initiation in neurons in vitro and in vivo (Lloyd et al. 2012; 
Moughamian and Holzbaur 2012). In humans, mutations in the CAP-Gly domain of 
dynactin are sufficient to cause a lethal form of parkinsonism known as Perry syndrome 
(Farrer et al. 2009). 
 
The mechanisms controlling the initiation of retrograde transport involve plus-end 
binding proteins or +TIPs (Akhmanova and Steinmetz 2008)  including CLIP-170, 
p150Glued, and end binding proteins EB1 or EB3, collectively referred to as EBs 
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(Moughamian and Holzbaur 2012; Moughamian et al. 2013). Dynein is thought to be 
dynamically recruited to the microtubule plus end via hierarchical interactions of EBs, 
CLIP-170, and p150Glued (Ayloo et al. 2014; Bieling et al. 2008; Dixit et al. 2009; 
Duellberg et al. 2014; Lomakin et al. 2009; Moughamian et al. 2013; Watson and 
Stephens 2006) (Figure 3.1A). Although many of the molecular players in this pathway 
are known, how this recruitment pathway is regulated in neurons is not understood. 
CLIP-170 may serve as one crucial regulatory point, as this protein can link p150Glued to 
EBs, and CLIP-170 binding interactions are regulated by phosphorylation (Lee et al. 
2010; Rickard and Kreis 1991). CLIP-170, the first identified +TIP, was initially 
characterized as a cytoplasmic linker between endosomes and microtubules (Pierre et 
al. 1992; Rickard and Kreis 1996). CLIP-170 can assume a folded, autoinhibited 
conformation when phosphorylated in the third serine-rich domain, or an open 
conformation when dephosphorylated (Lansbergen et al. 2004; Lee et al. 2010). These 
observations led to the hypothesis that CLIP-170 phosphorylation may provide a way to 
dynamically regulate recruitment of vesicular cargo to microtubules; however, direct 
evidence for this model in neurons is lacking.  
 
Post-translational modifications of the microtubule track are another potential 
mechanism to regulate the recruitment of microtubule motors (Wehenkel and Janke 
2014; Yu et al. 2015). In neurons, there is a spatial gradient of tubulin modifications 
along both axons and dendrites (Janke and Kneussel 2010). Intriguingly, the retrograde 
transport initiation zone in the distal axon defined by live cell imaging (Moughamian and 
Holzbaur 2012) coincides with a region enriched for tyrosinated (Tyr) α-tubulin (Brown et 
al. 1993; Robson and Burgoyne 1989). Most α-tubulins are initially synthesized with a C-
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terminal EEY motif, but the terminal tyrosine of this motif can be cleaved by a tyrosine 
carboxypeptidase following assembly of tubulin dimers into the microtubule lattice 
(Kumar and Flavin 1981). The cleavage of the terminal tyrosine to form detyrosinated α-
tubulin (Detyr) can only be reversed following disassembly of the microtubule, as the 
enzyme tubulin tyrosine ligase (TTL) acts on soluble Detyr tubulin dimers (Ersfeld et al. 
1993; Prota et al. 2013). Both CLIP-170 and p150Glued are sensitive to the C-terminal 
tyrosine motif of Tyr-α-tubulin (Bieling et al. 2008; Peris et al. 2006), suggesting that this 
modification may play a role in spatially defining retrograde transport initiation in the 
distal axon, although this hypothesis has not been tested. 
 
Here, we address the regulation of transport initiation using both in vitro reconstitution of 
organelle binding to microtubules and live cell assays in primary neurons. We find that 
the phosphodeficient, open conformation of CLIP-170 effectively promotes transport 
initiation in vitro and in neurons. We also find that isolated neuronal vesicles, in complex 
with motors/ adaptors, show a robust preference for Tyr-microtubules over Detyr-
microtubules. These mechanisms interact, as CLIP-170 phosphorylation levels further 
modulate motor-cargo recruitment to Tyr-microtubules. Together, our observations fit a 
multi-modal recruitment model, where both the microtubule modification status and 
CLIP-170 phosphorylation specifically tune the kinetics of transport initiation to the 
requirements of the cell. Computer simulations of organelle dynamics in the distal axon 
indicate that CLIP-170 primarily regulates the time to microtubule encounter, while the 
tyrosination state of tubulin regulates the likelihood of binding. Together, these 
mechanisms provide spatiotemporal specificity, with spatial regulation controlled by the 
distal gradient of Tyr-microtubules and temporal regulation via control of the 





3.3.1. CLIP-170 comets serve as docking sites for p150Glued vesicles in cells 
Conformational changes in CLIP-170 regulate its association with microtubules and the 
accessibility of the C-terminus for binding to other +TIPs (Lansbergen et al. 2004). 
Phosphomimetic mutations in the third serine rich domain of CLIP-170 promote a closed, 
autoinhibited conformation while phosphodeficient mutations promote an open 
conformation (Lee et al. 2010). We generated phosphomimetic (CLIP-E) and 
phosphodeficient (CLIP-A) constructs by mutating 5 key serine residues to Ala or Glu, 
respectively (Figure 3.1B), and confirmed previous observations (Lee et al. 2010), using 
confocal microscopy to show that CLIP-A decorates microtubule plus end as comets that 
are significantly longer than CLIP-E comets (APPENDIX I, Figure S1A, B). The C-
terminal Zinc knuckle and EEY motif of CLIP-170 are exposed in phosphodeficient CLIP-
A; these motifs can recruit dynactin through a direct interaction with the p150Glued subunit 
(Duellberg et al. 2014; Galjart 2005). Co-expression of CLIP-A with myc-tagged 
p150Glued induces the pronounced localization of p150Glued-positive puncta to CLIP-170 
comets (Figure 3.1C, D). The resulting linear punctate arrays are reminiscent of vesicles 
binding to microtubules (Gill et al. 1991; Vaughan et al. 1999). As in vitro studies have 
shown that the CAP-Gly domain of p150Glued binds directly to CLIP-170 (Weisbrich et al. 
2007), we tested whether the localization of p150Glued puncta to CLIP-170 comets was 
dependent on this interaction by comparing the localization of wild type p150Glued to that 
of a G71R point mutation in the CAP-Gly domain. This mutation is causative for the 
lethal neurodegenerative disease known as Perry syndrome (Farrer et al. 2009), and 
acts as a loss-of-function mutation for the CAP-Gly domain (Moughamian and Holzbaur 
2012). As shown in Figure 3.1C, D, the recruitment of myc-tagged p150Glued-positive 
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puncta to CLIP-A comets observed in cells expressing wild type p150Glued was abolished 




Figure 3.1 CLIP-170 comets serve as docking sites for p150Glued vesicles in cells. 
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(A) Deconvolved max projection STED image of microtubules in the neuronal growth 
cone with the cell border outlined in white (left). Schematic of the recruitment of dynein-
dynactin organelles in the neuronal growth cone (right). (B) Schematic of p150Glued 
(above) showing the CAP-Gly, basic (+), and coiled-coil domains. Schematic of CLIP-
170 with relevant CAP-Gly, Ser rich, coiled-coil, and Zinc knuckle (Zn) domains. The 
phosphorylation sites (S-309, -311, -313, -319, -320) and phosphomutant constructs are 
shown below. (C) Confocal slices of COS-7 cells co-transfected with HT-CLIP-A and 
either full-length myc-p150Glued WT or G71R (above). Upsampled images of individual 
comets show punctate p150Glued associated with CLIP-A comets (below). The dashed 
white lines denote where line profiles were performed in D. (D) Line intensity profiles 
along upsampled images in C. (E) 3D-STORM super-resolution was used to image 
microtubules in fixed COS-7 cells (Movie S1). Shown are cropped microtubule plus ends 
from the two different conditions. CLIP-A (magenta) fully decorates the plus end as 
comet like structures and discrete p150Glued clusters associate with the CLIP-A comet 
(tubulin is unlabeled in these images). This shows that these p150Glued puncta form 
discrete punctate structures (white arrowhead) on CLIP-A comets; the morphology of 
these punctae are consistent with a vesicular population. In addition, there is a separate 
population of point-localized individual p150Glued molecules (gray arrowhead). (F) 
Histogram of the maximum equatorial diameter for of ellipses manually fit around 




To better visualize the population of p150Glued-positive puncta in cells, we used direct 
Stochastic Optical Reconstruction Microscopy (dSTORM) super-resolution microscopy. 
This approach more clearly revealed discrete clusters of localized p150Glued associated 
with CLIP-A comets (Figure 3.1E, S1D, Movie S1). Using dSTORM, we measured the 
size distribution of p150Glued-positive puncta, and found a mean diameter of 103±2nm 
(Figure 3.1F); parallel analysis on STED-acquired images resulted in an average 
diameter of 106±3nm. These measurements are very similar to the 90nm diameter 
determined for isolated dynactin-positive neuronal vesicles as measured by EM 
(Hendricks et al 2010). Thus, a population of p150Glued-positive vesicles dock at CLIP-
170 comets in cells; this docking requires an intact CAP-Gly domain. 
 
3.3.2. Reconstitution of CLIP-170 dependent organelle recruitment in vitro 
To study the regulation of organelle recruitment by CLIP-170 phosphorylation at the 
single molecule level, we moved to an in vitro system using neuronal vesicles isolated 
from the brains of p50-EGFP transgenic mice (Hendricks et al. 2010; Ross et al. 2006) 
visualized with single molecule total internal fluorescence (TIRF) microscopy. Vesicles 
co-purify with an endogenous complement of dynein, dynactin, and kinesins (APPENDIX 
I, Figure S2), are positive for markers of late-endosomes/ lysosomes (Rab7/ LAMP-1) 
but not early endosomes (Rab5), and exhibit dynein-dependent motility in vitro 
(Hendricks et al. 2010). To mimic recruitment of organelles to the GTP-like microtubule 
lattice at the plus end, we used Guanosine-5'-[(α,β)-methyleno]triphosphate (GMPCPP) 
stabilized microtubules (Alushin et al. 2014) that specifically recruit +TIPs including EB1 
and CLIP-170 (Dixit et al. 2009; Lopez and Valentine 2016; Zanic et al. 2009), and 
provide a stable landing platform more tractable for automated analysis of landing rates 
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than dynamic microtubules. To this, we added purified recombinant unlabeled EB1 and 
high speed supernatant (HSS) from COS-7 cells transfected with either HaloTag (HT) 
CLIP-A or CLIP-E, or HSS from mock-transfected cells (Mock-HSS)(Figure 3.2A). As 
endogenous CLIP-170 is not enriched on our vesicle population (Figure 3.2B), it likely 
functions as a cytosolic accessory factor. To ensure equal levels of HT-CLIP in the 
assay, we measured the absorbance of the TMR-labeled protein (APPENDIX I, Figure 
S3A, B); HT-CLIP levels were further confirmed by Western blotting (APPENDIX I, 
Figure S3C). 
 
To analyze landing rates of vesicles loading onto microtubules, we applied unbiased, 
whole-field multi-particle tracking using uTrack software (Jaqaman et al. 2008) to track 
particles, map their starting coordinates to microtubule masks, and measure landing 
rates and dwell times (APPENDIX I, Figure S3F). Representative kymographs of p50-
GFP-vesicles show processive, bidirectional, or confined motility, defined by mean 
squared displacement (Figure 3.2C). p50-GFP-vesicles with EB1 in the absence of 
exogenous CLIP-170 show a low, basal rate of microtubule landing (Figure 3.2D). In the 
presence of EB1+CLIP-A, vesicles show a 2-fold enhancement of the landing rate, an 
effect not seen in any other condition (Figure 3.2E). Importantly, however, dwell times 
were not significantly different among conditions, suggesting that the increased 
recruitment induced by CLIP-A does not affect the characteristic dwell time of the motor-




Figure 3.2 Reconstitution of CLIP-170 dependent organelle recruitment in vitro. 
(A) Schematic of in vitro reconstitution assay with p50-GFP-vesicles, EB1, and CLIP-A 
or CLIP-E in COS-7 cell extract HSS. (B) Western blot of fractions from neuronal vesicle 
isolation from mouse brain shows p150Glued and DIC are enriched in the vesicle fraction. 
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Most of the CLIP-170 is retained in the low speed pellet and only a faint band for 
endogenous CLIP-170 is found in the vesicle fraction. Cytosolic marker GAPDH is not 
enriched in the vesicle fraction. (C) Representative kymographs of p50-GFP-vesicles on 
GMPCPP microtubules show that they exhibit processive, bidirectional, and confined 
motility, as defined by mean squared displacement analysis of particle trajectories. (D) 
Representative kymographs of p50-GFP-vesicles on single GMPCPP microtubules from 
each of the three conditions (100nM EB1 + Mock-HSS or CLIP-A or CLIP-E in motility 
assay buffer). The estimated final concentration of TMR-labeled HT-CLIP in this assay 
was ~100nM. EB1 + Mock-HSS and EB1 + CLIP-E show a basal landing rate, whereas 
there is an increase in organelle recruitment with CLIP-A. At least three different 
preparations of cell lysates were used. (E) Quantification of the landing rates in each of 
the experimental conditions shows a significant increase in organelle recruitment only 
with EB + CLIP-A (n >= 22 movies per condition with each movie with > 500 events per 
movie; N >= 3 independent vesicle isolations; Kruskal-Wallis (KW) one-way ANOVA with 
Tukey post-tests) (F) Empirical cumulative distribution function (CDF) for microtubule 
dwell times of all non-fixed particles. The stair plot starts at 0.1s as this is the minimum 
observable dwell time. Double exponential fit obtained via Maximum Likelihood 
Estimation (MLE) with 100 bootstrapped fits to obtain 95% CI. The dwell time 
distributions for Mock-HSS, CLIP-A, CLIP-E were compared in pairs using a two sample 
Kolmogorov-Smirnov (KS) test with a Bonferroni correction (p > 0.20 for all comparisons; 
n > 1500 particles per condition; N >= 3). 
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3.3.3. CLIP-170 phosphorylation state modulates retrograde transport initiation in 
neurons 
Next, we used live-cell imaging of primary dorsal root ganglion (DRG) sensory neurons 
to test whether the phosphorylation state of CLIP-170 regulates retrograde transport in 
the distal axon (Moughamian and Holzbaur 2012). We depleted endogenous CLIP-170 
using siRNA, and expressed siRNA-resistant WT or phosphomutant forms of CLIP-170. 
To visualize retrograde transport we also expressed LAMP-1-RFP. To unambiguously 
measure retrograde transport initiation, we photobleached a 40µm region of axon 10µm 
proximal to the distal growth cone tip, then measured the flux of LAMP-1-RFP organelles 
moving in the retrograde direction from the growth cone into the bleached region (Figure 
3.3A). CLIP-170 knockdown reduces distal initiation (Figure 3.3B). As previously noted, 
the effect of CLIP-170 knockdown on distal initiation is specific, as it does not 
significantly alter retrograde flux along the mid-axon (Moughamian et al. 2013). 
Quantitative analysis of OregonGreen-labeled CLIP rescue constructs demonstrated that 
all expressed to similar levels (APPENDIX I, Figure S4), but strikingly, only expression of 
either CLIP-WT or CLIP-A was capable of rescuing transport initiation to normal levels 
following CLIP-170 knockdown. In contrast, CLIP-E only partially rescued the deficit 
caused by loss of endogenous CLIP-170 expression (Figure 3.3B, C; Table S1). 
Importantly, the number of vesicles in the growth cone was comparable across all 
conditions, indicating that the decreased flux observed in the knockdown and CLIP-E 
rescue experiments was not due to depletion of the distal vesicle pool, nor do we see a 
deficit in anterograde transport (Figure 3.3D). Thus, consistent with our in vitro results, 






Figure 3.3 CLIP-170 phosphorylation state modulates retrograde transport 
initiation in neurons. 
(A) Schematic of live-cell assay for retrograde transport initiation in neurons. (B) 
Representative kymographs for each condition with a schematic tracing of the analyzed 
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vesicles to the right. The dashed red line indicates 3.5µm from the distal end of the 
bleaching ROI and is the site for flux analysis. (C) Quantification of retrograde flux for all 
conditions. CLIP-170 knockdown reduces the efficiency of retrograde flux and this is 
rescued by CLIP-WT or CLIP-A, but CLIP-E shows incomplete rescue (n= 18-36 
neurons total, N > 3 experiments; KW ANOVA with Tukey post-tests). A complete list of 
the pairwise post-tests is shown in Table S1. (D) Quantification of the number of LAMP-
1-RFP vesicles in the growth cone at the start of the movie shows a comparable 
distribution of vesicles indicating that the reduced retrograde flux in the siRNA or siRNA 
+ CLIP-E is not due to a reduced distal vesicle pool. 
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3.3.4. The distal axon is rich in tyrosinated α-tubulin 
The retrograde transport initiation zone observed in our live-cell experiments is 
coincident with the region of the distal axon thought to be enriched for tyrosinated α-
tubulin (Brown et al. 1993; Robson and Burgoyne 1989). We used super-resolution 
imaging to more precisely map the tyrosination state of α-tubulin along the axon. 
Stimulated Emission Depletion (STED) imaging of the distal axon of cultured DRG 
neurons shows a profound enrichment of Tyr-tubulin over Detyr-tubulin distally (Figure 
3.4A,B). We measured the Tyr/Detyr gradient, which stretches ~20μm from the axon tip 
and then decreases moving proximally toward the cell body (Figure 3.4C). This gradient 
correlates spatially with the distal loading zone observed in live cell assays, and in 
conjunction with previous observations that p150Glued puncta preferentially localize to 
tyrosinated microtubules in nonpolarized cells (Peris et al. 2006; Vaughan et al. 1999) 




Figure 3.4 The distal axon is rich in tyrosinated α-tubulin. 
(A) STED super-resolution images of the distal axon shows an enrichment of tyrosinated 
α tubulin (white arrowhead distal axon; gray arrowhead ~30µm proximal to the distal 
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axon tip) (B) Detyrosinated α tubulin is enriched in the proximal axon, relative to 
tyrosinated α tubulin. The white arrowhead shows the first axonal branch point after 
exiting the cell body. The cell body was identified by morphology, but is not shown in 
these images. (C) Bootstrapped mean and 95% CI for line intensity profiles of Tyr/ Detyr 
in the distal axon (n = 4 neurons per condition, 10 line profiles per neuron; N = 2). The 
blue line indicates a ratio of 1. The images for Tyr or Detyr staining represent paired 
images where the Tyr distal axon in A is from the same neuron as the Tyr cell body 
staining in B with the same true for Detyr. Representative paired images were chosen 
from >4 images per condition, per experiment of similar quality. 
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3.3.5. Tyrosinated α-tubulin promotes robust organelle recruitment in vitro 
We directly compared the recruitment of organelles to Tyr- and Detyr-microtubules using 
an in vitro reconstitution assay (Figure 3.5A). Tubulin purified from HeLa cells is primarily 
tyrosinated; brief treatment with Carboxypeptidase A (CPA) produces a population highly 
enriched in Detyr tubulin (Figure 3.5B) (Barisic et al. 2015; Kreitzer et al. 1999). 
Microtubules were polymerized from either Tyr- or Detyr-tubulin and GMPCPP, and 
differentially labeled with AF-647- and TRITC-conjugated tubulin at a low ratio (5%); 
there was no significant difference in length between Tyr/ Detyr-microtubules 
(APPENDIX I, Figure S5A). Labeled Tyr- and Detyr-microtubules were flowed into the 
same chamber, allowing the simultaneous measurement of landing rates.  
 
Kymographs of interactions of p50-GFP-vesicles with Detyr-microtubules show a low 
basal landing rate (Figure 3.5C), similar to landing rates observed with microtubules 
polymerized from bovine brain tubulin (Figure 3.2E). In contrast, we observed a more 
than 4-fold increase in the landing of p50-GFP vesicles onto Tyr-microtubules (Figure 
3.5D Movie S2). The choice of fluorescent label did not affect our observations, as the 
reversing the labels on Tyr-/ Detyr-microtubules did not affect the results (APPENDIX I, 
Figure S5 B-D, Movie S3). Importantly, we found that despite the marked differences in 
landing rates, dwell times for vesicles bound to either Tyr- or Detyr-microtubules were 
very similar. Thus, the mechanisms that promote recruitment to the microtubule are 





Figure 3.5 Tyrosinated α-tubulin promotes robust organelle recruitment in vitro. 
(A) Schematic of the p50-GFP-vesicle recruitment assay using GMPCPP stabilized Tyr-/ 
Detyr-microtubules labeled separately with either 5% AF-647 or TRITC. (B) Western of 
Tyr/ Detyr tubulin purified from HeLa cells shows a homogenous population of fully 
tyrosinated or fully detyrosinated tubulin, compared to brain tubulin. (C) Representative 
kymographs of p50-GFP-vesicle landing on Detyr versus Tyr microtubules. (D) 
Quantification of landing rate shows a robust and significant increase in landing rate on 
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Tyr microtubules (n = 70 movies per condition, each movie with > 500 events; N = 3 
independent vesicle isolations; Wilcoxon Rank-Sum test p < 1x10-10). (e) Empirical CDF 
for microtubule dwell times of all non-fixed particles with double exponential fit and 95% 
CI for fit parameters. The dwell time distributions for vesicles on Tyr or Detyr 
microtubules were compared using a two sample KS test (p = 0.07; n > 1x104 particles 
per condition, N = 3). 
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3.3.6. CLIP-170 phosphorylation regulates recruitment to Tyr-microtubules 
CLIP-170, with two tandem CAP-Gly domains per monomer (four per dimer complex), is 
also sensitive to Tyr-tubulin, and preferential recruitment of CLIP-170 to Tyr-
microtubules has been shown in cells and in vitro (Bieling et al. 2008; Peris et al. 2006). 
However, it is not known how phosphorylation affects the binding of CLIP-170 to Tyr-
tubulin. Using single molecule TIRF microscopy, we measured the landing rates on Tyr-/ 
Detyr-microtubules for TMR-HT-labeled CLIP-WT, CLIP-A, and CLIP-E expressed in cell 
lysates. Constitutively active kinesin-1 motor domain fused to a TMR-HT (CA-Kinesin-
1[560]) was used as a control; we saw robust localization to both Tyr- and Detyr 
microtubules. 
Maximum intensity projection images over time show colocalization of CLIP-WT and 
CLIP-A with Tyr-microtubules, but little binding to Detyr-microtubules (Figure 3.6A). 
CLIP-E was recruited poorly to either Tyr- or Detyr-microtubules. Quantification of 
landing rates confirms that CLIP-WT and CLIP-A show a significant preference for Tyr-
microtubules (Figure 3.6B, Table S2). Although CLIP-E retains a significant preference 
for Tyr, its landing rate is significantly reduced relative to CLIP-WT or CLIP-A 
(APPENDIX I, Table S2). The landing rates for CA-Kinesin-1[560] were similar on both 
Tyr- or Detyr-microtubules, confirming that sensitivity to Tyr- microtubules is not a 





Figure 3.6 CLIP-170 phosphorylation regulates recruitment to Tyr-microtubules. 
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(A) Image of max intensity projection over time shows selective localization of CLIP-WT 
and CLIP-A to Tyr microtubules. CLIP-E shows reduced localization to Tyr microtubules. 
(B) Quantification of landing rate on Tyr- or Detyr- microtubules shows a significantly 
increased landing rate of CLIP-WT and CLIP-A on Tyr-microtubules. CLIP-E retains a 
significant preference for Tyr-microtubules, but landing is significantly reduced compared 
to CLIP-WT or CLIP-A (a table of all pairwise post-tests is found in APPENDIX I, Table 
S2). Single molecule landing rates for CA-Kinesin-1[560] in cell extracts show no 
differences between Tyr-/ Detyr-microtubules (n > 24 movies per condition, each movie 
with > 500 events; N = 3 independent cell lysate preparations; KW ANOVA with Tukey 
post-tests). The estimated final concentration of TMR-labeled HT-CLIP in this assay was 
~0.5nM for HT-CLIP constructs or 2.5nM for CA-Kinesin-1[560]. (C) Image panel for 
ensemble recruitment assay using 100nM purified proteins. Faint GFP-p150[1-210] signal 
is present on Detyr microtubules and is likely mediated by the low affinity basic 
microtubule binding domain. (D) Quantification of the median normalized GFP 
fluorescent intensity per microtubule. The gray rectangle indicates the 95% CI for the 
median normalized GFP intensity for areas with no microtubules in each condition (n > 
100 microtubules per condition; N = 3; KW ANOVA with Tukey post-tests). No 
exogenous EB1 was added in the experiments shown in Figure 3.6A–D. 
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3.3.7. p150Glued CAP-Gly is a major factor on vesicles for sensing Tyr-α-tubulin 
To further define the domains involved in recruitment, we tested the specificity of purified 
recombinant constructs of CLIP-170 and p150Glued (APPENDIX I, Figure S6) for binding 
to Tyr- and Detyr-microtubules, in comparison to the motor domain of kinesin-1. We find 
that the N-terminal H2 fragment of CLIP-170 and the N-terminus of p150Glued [1-210] are 
both robustly sensitive to the tyrosination state of the microtubules (Figure 3.6C,D), 
consistent with previous results (Bieling et al. 2008; Peris et al. 2006). Importantly, we 
find that the ability of p150Glued to sense tubulin tyrosination requires only the CAP-Gly 
domain, as deletion of the low microtubule affinity basic domain does not reduce the 
preference for Tyr-microtubules, while deletion of the CAP-Gly completely abolishes 
microtubule binding (Figure 3.6C). Of the potential CAP-Gly proteins sensitive to tubulin 
tyrosination that we tested, only p150Glued is selectively enriched our vesicle fraction 
(Figure 3.2B). In previous work, we have shown that the CAP-Gly domain of p150Glued is 
the major determinant mediating the initial interaction of neuronal vesicles with the 
microtubule, as vesicle binding is effectively blocked by pre-incubation with a 
monoclonal antibody specific for this domain but not by antibodies to dynein or kinesin 
motors (Hendricks et al. 2010). Thus, we conclude that the CAP-Gly domain of p150Glued 
is likely the major determinant regulating the specificity of neuronal vesicles for 
tyrosinated microtubules. 
 
3.3.8. Simulation of vesicle diffusion and microtubule capture in the distal axon 
Our experimental data indicate that both the phosphorylation state of CLIP-170 and the 
tyrosination state of the microtubule contribute to effective cargo capture. To rigorously 
test our model, we performed Monte-Carlo simulation of vesicle diffusion and 
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microtubule capture using experimentally derived parameters. In the simulation, vesicles 
initiate at random positions in the growth cone and undergo 2D diffusion until they reach 
the microtubule, upon which capture occurs at a pre-specified probability. We model the 
open conformation of CLIP-170 as an extended ~135-nm rod (Scheel et al. 1999) that 
can increase the effective microtubule search radius when bound to the lattice. We 
simulated two extremes, one where CLIP-170 does not decorate the microtubule as a 
model for CLIP-E, and a second scenario assuming full microtubule decoration as model 
for CLIP-A, simulated by dilating the microtubule mask by a disk structuring element of 
radius 135nm. The tyrosination state of microtubules is incorporated into the model by 
altering the normalized binding probability, with binding probabilities of 1 and 0.25 for 
Tyr- and Detyr-microtubules respectively, values empirically determined from vesicle 
landing rates on Tyr- or Detyr-microtubules (Figure 3.5D). To model the diffusion 
constant of vesicles in the cytoplasm we used an empirically determined diffusion 
constant, D, of 0.006µm2/sec (Zajac et al. 2013). However, we also performed parallel 
simulations over a broad range of diffusion constants. For each condition, 1000 vesicles 
were randomly seeded within the growth cones of four different simulation spaces traced 
from experimentally captured STED images. Vesicles were allowed to diffuse for a 
maximum of 20 minutes simulated time and the position of each vesicle was determined 
every 100ms (pseudocode shown in APPENDIX I, Figure S7 A). All simulations for a 
given condition were repeated five independent times for a total of 5000 simulated 
vesicles per neuron (2x104 per condition). 
 
CLIP-A decoration reduces the effective distance to the microtubule compared to CLIP-
E, thus increasing the microtubule search radius. At a binding probability of 1 (Tyr), this 
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dramatically reduced the effective time for microtubule capture of randomly seeded 
vesicles undergoing 2D diffusion (Figure 3.7B). The effect of CLIP-A in reducing the 
median time to microtubule capture holds over three orders of magnitude of diffusion 
constants, from 0.001 – 1.0µm2/sec (Figure 3.7C, Figure S7 B). Strikingly, we found a 
2.4 fold increase in the number of vesicles that never encounter a microtubule over the 
20 min course of the simulation in our models of CLIP-E as compared to CLIP-A 
(APPENDIX I, Figure S7 C). To our surprise, our modeling revealed that decreasing the 
binding probability to 0.25 to mimic binding to Detyr-microtubules had only a modest 
effect on the median time to microtubule capture (Figure 3.7B). We also repeated our 
simulation limiting CLIP-A decoration to the terminal ~2 microns of the microtubule (D = 
0.006µm2/sec). Again, we saw that CLIP-A significantly reduced the median capture 
time, in this case by an average of 5.0s (95% CI 4.8 - 5.1) as compared to CLIP-E. 
Finally, to test the overall utility of our model, we calculated the predicted rate of 
retrograde flux from our simulation. The flux rate observed in our simulation is not too far 
from our measured rates of flux in primary neurons, further supporting the predictive 
power of our modeling (Figure 3.7D). 
 
Thus, both our experimental observations and our simulations are consistent with a 
multi-modal recruitment model, where CLIP-170 phosphorylation and the tyrosination 
state of microtubules regulate transport initiation via interacting pathways. The primary 
role of CLIP-170 is to extend the microtubule search radius, reducing diffusion times in a 
region of the cell characterized by sparse microtubules, while gradient of Tyr-
microtubules provides spatial specificity by promoting efficient organelle recruitment. 
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Figure 3.7 Simulation of vesicle diffusion and microtubule capture in the distal 
axon. 
(A) STED image Tyr-microtubules in the neuronal growth cone with the cell border 
outlined in white (left) and a schematicgrowth cone (right). (B) Median (with 
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bootstrapped 95% CI of the median) for the effective time to microtubule capture in 
computer simulations with CLIP-E or CLIP-A, and either Tyr or Detyr binding 
probabilities (D = 0.006um2/sec). (C) Simulated retrograde flux for four different traced 
neuronal growth cones used in the simulation. In some neurons, CLIP-A decoration 
increases the simulated retrograde flux. (d) Median time to microtubule capture using 
Tyr binding probabilities and a range of diffusion coefficients (also see Figure S7). (e) 
Working model for the regulation of transport initiation in neurons. A gradient of 
tyrosinated α-tubulin is enriched in the distal axon provides spatial regulation and 
promotes efficient binding in a region where many cargos originate. CLIP-170 is highly 
phosphorylated and not microtubule associated in the growth cone at baseline. Transient 
or local dephosphorylation may provide temporal regulation and is required for efficient 




3.4.1. Multi-modal regulation of transport initiation. 
The initial recruitment of motor-cargo complexes to microtubules may be the rate-limiting 
step of intracellular transport, and this process is likely to be regulated for efficient, 
coordinated organelle motility in the cell. Here, we show that CLIP-170 phosphorylation 
regulates organelle transport initiation in vitro and in neurons in a mechanism dependent 
on the canonical plus end tracking EB proteins. In addition, we find regulation at the level 
of the microtubule track, as enrichment of tyrosinated α-tubulin in the microtubule lattice 
also promotes robust organelle recruitment. 
 
Together, these results favor a multi-modal recruitment model where interacting layers of 
regulation promote efficient, robust, and regulated transport. Multi-modal recruitment 
advances the “search-capture” model for recruitment of dynein-dependent cargo 
(Vaughan 2005) in at least two important ways. First, the observation that Tyr-
microtubules preferentially recruit motor-cargo can account for cargo landing anywhere 
along the Tyr microtubule lattice, which extends the potential landing zone up to 20µm 
from the axon tip, a much more extensive zone than the ~1µm EB- comet tails at 
dynamic microtubule plus ends. Thus, spatial regulation of microtubule post-translational 
modifications may account for regional differences in transport at the cellular scale. 
 
Second, layered regulatory interactions allow tuning of transport initiation that may be 
responsive to the specialized cytoskeletal architecture of differentiated cell types. For 
example, cells with sparse microtubules or slow rates of vesicle diffusion may exhibit 
distance-limited transport and rely on CLIP-170-dependent extension of the microtubule 
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search radius to decrease diffusion distance. In contrast, cells with dense microtubule 
networks may exhibit capture-limited transport, relying on a spatially defined enrichment 
of tyrosinated tubulin to increase the binding efficiency of cargo within the microtubule 
search radius. 
 
In the specific case of retrograde transport initiation in the neuron, high levels of Tyr-
tubulin in the distal axon (Brown et al. 1993; Robson and Burgoyne 1989) coincide with 
the region where many essential cargo and signaling factors initiate transport. Although 
we modeled LAMP1-positive vesicles here, all other cargoes we have examined require 
this mechanism for retrograde transport initiation, including Rab5-positive endosomes, 
TrkA/TrkB signaling endosomes, and mitochondria (Moughamian et al. 2013). CLIP-170 
contributes by extending the microtubule search radius in the growth cone, where 
microtubule density is low. This mechanism can be tightly regulated in time, as the 
phosphorylation state of CLIP-170 modulates auto-inhibition and thus allows for 
temporal tuning of the CLIP-170 dependent recruitment pathway. In combination, these 
pathways give robust spatial and temporal control of transport initiation based on cellular 
needs. 
 
3.4.2. CLIP-170 and retrograde transport initiation. 
We propose that the distal pool of CLIP-170 is highly phosphorylated and thus 
preferentially assumes the closed conformation. The transient or local dephosphorylation 
of CLIP-170 would relieve autoinhibition and favor the open conformation that promotes 
efficient transport initiation. Recent large-scale phosphoproteomic studies in mammalian 
tissue indicate that CLIP-170 in brain is highly phosphorylated (Huttlin et al. 2010; Liao 
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et al. 2012), and therefore autoinhibited. The predominance of auto-inhibited CLIP-170 is 
consistent with recent immunofluorescent staining in the Drosophila and mammalian 
neuronal growth cones, where much of either D-CLIP-190 or CLIP-170 was found to be 
soluble or associated with F-actin patches (Beaven et al. 2015). Here, we show that 
dephosphorylation of CLIP-170 is likely to be an important and highly regulated step in 
the initiation of transport in the distal axon. However, CLIP-170 may do more than bind 
microtubules in the distal axon. For example, CLIP-170 interacts with the formin mDia1 
(Lewkowicz et al. 2008), and may facilitate crosstalk between actin and microtubules. 
With respect to axonal transport, the enrichment of CLIP-170 in actin-rich regions of the 
growth cone suggests there may be a pathway to promote efficient translocation of actin-
coated endosomes to microtubules for transport initiation. 
 
3.4.3. Regulation of transport by post-translational modifications. 
In the proposed model, post-translational modifications of microtubules and +TIPs work 
together to regulate transport initiation. Post-translational modifications of microtubules 
have received much attention recently, with a growing catalogue of elements 
contributing to the ‘tubulin code’ (Wehenkel and Janke 2014; Yu et al. 2015). Here, we 
find a dramatic difference in the recruitment of organelles depending on the tyrosination 
state of α-tubulin. At the molecular level, CAP-Gly proteins such as p150Glued and CLIP-
170 are highly sensitive to this modification, shown in (Bieling et al. 2008; Peris et al. 
2006) and this report, while Kinesin-1 recruitment is insensitive to the tubulin tyrosination 
state in our assays, further demonstrating the specificity of the tubulin code. Additional 
support for a key role for α-tubulin detyrosination in regulating retrograde axonal 
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transport comes from (Song et al. 2015),who found that tubulin tyrosine ligase (TTL) is 
important for injury signaling after neuronal damage.  
 
3.4.4. Why do cells need multiple recruitment mechanisms? 
Although cells have evolved multiple mechanisms to promote robust transport initiation, 
it may not be immediately evident why the microtubule binding domains of motor 
proteins alone are not sufficient. Many kinesins are autoinhibited when not bound to 
microtubules, and thus it is not surprising that kinesin-dependent microtubule recruitment 
may require additional factors (Hirokawa et al. 2009). While cytosolic dynein is not 
known to be autoinhibited, recent structural work suggests potential autoinhibitory states 
(Torisawa et al. 2014). But even if dynein were not structurally autoinhibited, dynein's 
microtubule binding interactions are governed by nucleotide concentration, and the high 
cellular ATP levels ( ~1mM) (Rangaraju et al. 2014), favor the weak binding state of 
dynein (Porter and Johnson 1983). These predictions agree with both biochemical and 
immunostaining observations that a significant fraction of dynein is cytosolic (Gill et al. 
1991; Vaughan et al. 1999). Thus, motor-dependent recruitment alone may not be 
sufficient to explain the rapid and robust recruitment of motor-cargo complexes to 
microtubules in cells (Zajac et al. 2013). 
 
3.4.5. Recruitment mechanisms promote landing and then let go. 
Both CLIP-A-dependent recruitment and Tyr-tubulin-dependent recruitment lead to an 
increased landing rate, without significant changes in the distribution of dwell times 
(Figure 3.2 and Figure 3.5). This raises an interesting biophysical question as to how the 
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apparent on-rate for cargo recruitment to the microtubule is increased while the off-rate 
or dwell time is unchanged. In the traditional theory of diffusion-controlled reactions the 
reaction rate is governed by collision frequency and the on-rates do not change while the 
off-rates determine the duration of binding. However, this does not fit the observed data. 
One explanation may be that recruitment mechanisms change the spatial factor for the 
reaction by introducing multiple extended, flexible proteins such as p150Glued or CLIP-
170 to increase the number and types of spatial conformations available for motor-
mediated attachment. Importantly, the in vitro dwell time data agree with evidence from 
axonal transport studies in neurons, where the CAP-Gly domain of p150Glued is important 
for transport initiation in the distal axon, but it is not required to maintain sustained mid-
axonal retrograde transport (Moughamian and Holzbaur 2012; Moughamian et al. 2013). 
This suggests that, although the p150Glued CAP-Gly must be accessible for microtubule 
recruitment, there is a mechanism to disengage the CAP-Gly domain so that it does not 
act as a brake to prevent sustained dynein motility (Ayloo et al. 2014). Recent structural 
work has shown that a subset of purified dynactin complexes have the N-terminus of 
p150Glued folded back on itself, suggesting a structural conformation where the CAP-Gly 
domain is stably disengaged from the microtubule; however the flexibility of this region 
made it difficult to visualize the CAP-Gly domain directly (Chowdhury et al. 2015; 
Urnavicius et al. 2015). The mechanism of disengagement and whether it occurs due to 




3.4.6. Distinct loading mechanisms in the distal versus mid-axon. 
We have previously shown that p150Glued, CLIP-170, and EB1 are required for efficient 
distal transport initiation, but knockdown does not significantly affect mid-axonal 
transport (Moughamian and Holzbaur 2012; Moughamian et al. 2013). Lis1, however, is 
a +TIP required for both distal and mid-axonal transport initiation (Moughamian et al. 
2013). When Lis-1 binds to dynein it induces a stable complex strongly bound to 
microtubules (Huang et al. 2012; Toropova et al. 2014). In the mid-axon, where teams of 
dynein mediate processive retrograde transport (Chowdary et al. 2015), individual motor 
detachment may be followed by Lis1 recruitment, leading to the formation of a stable 
motor-cargo-microtubule complex until transport can resume. Lis1 then likely detaches 
from the motile dynein complexes, as observed in fungi (Egan et al. 2012; Lenz et al. 
2006). However, the requirement of CLIP-170 for distal transport initiation in our assays 
indicates that mechanisms for Lis1-dependent initiation in fungi are insufficient to explain 
transport initiation in neurons. 
3.4.7. Inefficient transport initiation leads to neurodegeneration 
The importance of retrograde transport initiation in neurons is highlighted by the fact that 
mutations in p150Glued that selectively disrupt transport initiation cause human 
neurodegeneration (Farrer et al. 2009; Lloyd et al. 2012; Moughamian and Holzbaur 
2012). Patients with mutations in the CAP-Gly domain develop Perry syndrome, a late-
onset rapidly progressive and fatal Parkinsonism (Wider and Wszolek 2008). In addition, 
patients with nonsense mutations in CLIP-170 develop intellectual disability, seizures, as 
well as other complications (Larti et al. 2015). So what makes neurons especially 
vulnerable to reduced efficiency of transport initiation? First, a number of essential 
cargos initiate transport from the distal axon, including signaling endosomes carrying 
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neurotrophic factors and autophagosomes (Cosker et al. 2008; Maday et al. 2012). 
There is also a lower density of microtubules in the distal axon relative to the axon shaft, 
increasing the distance required for diffusion to microtubules. Further, decreased 
microtubule stability is associated with neurodegenerative diseases (Cartelli et al. 2012; 
Esteves et al. 2010), and tubulin tyrosine ligase expression may decrease with age 
(Gabius et al. 1983); these changes are predicted to further decrease binding efficiency. 
Importantly, the mechanisms regulating transport initiation described here suggest 
potential therapeutic approaches. Modulating either α-tubulin tyrosination or CLIP-170 
activation may boost transport initiation and thus mitigate transport defects. However, 
“more is better” is not the simple motto for retrograde transport initiation, as the disease, 




All animal protocols were approved by the University of Pennsylvania IACUC. 
Protein biochemistry 
Tyrosinated tubulin was purified from Hela S3 cells (ATCC, CCL-2.2) as described 
(Barisic et al. 2015). Carboxypeptidase A (CPA, Sigma C9268, app 6U/mg of tubulin) 
was added to the soluble tubulin to produce detyrosinated tubulin and the tyrosination 
status of the tubulin was verified by Western blot (Figure 3.5B). See the Supplemental 
Experimental Procedures for additional information. 
In vitro reconstitution of microtubule recruitment 
Double-cycled GMPCPP microtubules were polymerized according to (Gell et al. 2010) 
using with 5% labeled tubulin (AlexaFluor-488,-647, or TRITC; Cytoskeleton) and 95% 
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unlabeled tubulin (bovine brain or HeLa tubulin). Cell lysates from COS-7 cells (ATCC, 
CRL-1651) were prepared as follows: cells expressed recombinant HaloTag constructs 
for ~22hours, labeled with TMR-Halo ligand (Promega), and then lysed in 40mM 
HEPES, 120mM NaCl, 0.1% Triton X-100 supplemented with protease inhibitors (2mM 
phenylmethylsulfonyl fluoride, 53µM p-Tosyl arginine methyl ester, 210µM leupeptin, 
1.5µM pepstatin-A). Lysates were clarified by centrifugation at 17K xg and again at 352K 
xg to obtain high speed supernatant (HSS). The relative concentration of TMR-labeled 
protein in cell extracts was determined by measuring the absorbance of TMR at 555nm 
in reference to a standard curve of TMR at known concentrations. EGTA and EDTA 
were excluded from all buffers to maintain the integrity of the CLIP-170 Zn knuckle. 
Motility assays were performed in flow chambers made from silanized (PlusOne Silane, 
GE) #1.5 coverslips (Warner) attached to glass slides using adhesive tape and vacuum 
grease. Typical chamber volumes were ~15µl, incubation times were 5 minutes, and 
chambers were washed with 3-4 chamber volumes between incubations. Following 
incubation with monoclonal anti-β-tubulin (Sigma T5201) diluted 1:200 in Motility Assay 
Buffer (MAB, 10mM PIPES, 50mM K-Acetate, 4mM MgCl2, pH 7.0) and blocking with 
5% pluronic F-127; labeled GMPCPP-stabilized microtubules were introduced; 
chambers were pre-incubated with MAB supplemented with (0.3mg/ml BSA, 0.3mg/ml 
casein, 1mM ATP, 15mg/ml D-Glucose, 10mM DTT); this buffer with supplements also 
served as the ‘assay buffer’ for all in vitro assays except Figure 6C-D where purified CA-
Kinesin-1 was supplemented with 1mM AMP-PNP and no ATP was added to purified 
proteins. Vesicles diluted in assay buffer were added as noted with or without cell extract 
and unlabeled EB1, followed by an oxygen scavenging system (0.5mg/ml glucose 
oxidase, 470 U/ml catalase, and 15mg/ml glucose). All assays with labeled Tyr or Detyr 
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microtubules included an approximately equal number of repeats with the fluorescent 
label for Tyr or Detyr reversed (Figure S5 B-D). 
Vesicles were isolated from B6.SJL.Tg-(Thy1.2-p50-EGFP) mice (Ross et al. 2006), as 
described (Hendricks et al. 2014). For more information, see APPENDIX I. 
 
Cell culture and live-cell imaging 
Dorsal root ganglia were dissected from adult wild type mice, isolated, transfected using 
Amaxa Nucleofector SCN program 6 (Lonza), and cultured for 4 days in vitro (DIV) 
(Moughamian and Holzbaur 2012; Perlson et al. 2009). Live-cell photobleaching and 
imaging of distal retrograde transport initiation was performed according to (Nirschl and 
Holzbaur 2016). For more information, see APPENDIX I.   
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All CLIP-170 knockdown and rescue neurons used for live-cell imaging experiments met 
the following criteria: low expression of recombinant HT-CLIP-170 protein; axonal 
processes extending > 500µm from the cell body; normal axonal contours and 
morphology with no swellings, bulbs, or membrane blebbing; normal mid-axonal LAMP-
1-RFP transport (as shown in (Moughamian et al. 2013)). 
 
COS7 cells were cultured in DMEM media, supplemented with 10% fetal bovine serum 
and 1% L-glutamine. Cells at ~80% confluence were transfected using FuGENE6 
(Roche).  
For immunofluorescence, Cos7 cells were fixed in 4% PFA and neurons were fixed with 
4% PFA/ sucrose for 10 min.  Cells were permeabilized with 0.2% Triton-X100 in PBS 
for 15 min, blocked, and incubated with primary antibodies overnight at 4C, then 
secondary antibody for 1hour at RT. Samples were mounted in Mowiol-488 
(Calbiochem). 
 
Image processing and analysis 
Particle tracking of TIRF images was performed in MATLAB R2015a (Natick, 
Massachusetts) using the open-source uTrack package (v.2.1.3) from the Danuser lab 
(Jaqaman et al. 2008). An initial parameter sweep was conducted to find the optimal 
uTrack parameters for detecting local maxima, multi-Gaussian fitting, track linking, and 
gap closing (Figure S4). For more information, see APPENDIX I. 
 
Distal flux image analysis: Kymographs of LAMP-1-RFP transport initiation were 
prepared using the Kymograph Clear 1.0 ImageJ plugin (Mangeol et al. 2016). Using the 
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mask of the bleached region, a line was automatically generated 50 pixels (~3.5µm) 
retrograde to the distal end of the bleached region for retrograde flux analysis. A vesicle 
counted in the flux measurement if it started distal to the bleached region and moved 
retrograde 3.5µm through the site of flux measurement, regardless of later directional 
reversals. The number of vesicles crossing the flux line was manually counted for every 
neuron, with the analyst blinded to experimental condition. 
Movies 2-4 were processed with the ImageJ (NIH) background subtraction plugin (rolling 
ball, 20pixel radius) for improved visualization. However, all TIRF particle tracking and 
analysis was performed on raw, unprocessed data. Individual line scans in Figure 3.4 
were drawn along the β-tubulin image, Tyr- or Detyr- intensity along this line was 
normalized to β-tubulin intensity for each image, and the normalized Tyr/Detyr ratio was 
smoothed with a sliding window mean filter prior to calculating the bootstrapped mean 
and 95% CI intensity values. MT images in Figure 3.6 were background subtracted using 
the method above for visual clarity. The GFP intensity images (Figure 3.6C) for 
measuring fluorescent intensity were filtered with a Gaussian kernel to reduce the 
contribution of high frequency noise. Where specified, images were deconvolved using 
Huygens Professional. 
 
Simulation of vesicle diffusion and microtubule capture in the distal axon 
Computer simulations were performed as described in the results section. Pseudocode 
for the simulation of vesicle diffusion and microtubule capture is shown in Figure S7A. 




Statistical tests and distribution fitting were performed in MATLAB R2015a, as noted in 
the legends. Box and whisker plots show the median (red bar) and interquartile range 
(IQR, blue box) with whiskers extending to the most extreme inliers. Statistical outliers, 
defined as data greater than median +/- 1.5*IQR, were included in all analysis, but are 
not shown in boxplots to avoid compression of the majority of data. Statistical 
abbreviations: n = number of observations per condition, per experiment; N = number of 
independent experiments. For more information, see APPENDIX I. 
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4. CHAPTER 4: Cell DECODER: A Neural Network Toolbox for 
Phenotypic Profiling in Biological Image Analysis4 
 
  
                                                
4 This chapter is prepared in the format of a brief communication: 
Nirschl JJ, Moore ASM, Holzbaur ELFH. Cell DECODER: A Neural Network 
Toolbox for Phenotypic Profiling in Biological Image Analysis 
 
Contributions: 
JJN and ELFH designed experiments JJN and ASM acquired microscopy data.  
JJN developed software, performed experiments, and analysis. JJN and ELFH 
wrote the chapter, with contributions from all authors. 
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4.1. Abstract 
Advances in microscopy have increased image dataset size and complexity in biology.  
Large image datasets benefit from automated processing tools that leverage machine 
learning, including convolutional neural networks (CNNs) or “deep learning”. However, 
there are few tools that allow biologist to leverage CNNs in their research. We develop 
the Cell DECODER toolbox, a CNN-based pipeline for unsupervised feature extraction 
and phenotypic profiling. We train a 50-layer deep residual network on a large and 
diverse dataset from The Human Protein Atlas.  We use this trained neural network to 
extract “deep features” for unsupervised phenotypic profiling on a different task. We 
show that networks trained on one dataset encode robust image phenotypes that are 
sufficient to cluster subcellular structures by type and separate drug compounds by the 
mechanism of action on a different task, without additional training, supporting the 
strength and flexibility of this approach. This approach can be used for quality control, 
grouping images by phenotype, and exploring relationships among image phenotypes to 
discover relationships between experimental conditions or genetic and pharmacologic 




While imaging is a foundation of cell biology, recent advances in fluorescent probes and 
microscopy technology have made image datasets larger and more complex than ever 
before. The rapid exploration and visualization of large, high-dimensional datasets is 
critical for identifying phenotypes and designing specific, testable, and quantitative 
image analysis pipelines. This is especially true for high-throughput microscopy screens 
where there can be tens of thousands of images and specific, testable image 
phenotypes may not be known before the screen. Thus, there is a need for 
computational image analysis tools that are fast and capture a diverse and robust set of 
image phenotypes. 
 
There are many excellent tools for directed image analysis approaches including 
segmentation and traditional feature extraction pipelines (Carpenter et al. 2006; Rajaram 
et al. 2012; Sommer and Gerlich 2013; Sommer et al. 2011). This approach is the 
method of choice when specific image features are known and easy to specify in terms 
in a set of discrete image processing steps. However, these traditional approaches can 
require complex segmentation schemes and parameter optimization in addition to long 
computational runtimes. Traditional feature extraction is also limited in that it may not 
fully represent the complexity or diversity of image phenotypes due to previously 
unrecognized image features. Finally, although many human experts can easily 
appreciate and recognize complex phenotypes in cells, such as the difference between 
two cell lines, these concepts can be difficult to express as an image transform or even 
multi-parametric phenotypic profile. Thus, there is a need for computational image 
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analysis tools that can extract complex image features in order to allow for the full 
exploration and characterization of phenotypes in image based assays.  
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Deep convolutional neural networks (CNNs) are powerful representation learning 
algorithms that have shown remarkable success in image classification and object tasks 
in basic, commercial, and medical research applications (LeCun et al. 2015; Litjens et al. 
2016; Peng et al. 2016). These algorithms can learn abstract image phenotypes that are 
difficult to manually engineer using traditional approaches. In addition, the application of 
trained networks can be remarkably fast on both CPUs and graphical processing units 
(GPUs) due to optimized linear algebra libraries available on most modern computers.  
 
We have developed the Cell DEep learning and COmputational DEscriptoR 
(DECODER) toolbox, a set of high-level Python modules, trained neural networks, and 
Jupyter notebook tutorials for deep feature extraction and unsupervised phenotypic 
profiling. A schematic overview of this pipeline is illustrated in Figure 4.1. We use state-
of-the-art deep residual networks (He et al. 2015) and train on a large and diverse set of 
fluorescent micrographs curated from The Human Protein Atlas (Thul et al. 2017; Uhlen 
et al. 2010). We use this dataset to train networks with robust hidden-layer 
representations or “deep features” for feature extraction and unsupervised phenotypic 




Figure 4.1 Schematic overview of Cell DECODER pipeline. 
(A) High throughput microscopy screens can generate many thousands of images, 
which make manual exploration impractical. Image Credit: The Human Protein Atlas. (B) 
Pre-trained CNNs can be used to extract “deep features” that preserve image 
phenotypes. (C) The deep features (1024 dimensional vector) can be reduced to fewer 
dimensions for visual exploration using dimensionality reduction approaches such as t-
distributed Stochastic Neighbor Embedding (SNE) (van der Maaten and Hinton 2008). 
The network is agnostic to the true label (drug, gene knockout), but the label can be 
used to color the data after the fact to look for batch effects or experimental conditions 
that share similar image phenotypes. Each point corresponds to one image.  
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4.3. Results and discussion 
The first step is to train a state-of-the-art deep residual network on a large, diverse set of 
fluorescent micrographs of >600,000 cells from 22 cell lines, curated from The Human 
Protein Atlas (Thul et al. 2017; Uhlen et al. 2010). During training, the network will learn 
hierarchical image features in order to correctly predict cell type from an RGB image of 
DNA, endoplasmic reticulum, and microtubules. These hidden-layer representations or 
“deep features” then basis for our unsupervised phenotypic profiling. 
 
We trained our networks to predict a cell line from 22 different human cell lines using 
images of cells stained for DNA, ER, and microtubules (97% accuracy). After training, 
we remove the final classification layer, which predicts cell type, to leave a 1024 
dimensional vector as the output. This vector representing a high-dimensional image 
phenotype, which can be visualized with dimensionality reduction techniques such as 
tSNE (van der Maaten and Hinton 2008). When the 1024 dimensional vector is reduced 
using tSNE the held-out test images of cell lines from The Human Protein Atlas organize 
into different clusters (Figure 4.1C). The clusters are colored based on the true cell type 
and similar colors (cell lines) cluster together. However, the network was trained for the 
task of classifying cell line from an image, so this clustering is expected. The real test is 
whether these deep features contain useful representations to explore image 
phenotypes from different datasets and tasks. 
 
Our first external test uses grayscale DAPI images of binucleate and mononucleate cells 
from the IICBU 2008 benchmark suite (Shamir et al. 2008). The goal is to use 
unsupervised phenotypic profiling to determine whether “deep features” from a network 
96 
trained to predict cell type can be used to separate binucleate and mononucleate cells 
without having been trained for this task. In addition, we can assess whether our 
approach will generalize to different datasets since these images were acquired using a 
different form of microscopy (widefield), at a different magnification, and a different color 
depth (grayscale) than The Human Protein Atlas training set (confocal, 100x, RGB). We 
extracted features using the pre-trained network, with the network agnostic to the true 
label (binucleate vs mononucleate), and applied color labels after the fact. Movie S 5 
shows the 3D scatterplot with a separation of the classes. 
 
Our second external test moved to a multi-class scenario that included grayscale images 
of ten different subcellular structures from the HeLa structures dataset (Boland and 
Murphy 2001; Murphy et al. 2000). This dataset differs from the training set in that 
images represent maximum intensity projections of Z-stacks instead of single confocal 
slices. Interestingly, phenotypic profiling reveals clusters that recapitulate subcellular 
structures as well as semantic relationships between subcellular clusters, as seen in 
Movie S 6. For example, actin and microtubules, which are both linear filamentous 
structures, are closer in the tSNE embedding than vesicular structures such as 
endosomes and lysosomes. The nucleus/ nucleolus and cis/trans Golgi are close in the 
embedded space. Finally, we apply our unsupervised profiling approach to the published 
image-based drug screen BBBC021v1 (Caie et al. 2010), available from the Broad 
Bioimage Benchmark Collection (Ljosa et al. 2013).This high-content screen applied 
small molecules to MCF-7 cells for 24 hours, after which cells were fixed and labeled for 
DNA, F-actin, and α-tubulin for imaging as described (Caie et al. 2010). We find that 
cytoskeletal drugs with opposing mechanisms of action separate from each other, and 
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from the negative control condition (DMSO) both in 2D scatterplots as well as when 
comparing their tSNE feature vectors using the cosine distance (Figure 4.2). 
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Figure 4.2 Phenotypic profiling of small molecules in BBBC021 
(A) Phenotypic profiling of DMSO versus the F-actin stabilizing drug jasplakinolide and 
the depolymerizing drug latrunculin B, shown as a 2D scatterplot of tSNE embedded 
features (top). We compare the cosine distance (1- cosine similarity) between the 2D 
tSNE feature vector for each image and the mean DMSO vector, scaled 0-1. A value of 
0 represents perfect agreement whereas a value of 1 represents diametrically opposed 
vectors. Each point corresponds to one image. Due to the large number of DMSO 
images, we sampled a random N subset of DMSO points to match the N of the treatment 
group in each panel. The tSNE embeddings in A, B, and C are performed independently, 
and since it is stochastic, the tSNE scales are different for each embedding. Thus, the 
scale of the tSNE components and relative position of individual points will be different in 
each panel. (B) Phenotypic profiling of microtubule destabilizing (nocodazole) and 
stabilizing (taxol) compounds. (C) Phenotypic profiling of the protein synthesis inhibitors 
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Anisomycin and the proteasome inhibitor MG-132. The two compounds appear to fall 
along a continuum of the same phenotypic space and their feature vectors differ from the 
DMSO control.   
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Thus, we have shown that training a large CNN on fluorescence microscopy images 
produces robust hidden-layer representations or “deep features” that can be applied to 
new datasets with different cell types, bit depths, and fluorescent labels while retaining 
useful semantic information about biological image phenotypes. All of these results were 
obtained without any training on the new datasets. This type of unsupervised image 
phenotype exploration can reveal novel relationships among genetic or pharmacologic 
pathways that may have similar image phenotypes. It can also be used for quality 
control. For example, coloring the data in the scatterplot by the variables such as the 
experiment date could reveal batch effects, where the data is clustered by technical 
variation rather than biological variation. 
 
A supplemental resource of this work includes multiple pre-trained neural networks and 
Jupyter notebook tutorials for network training, transfer learning, and phenotypic 
profiling. We have multiple networks trained on a large set of biological images including: 
22 cell lines from the Human Protein Atlas, 18 subcellular organelles and structures from 
The Human Protein Atlas, and mixed biological samples and microscopy types (yeast, E. 
coli, mammalian cell lines, confocal, widefield, etc.). These networks trained on large 
datasets can be fine-tuned on smaller datasets, which will make getting started in deep 
learning accessible to more biologists. However, we note that this toolbox is not meant 
to replace popular high-level deep learning application programming interfaces (APIs) 
meant for developers, such as NVIDIA DIGITS or Keras, which provide extensive tools 
and support for training custom neural networks. Rather, Cell DECODER is aimed at cell 
biologists who wish to apply deep learning models pre-trained on biological datasets for 
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phenotypic profiling of their own image datasets with minimal additional training or 
customization.  
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4.4. Materials and Methods 
Training datasets 
Individual grayscale fluorescence microscopy images from The Cell Atlas of The Human 
Protein Atlas v16 were downloaded on January 2017. The original images were acquired 
at 100x magnification (2048 x2048 pixels), as described on The Human Protein Atlas 
website and associated metadata. We modified the original images by applying a low-
pass Gaussian filter to reduce jpeg compression artifacts, down-sampling to 655x655 
(250nm per pixel) using the least-squares image resizing ImageJ plugin from EPFL, and 
making RGB images from the individual down-sampled grayscale images.  
 
The images were allocated into a training and held-out test dataset. We used ten-fold 
cross-validation to split the training dataset into ten folds to monitor training progress and 
tune neural network hyperparameters. However, a single fold was randomly chosen for 
phenotypic profiling. Future work will average multiple networks to form an ensemble 
phenotypic profile, which may improve performance. 
 
We used a principled approach to data augmentation in order to increase the diversity of 
images presented to the network. Fluorescence microscopy images of cells in culture 
retain their cell identity regardless of random cropping, image flipping, mirroring, rotation, 
or subtle intensity/ contrast adjustments. Since there were multiple cells within each 
image, we augmented the dataset on-the-fly during training by taking a randomly 
cropped 224x224 pixel field of view within each 655x655 down-sampled image. We also 
used random rotation, horizontal/ -vertical flipping, and contrast/-saturation adjustment 





The IICBU binucleate dataset used in Movie S 5 was originally described in Shamir et al. 
(2008). HeLa images of subcellular structures used in Movie S 6 were originally 
described in Boland and Murphy (2001). The image-based drug screen BBBC021v1 was 
originally described in (Caie et al. 2010), and made available from the Broad Bioimage 
Benchmark Collection (Ljosa et al. 2013). 
 
Implementation 
We implemented Cell DECODER in Python 3.5 using the Microsoft Cognitive Toolkit 
CNTK (Seide and Agarwal 2016). We adapted the ResNet 50 architecture from (He et 
al. 2015) by reducing the number of parameters in each layer by half and adding a 
dropout layer with a probability of 0.5 at the final pooling layer (pool 5). We trained for 
150 epochs using momentum stochastic gradient descent and on-the-fly data 
augmentation including randomly applied: rotation, horizontal flipping, 
brightness/intensity/ saturation jitter (Krizhevsky et al. 2012), and scale jitter applied via 
randomly cropping images to the range (0.4, 0.875) of the original 655x655 input image 
before rescaling to 224x224. The network architecture and learning parameters will be 
uploaded with the source code. Training was performed on Windows 10 PC with two 
Intel Xenon E5-2623 processors, 96GB RAM, and a NVIDIA Titan-X Pascal GPU. 
Training lasted approximately 22 hours (10ms per image). The MATLAB package for 




We used the cosine distance to compare the similarity of the 2D tSNE feature vectors in 
Figure 4.2 because the tSNE embedding produces a nonlinear manifold and Euclidean 
distance isn’t an accurate representation of true distance or similarity in high dimensional 
space (van der Maaten and Hinton 2008). 
 
Code and data availability 
The Cell DECODER source code and the data that support these results will be 
uploaded to https://github.com/jnirschl/ within 6 months of publication. Microscopy 
images from The Human Protein Atlas are Copyright of The Human Protein Atlas and 
used under the CC BY-NC-ND 4.0 License. The images must be obtained from The 
Human Protein Atlas, as the NoDerivatives clause limits the distribution of modified 
images. The IICBU 2008 binucleate dataset can be obtained from Goldberg lab at the 
NIH (https://ome.grc.nia.nih.gov/iicbu2008/) The HeLa structures dataset can be 
obtained at the Murphy lab (http://murphylab.web.cmu.edu/data/2Dhela_images.html). 
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5. CHAPTER 5: Deep learning tissue segmentation 
in cardiac histopathology images5 
 
  
                                                
5 This chapter is adapted from: 
Nirschl JJ, Janowczyk A, Peyster EG, Frank, R, Margulies, K, Feldman M, and 
Madabhushi A. (2017). Deep Learning Tissue Segmentation in Cardiac 
Histopathology Images. In S. K. Zhou, H. Greenspan, & D. Shen (Eds.), Deep 
Learning for Medical Image Analysis. Cambridge, MA: Elsevier Academic Press. 
 
Contributions: 
JJN, AJ, and AM designed experiments. EGP, KBM, and MDF acquired, 
organized, and digitized the slides. RF and MDF reviewed the cardiac 
histopathology annotations. JJN performed the experiments and analysis. AJ 
contributed new computational tools. JJN, AJ, MDF, and AM interpreted the 
analyzed data, which was reviewed by all authors. JJN wrote the chapter, with 
contributions from all authors. 
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5.1. Abstract 
Cardiac biopsies are obtained for the diagnosis of acute heart failure as well as post-
heart-transplant rejection. On histology, both are characterized by an expansion of the 
cellular and acellular stromal tissue as well as morphologic changes within myocytes, 
among other features. There is growing evidence, from a number of diseases, that 
computer-extracted features of tissue and nuclear architecture are not only useful for 
diagnostics, but can also predict disease recurrence, progression, and patient outcome. 
Automated tools to segment myocytes and stroma with high fidelity are a critical first 
step toward developing predictive models to improve diagnosis, prognosis, and 
reproducibility in cardiac pathology. Whole-slide imaging in digital pathology is producing 
large, rich data sets for machine learning algorithms that learn features representations 
directly from data, such as deep neural networks or “deep learning”. Deep learning has 
achieved state of the art performance in computer vision and is becoming ubiquitous 
within the realm of digital pathology. Here, we present a deep learning framework for 
myocyte and stroma segmentation in H&E stained cardiac tissue using a data set of 103 
patients with clinical heart failure or non-heart failure controls. We provide a tutorial for 
how to use the AlexNet architecture, implemented in Caffe, to train a pixel-level classifier 
for segmentation. We compare the performance of our deep learning approach to a 
random forest classifier with 333 intensity and texture features and test on 20 held-out 
patient images with expert ground-truth annotation of tissue boundaries. We find our 
deep learning segmentation outperforms random forests in terms of mean (a) AUC (0.95 
vs 0.80), (b) F-score (0.96 vs 0.91), (c) TPR (0.96 vs 0.92), (d) TNR (0.94 vs 0.67), and 




The advent of whole-slide imaging (WSI) has increased the digitization of pathology 
slides, which is generating large, information-rich data sets where modern computer 
vision and machine learning methods thrive (Bhargava and Madabhushi 2016; Ghaznavi 
et al. 2013; Madabhushi and Lee 2016). Traditional approaches for image analysis in 
digital pathology have involved manually engineering image features to use in a machine 
learning classifier (Bhargava and Madabhushi 2016). These features generally involve 
pixel intensity statistics, texture descriptors, and image decompositions, as well as task-
specific features. However, representation learning methods, such as deep convolutional 
neural networks or “deep learning”, have made significant advances in computer vision 
and are becoming increasingly common in medical image analysis (Bhargava and 
Madabhushi 2016; LeCun et al. 2015). Deep learning has many potential applications to 
digital pathology because it excels at tasks with large and complex training data sets, 
such as WSI. In addition, since deep learning models do not carry domain or tissue-
specific information, a general workflow can be rapidly applied to problems across 
different domains. In this chapter, we provide a brief introduction to digital pathology, 
deep learning, and cardiac histopathology. We then present a workflow for segmentation 
of myocytes versus stroma in cardiac histopathology images. The long-term motivation 
for developing this segmentation workflow is to allow the exploration of whether 
computer-extracted histomorphometric features of tissue architecture from cardiac 




Manual pathological examination takes advantage of the human visual system, which 
excels at automatically and efficiently partitioning an image into distinct components. 
The pathologist uses domain knowledge to provide biological context to the image and 
interpret structures into their appropriate tissue or cellular subtypes. This is followed by 
the identification of image features that can be used to label tissue as normal or 
abnormal. The final diagnosis is made through a combination of diagnostic criteria, 
histopathological image features, and prior experience. Computational analysis of digital 
pathology slides takes a similar process; image segmentation generally precedes the 
extraction of tissue-specific and disease-relevant features, which are ultimately used for 
diagnosis. 
 
Image segmentation in digital pathology involves the partitioning the image into 
histologic primitives, or the biologically-relevant tissue, cellular, or sub-cellular structures 
(e.g. stromal tissue, nuclei, etc.) (Cireşan et al. 2013; Wang et al. 2014; Xu et al. 2016a; 
Xu et al. 2016b). This allows the extraction and quantification of tissue or cell-specific 
features that can be used for diagnosis or prognosis (Basavanhally et al. 2011; Beck et 
al. 2011; Doyle et al. 2012; Lewis et al. 2014; Litjens et al. 2016; Madabhushi et al. 
2011). The process of applying computerized image analysis to quantify histologic 
features is known as quantitative histomorphometry. One important reason to segment 
histologic primitives prior to quantitative histomorphometry is to account for features that 
may have different predictive power depending on their context within the tissue. For 
example, normal cardiac tissue has stroma but it is limited to perivascular regions. 
However, when stroma is embedded between myocytes it is abnormal and can 
represent disease or fibrosis, as shown in Figure 5.1. Although segmentation is an 
111 
important step in digital pathology, manual segmentation is neither efficient nor routinely 
incorporated into clinical practice. Thus, developing automated algorithms for robust 
tissue segmentation is an important prerequisite for quantitative histomorphometry and 
predictive modeling. 
 
Representation learning methods, such as deep convolutional neural networks or “deep 
learning”, have made significant advances in computer vision and are becoming 
increasingly common in medical image analysis (Bengio et al. 2013; Bhargava and 
Madabhushi 2016; LeCun et al. 2015). Deep learning has many potential applications to 
digital pathology because it excels at tasks with large and complex training data sets, 
such as WSI. In addition, since deep learning models do not carry domain or tissue 
specific information, a general workflow can be applied to multiple cases. Deep learning 
differs from conventional approaches in that important features are not specified and 
designed a priori, but are rather learned directly from the data. A representation learning 
approach to image segmentation in   digital pathology reduces the time spent 
engineering features and ensures that the biological diversity and technical variance of 
the data set is captured. 
 
In general, deep neural networks work by arranging nodes or artificial “neurons” in 
successive, convolutional, max-pooling, and fully connected layers as described 
elsewhere (Bengio 2009; Schmidhuber 2015). Parameters that specify neuron weighting 
are iteratively adjusted during training to approximate functions from data in a way that 
minimizes a loss function, which is typically correlated with the task at hand (e.g. class 
separation). The net result is the extraction of hierarchical features that map the input 
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image into abstract feature vectors that capture complex and nonlinear relationships in 
the data. Deep learning has recently been successfully applied to a number of digital 
pathology problems including localizing invasive ductal carcinoma (Cruz-Roa et al. 
2014), mitosis detection (Cireşan et al. 2013; Wang et al. 2014), colon gland 
segmentation (Kainz et al. 2015), epithelial and stromal segmentation (Xu et al. 2016a), 
and histopathological diagnostic support (Litjens et al. 2016). In this work, we explore the 
use of a deep learning framework for tissue segmentation in cardiac histopathology. 
 
The two most prominent tissue classes in cardiac tissue are the myocytes, responsible 
for heart contraction, and the stroma, consisting of cellular and acellular support tissue. 
The stromal tissue is generally minimal in normal heart tissue. However, in the context of 





Figure 5.1 Example of normal and abnormal cardiac tissue. 
(A) Cardiac biopsy from a patient without heart failure shows stroma limited to 
perivascular regions as well as regular, dense arrays of cardiomyocytes. (B) A biopsy 
from a patient with clinical heart failure shows an expansion of stromal tissue that 
disrupts the cardiomyocyte arrays. In addition, myocytes and their nuclei can be 
enlarged relative to normal tissue. Segmentation of myocytes and stroma is a first step 
toward quantifying these tissue abnormalities. Images are 2000 µm x 2000 µm at 5x 
magnification. Reprinted with permission from Elsevier Academic Press (Nirschl et al. 
2017b), copyright (2017). 
  
114 
Cardiac biopsy is performed in the setting of new-onset heart failure, or for post-
transplant rejection surveillance in adult heart transplant recipients (Cooper et al. 2007; 
Costanzo et al. 2010). Histopathological examination of these cases shows an 
expansion of the cellular and acellular stromal tissue, fibrosis, and morphological 
changes within myocytes, among other features. Manual review of biopsies is time 
consuming and intra- and inter-observer variability is high, even using revised diagnostic 
guidelines (Angelini et al. 2011). 
 
In cardiac biopsies, some features based on diagnostic criteria and domain knowledge 
include the percent tissue area that is stroma (fibrosis), lymphocyte presence and 
number in each tissue compartment, as well as morphological features of myocytes and 
their nuclei. Together, these features may allow automatic and quantitative prediction of 
the risk of heart failure or cardiac rejection, which would significantly improve efficiency, 
reliability, and quality of care for the treatment of heart failure and heart transplant 
patients. 
 
In the remainder of this chapter, we focus on developing a deep learning framework for 
myocyte and stroma segmentation in cardiac histopathology images. Section 5.3 
describes the design and implementation of two models for tissue segmentation, a deep 
learning approach or a random forest classifier with handcrafted features. We present 
our results for these experiments in Section 5.4. The first set of experiments compares 
the segmentation performance of a deep learning model to a traditional feature-
engineered approach and supervised machine learning classifier. The second highlights 
the sensitivity of deep learning to the fidelity of the training annotations as well as patch 
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representation within the training set. We conclude in Section 5.5 with potential 
downstream applications of myocyte and stroma segmentation in heart failure and 
rejection. 
5.3. Experimental Design and Implementation 
5.3.1. Data set description 
The data set includes 103 whole-slide images of H&E stained, full-thickness cardiac 
biopsies obtained at the time of death for non-heart-failure controls (52 patients) or heart 
transplant for patients with end-stage heart failure (51 patients). Images were scanned at 
20x magnification using an Aperio ScanScope slide scanner and down- sampled to 5x 
magnification for image processing and analysis. An equal number of patients from each 
disease class (10 failing or non-failing) were randomly allocated to a held-out validation 
set and the remaining patients were used for training, such that 83 patient WSI were 
used for training models and 20 patients were kept as a held-out validation cohort. 
 
5.3.2. Manual ground truth annotations 
For each patient in the training data, at least 1x 104 µm2 tissue area of the WSI, per 
class, was manually annotated as myocyte or stroma. Training patches were selected 
from these annotated regions with hypersampling of regions at the interface between 
two tissue classes (myocyte or stroma), which we refer to as edge-hypersampling. See 
Figure 5.2 for example training annotations used for patch selection. 
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Figure 5.2 Ground truth for myocytes or stroma. 
(A) Original images. (B) Binary ground truth mask for myocytes (top) or stroma (bottom) 
for pixel-level training annotations. White pixels indicate class membership. (C) Overlay 
image of binary mask in B on original image in A. Images are 500 µm x 500 µm at 5 x 
magnification. Reprinted with permission from Elsevier Academic Press (Nirschl et al. 
2017b), copyright (2017). 
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Manual ground truth annotations from the 20 patients in the held-out validation set were 
used to assess segmentation performance. These validation annotations were 
performed on one ROI of 500 µmx 500 µm 5x magnification image for each patient. In 
each ROI, the entire field was annotated, in detail, to allow a pixel-level comparison of 
the manual and automated segmentation methods. Example ground truth validation 
annotations are shown in Section 5.4. 
5.3.3. Implementation 
There are a number of excellent and well-maintained platforms for implementing deep 
learning. Apart from language, speed, and ease of implementation, an actively 
maintained package with a strong development community is important. We provide an 
abbreviated list of platforms in Table 5.1. In this tutorial, we use the open-source 
framework Caffe (Jia et al. 2014). We direct the reader to (Jia et al. 2014) and the Caffe 
online documentation for additional information. 
 
 
Table 5.1 Abbreviated list of deep learning software packages 
Reprinted with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright 
(2017). 
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5.3.3.1. Network architecture 
Many software platforms have existing networks that can be modified for new specific 
uses cases. In this example, we use a modified version of the AlexNet architecture 
(Krizhevsky and Hinton 2010; Krizhevsky et al. 2012), which was used in the 32 x 32 
CIFAR-10 challenge (Krizhevsky 2009). 
5.3.3.2. Building a training database 
The CIFAR-10 network requires training patches to be 32 x 32 pixels. The first step, 
then, then, is to determine the appropriate magnification for training patches. In general, 
we recommend the highest magnification that allows the histologic primitive of interest to 
fit within the patch window, while still containing contextual information outside of the 
histologic primitive. The patch should also have enough resolution and context for an 
expert to correctly classify the center pixel of image. For cardiac histopathology, we 
downsample the 20x magnification WSI to 5x apparent magnification, which allows a 
typical myocyte in cross-section to occupy approximately 50% of the patch window. 




Figure 5.3 Example training patches. 
Example 32 × 32 training patches used for both the deep learning and RF approach, 
where the center pixel of the patch determines the class label. (A) Myocyte training 
patches. (B) Stroma training patches. Each patch is 64 µm x 64 µm at 5x magnification. 




As mentioned previously, deep learning identifies discriminative features directly from 
training data. Thus, the next important consideration is the choice and representation of 
training patches. We find that training is more efficient when the transition zones, or the 
interfaces between one or more classes, are over-represented in the data set, as we 
later show in Experiment 2. To this end, we hypersample patches from the edges of the 
annotated training masks such that edge patches are over-represented in the training 
data set based on their distance to the mask edge. 
5.3.3.3. Training a deep learning model 
We train the deep learning classifier using 5 x 103 patches per patient, and augment the 
training set by rotating each patch by 90, 180, or 270 degrees for 1.66 x 106 patches per 
class and a total of 3.32 x 106 training patches. These patches were split into three 
training and testing-folds at the patient level with balanced myocyte and stroma patches. 
Each fold was trained for 6 x 105 iterations on a Tesla K20c GPU with CUDA 7.0 using 
the cuDNN setting, the AdaGrad solver (Duchi et al. 2011) built into Caffe, and a fixed 





Table 5.2 Deep learning hyperparameters 




5.3.4. Training a model using engineered features 
We compare our deep learning approach to a traditional segmentation workflow using 
engineered features and a Random Forest classifier. Random forests were chosen as a 
classifier because they are among the top performing supervised machine learning 
algorithms (Caruana et al. 2008; Caruana and Niculescu-Mizil 2006), they perform well 
on biomedical image data sets (Parmar et al. 2015), and require fewer adjustments to 
obtain stable results. 
The Random Forest classifier for myocyte and stroma segmentation was trained 
using 1000 trees and 333 engineered-features based on intensity and texture.  
Table 5.3 lists the features used here. The intensity features capture the differences in 
H&E staining between myocytes and stroma by considering intensity magnitude, 
variation, and higher-order moments. Texture features such as Co-occurrence of Local 
Anisotropic Gradient Orientations (CoLlAGe) features (Prasanna et al. 2014), Gabor 
features (Gabor 1946), and Haralick features (Haralick et al. 1973), among other texture 
features (Laws 1980), were designed to detect the edges of class boundaries as well as 
the heterogeneity and disorder of the stroma relative to myocytes. These features were 
computed for each 32 x 32  patch of the grayscale converted RGB image as well as the 
color-deconvolved hematoxylin or eosin grayscale image (Ruifrok et al. 2003). The 
feature vector and label for the center pixel patch was used for training. All of the training 
patches were used to construct a single RF model. 
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Category Length Features 
Intensity 13 x 3 images Energy, entropy, min, max, standard deviation, variance, 
mean, median, median absolute deviation, range, root 
mean squared, skewness, and kurtosis of patch intensity 
Texture 98 x 3 images 13 Haralick texture features, 25 Laws texture features, 1 
Local Binary Pattern, 21 XY gradient features, 6 Gabor 
features, 26 CoLlAGe features, 6CORF features 
 
Table 5.3 Description of features used for the Random Forest stroma classifier 
Intensity features were calculated on a 32 x 32 sliding window with the center pixel 
assigned the computed value for each patch. The three grayscale images of each patch 
that were used include a grayscale conversion of the RGB image and a color-
deconvolved hematoxylin or eosin grayscale image. Reprinted with permission from 
Elsevier Academic Press (Nirschl et al. 2017b), copyright (2017). 
5.3.5. Experiments 
5.3.5.1. Experiment 1: Comparison of Deep Learning and Random Forest 
Segmentation 
Experiment 1 compares the segmentation performance of  deep learning model to  a 
random forest model using engineered features in cardiac histopathology images. Each 
approach was trained using the same set of image patches and the output from each 
model is an image where each pixel is assigned a probability of class membership, 
between 0 and 1. Thresholding the probability output at 0.5 should maximally separate 
the classes, which is why a fixed threshold of 0.5 was used to create binary masks. 
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5.3.5.2. Experiment 2: Evaluating the Sensitivity of Deep Learning to Training Data 
Routine tissue annotation in digital pathology is generally performed at intermediate 
magnifications and produces masks that lack delineation of precise, pixel-level tissue 
boundaries. While this approach can rapidly annotate large regions of the WSI, it may 
have consequences for the data that ultimately go into the network. Since deep learning 
techniques learn models from the data presented, it is important to consider the training 
annotation method as well as the best procedure for sampling patches from within these 
annotations. Figure 5.4 shows an example of coarse annotations (A) versus fine 




Figure 5.4 Coarse versus fine training annotations. 
This figure shows two different approaches for generating training annotations for deep 
learning. (A) Coarse annotations maximize the tissue area that is annotated, but may 
lack precise class boundaries. (B) Fine training annotations capture less tissue area and 
may require more effort, but generate delineate class boundaries with pixel-level 
precision. Experiment 2 shows the effect of training annotation and patch representation 
on the deep learning output. Myocytes are annotated in the top row and stromal tissue in 
the bottom row. Images are 500 µm x 500 µm. Reprinted with permission from Elsevier 
Academic Press (Nirschl et al. 2017b), copyright (2017).  
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Uniform random sampling of patches from training annotations assumes that all patches 
provide equally valuable information for classification. This is not true in general, though, 
as WSI often contain large regions of tissue that are qualitatively very different and 
easily classified using simple approaches. However, the transition zones between tissue 
classes are more challenging, and we can direct the deep learning network to learn 
these boundaries better by modifying the patch representation within the training data. 
We modify patch representation by hypersampling patches near the edge of the training 
annotation, or edge-hypersampling, an approach also used in (Janowczyk et al. 2016). 
In this experiment we compare uniform and edge-hypersampling approaches for both 
coarse and fine, pixel-level training annotations. 
 
5.3.6. Testing and performance evaluation 
The fully annotated ROIs from the held-out patients were used to assess segmentation 
performance for both sets of experiments. We evaluate the segmentation performance 
for each experiment using multiple criteria including: the Area Under the Curve (AUC), 
F1 score, True Positive Rate (TPR), True Negative Rate (TNR), Positive Predictive 
Value (PPV), Modified Hausdorff Distance (MHD) (Dubuisson and Jain 1994; Powers 
2011). 
 
5.4. Results and Discussion 
5.4.1. Experiment 1: Comparison of deep learning and random forest segmentation 
An overlay of the probability output on the original image for each classifier is shown in 
Figure 5.5. Table 5.4 shows the quantitative evaluation of each classifier on 20 held- out 
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patients using the performance metrics listed in the previous section (AUC, F1 score, 
TPR, TNR, PPV, MHD). Qualitatively, the deep learning model produces much more 
confident predictions of class membership, as noted by the green or magenta intensity of 
the probability outputs. It is also clear that both the deep learning and random forest 
models perform well on regions far from the interface with the opposing class, as 
expected. Since large regions of the image are easier to classify both models achieve a 
high F1 score and TPR. However, only the deep learning model is able to achieve both a 
high TPR (sensitivity) and TNR (specificity). 
 
What is also evident from Figure 5.5 is that deep learning more accurately delineates the 
class boundaries. This is quantified in Table 5.4 using the MHD, which is a robust 
measurement for matching objects based on their edge points (Dubuisson and Jain 
1994). The MHD shows that deep learning more accurately delineates tissue boundaries 
compared to the random forest model. Finally, related to the previous point, deep 
learning excels at detecting fine features such as small myocytes embedded in stromal 
tissue. These are often assigned low probabilities in the random forest model, which are 
lost with thresholding. Together, these data suggest that deep learning should be used 
when precise delineation of tissue boundaries are desired. However, in the next 
experiment we examine the sensitivity of deep learning and highlight an important 




Table 5.4 Mean ± SD segmentation performance on validation set for Experiment 
1. 
Reprinted with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright 
(2017). 
 
Figure 5.5 Qualitative comparison of segmentation performance. 
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(A) The original H&E image and ground truth annotation. (B) Random forest probability 
output overlaid on the original image and binarized segmentation mask. (C) Deep 
learning probability output overlaid on the original image. The green or magenta channel 
intensity in the probability output probability of the pixel belonging to the myocyte or 
stroma class, respectively. White pixels in the binary masks represent the myocyte 
class. Images are 500 µm x 500 µm. Reprinted with permission from Elsevier Academic 
Press (Nirschl et al. 2017b), copyright (2017). 
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5.4.2. Experiment 2: Evaluating the sensitivity of deep learning to training data 
 
Figure 5.6 Effect of training annotations fidelity on DL performance. 
(A) Original image (top) and ground truth annotation. (B) DL network trained with uniform 
random patch sampling from coarse masks. (C) Network trained with edge-
hypersampling of patches from coarse masks. (D) Network with uniform random patch 
sampling of fine training masks. (E) Network trained with edge-hypersampling of fine 
training masks. Probability outputs overlaid on the original images (top row) and binary 
masks (bottom). Images are 500 µm x 500 µm. Reprinted with permission from Elsevier 
Academic Press (Nirschl et al. 2017b), copyright (2017). 
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Figure 5.6 shows the effect of coarse versus fine training annotations and edge 
hypersampling on deep learning segmentation. The first result is that coarse annotations 
produce coarse results. While it is not entirely surprising, the visual results are striking. 
Edge hypersampling can partially compensate for coarse annotations, but the best 
results are obtained after re-annotation with precise pixel-level boundaries. The effect of 
edge-hypersampling is less clear in the specific case of fine myocyte and stroma 
annotations. This is likely due to the fact that a majority of the annotations are already at 
the tissue interface and already considered “edges”. The addition of edge-hypersampling 




Table 5.5 Mean ± SD segmentation performance on validation set for Experiment 2 
Although, we manually annotate myocytes and stroma, due to their irregular boundaries, 
different histologic primitives may benefit from less time-consuming approaches. For 
example, reliable nuclei annotations can be obtained using an approach similar to 
Janowczyk et al. (Janowczyk et al. 2016). In this case, high fidelity “edge” annotations 
for the non-nuclei class were generated by dilating the nuclei mask and then subtracting 
the original mask. In any case, it is important for digital pathology users to match the 
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granularity of their training annotations with the quality of the desired output. Reprinted 
with permission from Elsevier Academic Press (Nirschl et al. 2017b), copyright (2017). 
5.5. Concluding remarks 
In this chapter we described the use of deep learning for the specific case of segmenting 
myocytes and stroma in cardiac histopathology images. We developed two models to 
segment myocytes and stroma, a deep learning approach and the use of a random 
forest classifier in conjunction with handcrafted features. A deep learning approach was 
used because this method has shown excellent performance in computer vision tasks 
and it excels with large data sets. 
 
We evaluated the performance of our two models using a held-out data set of 20 patient 
images with expert annotated tissue boundaries, where deep learning was superior in all 
metrics. Most notably, deep learning segmentation had both a high sensitivity and 
specificity as well as more accurate tissue boundaries, compared to a random forest 
model. In addition, our results suggested that deep learning is highly sensitive to the 
fidelity of the training annotations and that edge-hypersampling can improve 
segmentation performance. 
 
In summary, our deep learning framework required no feature engineering and showed 
improved segmentation performance compared to a classifier trained using handcrafted 
features. This will enable the identification and quantification of tissue-specific features 
predictive of heart failure or cardiac transplant rejection. Future work using these 
segmentation results will allow the development of features predictive of cardiac 
disease, and may eventually lead to pipelines for image-based predictors of outcome 
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based off cardiac histopathology. This has the potential to improve cardiac biopsy 
screening, provide real-time feedback for clinicians, and serve as an objective second 
reader for pathologists. 
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6. CHAPTER 6: A deep-learning classifier identifies patients with clinical 
heart failure using whole-slide images of H&E tissue6 
 
                                                
6 This chapter is in preparation for submission: 
Nirschl JJ*, Janowczyk A*, Peyster EG, Frank, R, Margulies, K, Feldman M, & 
Madabhushi A. A deep-learning classifier identifies patients with clinical heart 
failure using whole-slide images of H&E tissue biopsies. 
* Denotes equal contribution 
 
Contributions: 
JJN, AJ, and AM designed experiments. EGP, KBM, and MDF acquired, 
organized, and digitized the slides. RF and MDF interpreted the cardiac 
histopathology. JJN and AJ performed experiments and analysis. JJN, AJ, MDF, 
and AM interpreted the analyzed data, which was reviewed by all authors. JJN 
wrote the manuscript, with contributions from all authors. 
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6.1. Abstract 
Over 26 million people worldwide suffer from heart failure annually. When the cause of 
heart failure cannot be identified, endomyocardial biopsy (EMB) represents the gold-
standard for the evaluation of disease. However, manual EMB interpretation has high 
inter-rater variability. Deep convolutional neural networks (CNNs) have been 
successfully applied to detect cancer, diabetic retinopathy, and dermatologic lesions 
from images. In this study, we develop a CNN classifier to detect clinical heart failure 
from H&E stained whole-slide images from a total of 209 patients, 104 patients were 
used for training and the remaining 105 patients for independent testing. The CNN was 
able to identify patients with heart failure or severe pathology with a 99% sensitivity and 
94% specificity on the test set, outperforming conventional feature-engineering 
approaches. Importantly, the CNN outperformed two expert pathologists by nearly 20%. 




Cardiovascular diseases are the leading cause of death globally and the leading cause 
of hospital admissions in the United States and Europe (Kochanek et al. 2011). More 
than 26 million people worldwide suffer from heart failure annually and about half of 
these patients die within five years (Ambrosy et al. 2014; Mozaffarian et al. 2016). Heart 
failure is a serious, progressive clinical syndrome where impaired ventricular function 
results in inadequate systemic perfusion. The diagnosis of heart failure usually relies on 
clinical history, physical exam, basic lab tests, and imaging (Hunt et al. 2009). However, 
when the cause of heart failure is unidentified, endomyocardial biopsy (EMB) represents 
the gold standard for the evaluation and grading of heart disease (Cooper et al. 2007). 
The primary concern with the manual interpretation of EMB is the relatively high inter-
rater variability (Angelini et al. 2011) and limited clinical indications (Cooper et al. 2007; 
Stewart et al. 2005). Automated analysis and grading of cardiac histopathology can 
serve as an objective second read to reduce variability. 
 
With the advent of digital pathology, a number of groups have been applying computer 
vision and machine learning to these datasets to improve disease characterization and 
detection (Bhargava and Madabhushi 2016; Ghaznavi et al. 2013; Gurcan et al. 2009; 
Madabhushi and Lee 2016). Recent work has shown that sub-visual image features 
extracted from digitized tumor histopathology via computer vision and machine learning 
algorithms can improve diagnosis and prognosis in a variety of cancers (Basavanhally et 
al. 2011; Beck et al. 2011; Cruz-Roa et al. 2017; Doyle et al. 2012; Lee et al. 2014; 
Lewis et al. 2014; Litjens et al. 2016; Madabhushi et al. 2011; Romo-Bucheli et al. 2016; 
Yu et al. 2016). In contrast, image analysis on cardiac histopathology has received little 
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attention, although quantification of adipose tissue and fibrosis have been proposed in a 
few preliminary studies (Gho et al. 2014). 
 
Recently, many approaches for image analysis have applied deep convolutional neural 
networks (CNNs) or “deep learning” instead of engineered image features. Deep 
learning is an example of representation learning, a class of machine learning 
approaches where discriminative features are not pre-specified but rather learned 
directly from raw data (LeCun et al. 2015). In a CNN, there are many artificial neurons or 
nodes arranged in a hierarchical network of successive convolutional, max-pooling, and 
fully-connected layers. The hierarchical structure allows the model to approximate 
complex functions and learn non-linear feature combinations that maximally discriminate 
among the classes. Once a CNN model is trained on a sufficiently large data set, it 
should be able to generalize to unseen examples from the population. For a more 
detailed description of neural networks and their structure, we refer readers to Bengio et 
al. 2013 and Schmidhuber 2015 (Bengio et al. 2013; Schmidhuber 2015). 
 
Deep learning has already been successfully applied to detect cancer in biopsies (Wang 
et al. 2016a; Wang et al. 2014), diabetic retinopathy (Gulshan et al. 2016), and 
dermatologic lesions (Esteva et al. 2017). There are many other potential applications to 
digital pathology because deep learning excels at tasks with large and complex training 
data sets, such as whole slide images (WSI). In this study, we develop a CNN to detect 
clinical heart failure from cardiac tissue. We show that the CNN detects heart failure with 
high accuracy using only cardiac histopathology, outperforming conventional feature-
engineering approaches and two expert pathologists. We also show that these 
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algorithms are highly sensitive to tissue-level pathology, as our algorithms promote a re-




6.3.1. Dataset description and image analysis pipeline. 
The dataset consisted of left ventricular tissue from 209 patients, collected at the 
University of Pennsylvania between 2008 and 2013. There were two cohorts of patients: 
those with end-stage heart failure (Failing or Fal; N = 94) and a comparison group 
without heart failure (Non-failing or NF; N = 115). The failing cohort tissue was collected 
from patients with clinically diagnosed ischemic cardiomyopathy (ICM; N = 51) or 
idiopathic dilated cardiomyopathy (NICM; N = 43) who received heart transplants or left-
ventricular assist devices during the collection period and consented to the study. The 
patients in the non-failing cohort were organ donors without a history of heart failure, but 
where the heart tissue was ultimately not used for transplant. All patients with tissue 
sectioned, stained, and scanned during the collection phase were included for analysis. 
We randomly split the patients into two datasets: 104 patients were designated for 
training, and a separate cohort of 105 patients was held out as an independent test set. 
Patient demographics for the training and held-out test dataset are shown in Table 6.1. 
The training dataset was further split, at the patient level, into three-folds for cross-
validation to assess training and validate algorithm parameters. For each patients’ whole 
slide image (WSI), down sampled to 5x magnification, we extracted eleven non-
overlapping images or regions of interest (ROI 2500µm2) at random from within the 
Otsu-thresholded (Otsu 1979) and manually refined tissue border.
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Table 6.1 Patient demographics for the heart failure data set. 
Where applicable, data are shown as mean ± SD. The two sub-classes of heart failure 
are ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM). 
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The training images were used to build two independent models to classify patients with 
or without heart failure from cardiac histopathology. The primary classifier used a CNN 
with a modified AlexNet (Krizhevsky et al. 2012) architecture to transform the image 
pixels into the probability that the image came from a patient with heart failure. We 
compared our CNN to a traditional feature-engineering approach using WND-CHARM 
(Orlov et al. 2008), a generalized image pattern recognition system coupled to a random 
decision forest classifier (RF). WND-CHARM computed 4059 features for each image. 
The top 20 features (Table S3) were selected using the minimum Redundancy Maximum 
Relevance method (Peng et al. 2005) on the training set, and these top features were 
input to an RF classifier (Breiman 2001). 
 
For each image, both classifiers calculated the probability of whether that image came 
from a patient with heart failure. Images with probabilities greater than 50% were 
considered as a prediction of the “failing” class at the image-level. The image-level 
predictions were grouped by patient and the fraction of images predicted as ‘failing’ for 
each patient gave the patient-level probabilities. Figure 6.1 shows a summary of the 





Figure 6.1 Schematic overview of digital pathology workflow to detect heart 
failure. 
(a) Patients were divided into a training and test dataset. WSI were scanned and regions 
of interest (ROI) were extracted for image analysis. All ROIs from the same patient were 
given the same label, which was determined by whether the patient had clinical or 
pathological evidence of heart disease. (b) Three-fold cross validation was used to train 
heart failure classifiers using a deep learning model or engineered features in WND-
CHARM + a random decision forest classifier. (c) Trained models were evaluated at the 
image and patient-level on a held-out test dataset. 
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6.3.2. CNNs identify heart failure patients from histopathology with high accuracy 
We evaluated the performance of the CNN on the training set using three-fold cross 
validation. In addition, we applied each of the trained models to the held-out test dataset 
as an independent test for model generalization. Table 6.2 shows the classification 
accuracy for detection of clinical heart failure at the image and patient-level for both the 
training cross-validation and held-out test datasets. The CNN performs very well, 
detecting heart failure from histopathology at both the image and patient-level with 




Table 6.2 Image and patient-level performance evaluation for predicting clinical 
heart failure from H&E stained whole-slide images for validation folds of the 
training data set. 
The results are presented as the Mean ± SD of three models. Each model was trained 
on ~ 770 images from ~70 patients. The validation models were evaluated on the 
validation fold of ~35 patients. The models were then tested on a held-out data set of 
105 patients. The patient-level diagnosis is the majority vote over all the images from a 
single patient. Statistical comparisons between RF and DL models were determined by 
an unpaired two-sample t-test with an N of three folds. Statistical comparisons between 
DL and the pathologists used a one-sample t-test compared with the maximum value 
from either pathologist, with all p values ≤0.01. AUC: Area Under the Curve for the 
receiver operator characteristic. 
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Next, we compared the classification accuracy of the CNN to the WND-CHRM + RF 
model (Table 6.2). Although the WND-CHRM + RF model was able to identify heart 
failure patients, the accuracy and sensitivity was significantly lower than the CNN model 
at both the image and patient-level on the held-out test set (p < 0.05, unpaired two-
sample t-test). Thus, the learned features in the CNN result in a classifier that is more 
discriminative than a feature-engineering approach, which is capable of accurately 
detecting heart failure from cardiac histopathology. 
 
To address the question of how these algorithms compare to human-level performance, 
we had two pathologists independently review the 105 patients in the held-out test set. 
The pathologists were blinded to the patients’ clinical history, and they were only shown 
the same 11 images per patient that were used in evaluating the algorithms. For each 
patient, they gave a binary prediction of whether the set of images were from a patient 
with clinical heart failure or not. The pathologists both had an individual accuracy of 75% 
at the patient-level (Table 6.2) with a Cohen’s kappa inter-rater agreement of 0.40. The 
CNN significantly outperformed pathologists in all metrics with a 20% differential in terms 
of sensitivity and specificity (p < 0.05, one-sample t-test compared to the best human 
performance for each evaluation metric). 
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6.3.3. Review of correct and incorrectly classified images 
Representative images that were correctly classified by both algorithms are shown in 
Figure 6.2A. These images are exemplars for the well-described histological findings in 
normal tissue and heart failure, described in Figure S8. Images uniquely misclassified by 
the CNN are shown in Figure 6.2B. A qualitative review of these images by expert 
pathologists showed that a few contain minor tissue processing artifacts. However, many 
images have some features of both normal and abnormal myocardium such as large 
regions of healthy, densely packed myocytes or fibrosis and enlarged myocyte nuclei, 
respectively. This could make these images challenging for both computers and humans 
to classify when only given a single image. 
 
Review of the errors unique to the WND-CHARM + RF model reveals some obvious 
errors, such as classifying an image from a heart failure patient with extensive fibrosis as 
“Non-Failing” (Figure 6.2C, False Negative second row). There were also many 
examples in which the WND-CHRM + RF model made errors on images containing 
minor tissue-processing artifacts, such as small  areas of white space between bundles 





Figure 6.2 Review of classified images and unsupervised clustering of patients. 
Representative images from ROIs that were: correctly classified by both algorithms (a); 
errors unique to the Random Decision Forest (b); and errors unique to Deep Learning 
(c). The ground truth is shown in white text in the upper left corner of the image whereas 
the algorithm prediction is shown in the upper right and color coded with green = correct 
and yellow = incorrect. (d) ROIs from two patients without clinical heart failure that were 
classified with clinically “Failing” patients by both algorithms. These patients were later 
found to have evidence of tissue-level pathology by two independent pathologists. (e) 
Consensus clustering using WND-CHARM feature vector reveals evidence for three 
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clusters in the data. The consensus clustering dendrogram and class results are shown 
above the clustergram. Some patients form a small third cluster between the two larger 
groups, marked by an arrowhead, which was found to contain a patient with tissue 
pathology but no clinical heart disease. 
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While reviewing the errors, we identified several non-failing patients incorrectly predicted 
as “failing” with a very high probability by the CNN and WND-CHRM + RF at both the 
image and patient-level. The high likelihood of class membership assigned by both 
models prompted a detailed re-examination of these cases. Two expert pathologists, 
blinded to the patients’ clinical history, reviewed the tissue pathology and labeled their 
findings as mild-moderate pathology or severe tissue pathology. The consensus 
agreement of the pathologists was that two patients exhibited severe tissue-level 
pathology (Figure 6.2B) while the other cases had mild to moderate pathology or tissue-
processing artifacts. Thus, at least in a couple cases, our algorithm detected severe 
tissue pathology in patients without pre-existing heart failure. 
 
6.3.4. Non-failing patients with severe pathology cluster with heart failure patients 
To determine whether the misclassified patients reproducibly clustered with the incorrect 
class, we used unsupervised clustering. Consensus clustering is an unsupervised 
clustering and resampling technique that provides a visual and quantitative measure of 
the number and stability of discrete classes in a dataset (Monti et al. 2003). It involves 
subsampling a data set, hierarchical clustering using a distance metric, and computing 
the proportion of times items occupy the same cluster with repeated sub-sampling. Since 
both the CNN and WND-CHRM misclassified these patients, and the CNN hidden layer 
activations are difficult to interpret, we used the image-level WND-CHARM feature 
vectors for consensus clustering. 
 
We assessed 𝑘𝑘 ∈ {1, … ,10} clusters and the maximum for the consensus cumulative 
distribution function was at three clusters. Adding more clusters did not significantly 
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increase the consensus values. The consensus matrix for 𝑘𝑘 = 3 is shown in Figure 
6.2C. Although many patients cluster with patients that have similar heart function, a 
small subset of patients fall into a third, smaller cluster in-between the failing and normal 
clusters. Misclassified patients without heart failure, but who had severe tissue 
pathology, either fell into this third cluster or had a majority of their images in the failing 
cluster. 
 
The reproducible unsupervised clustering of these patients with the failing or 
intermediate cluster supports our original findings for a high likelihood of class 
membership in the failing class. This prompted the designation of a new ground truth 
label based on both the clinical history and histopathological findings. The two non-
failing patients described above were reassigned to an “abnormal or heart failure” class 
due to their severe pathology and reproducible clustering away from other non-failing 
samples. The remaining failing and non-failing patients did not change after review and 
were assigned to the “abnormal or heart failure” or “within normal limits” classes, 
respectively. 
 
6.3.5. CNNs accurately detect tissue pathology in heart failure patients 
Table 6.3 and Table 6.4 show the evaluation metrics for classification based on the new 
ground truth labels at the image and patient-level for both the cross-validation and held-
out test datasets, respectively. The CNN showed superior accuracy with a test set 
accuracy of 96.2 ± 1% compared to the 91.7± 1% accuracy using WND-CHARM + RF. 
The CNN also outperformed WND-CHRM + RF in nearly all other metrics on the held-
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out test set most notably, a higher accuracy, sensitivity, and area under the curve (AUC) 
for the Receiver Operator Characteristic (ROC) curve (all p < 0.01, unpaired t-test). 
 
 
Table 6.3 Patient-level performance evaluation for predicting clinical heart failure 
or severe tissue pathology from H&E stained whole-slide images for validation 
folds of the training data set. 
The results are presented as the Mean ± SD of three models. Each model was trained 
on ~770 images from ~70 patients. These models were evaluated on the validation fold 
of ~35 patients. The patient-level diagnosis is the majority vote over all the images from 
a single patient. Statistics were determined by an unpaired two-sample t-test with an N 
of three folds.  
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Table 6.4 Patient-level performance evaluation for predicting clinical heart failure 
or severe tissue pathology from H&E stained whole-slide images for the held-out 
test set. 
The results are presented as the Mean ± SD of three models. Each model was trained 
on ~770 images from ~70 patients. These models were evaluated on the held-out test 
set of 105 patients. The patient-level diagnosis is the majority vote over all the images 
from a single patient. Statistics were determined by an unpaired two-sample t-test with 
an N of three folds.   
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Figure 6.3 shows the corresponding ROC curves for the classifiers trained using labels 
based on clinical history and tissue pathology. We compared the image-level ROC 
curves between the CNN and WND-CHRM + RF using a two-sample Kolmogorov-
Smirnov test to show that the CNN significantly outperforms the feature-engineering 
approach. However, the difference between ROC curves at the patient-level results was 
not statistically significant. Although both algorithms are reasonably efficient at detecting 





Figure 6.3 Receiver Operator Characteristic (ROC) curve for detection of clinical 
heart failure or severe tissue pathology. 
(a) ROC curve for image-level detection on the training dataset (DL vs. RF, p < 0.0001, 
two-sample Kolmogorov-Smirnov (KS) test). (b) ROC curve for patient-level detection on 
the training dataset (DL vs. RF, ns, KS test). (c) ROC curve for image-level detection on 
the held-out test dataset (DL vs. RF, p < 0.0001, KS test). (d) ROC curve for patient-




In this study, we developed a CNN classifier to detect clinical heart failure from cardiac 
histopathology. Previous studies that have applied deep learning to digital pathology 
have used CNNs to generate pixel-level cancer likelihood maps (Cruz-Roa et al. 2017; 
Litjens et al. 2016) or segment relevant biological structures (e.g. glands, mitoses, 
nuclei, etc.) that are used as features for subsequent classification (Cruz-Roa et al. 
2014; Wang et al. 2016a). However, our CNN directly transforms an image into a 
probability of a patient-level diagnosis, which is similar to recent approaches that have 
applied CNNs to diagnose referable diabetic retinopathy and skin cancer (Esteva et al. 
2017; Gulshan et al. 2016). 
 
This direct diagnosis approach can work well but has the disadvantage that the features 
used by the CNN for classification aren’t immediately transparent or interpretable. A few 
methods have been proposed to visualize intermediate features in CNNs (Nguyen et al. 
2015), but what these intermediate features represent and how they are combined to 
make a diagnosis will require interpretation by pathologists. However, a benefit of 
representation learning approaches is that they may reveal novel image features, 
learned by the CNN, that are relevant to myocardial disease. The performance 
difference between the CNN and WND-CHRM + RF pipeline likely reflects the 




The highly accurate and reproducible performance by the CNN shows that cardiac 
histopathology contains robust image features sufficient for classification and diagnosis. 
However, a somewhat surprising finding of this study was that the CNN outperformed 
pathologists at detecting clinical heart failure by a significant margin, up to 20% in terms 
of sensitivity and specificity. Unlike cancer, where the definitive diagnosis is based on 
tissue pathology and genetic or molecular markers, heart failure is a clinical syndrome. 
In the clinical setting, pathologists are not called upon to determine whether a patient is 
in heart failure given a cardiac biopsy. Rather, when no cause of heart failure can be 
identified, pathologists interpret the tissue to identify potential etiologies (e.g. viral 
myocarditis, amyloidosis, etc.). However, it is interesting to note that the Cohen’s kappa 
inter-rater agreement of 0.40 in our task is similar to the value of 0.39 reported for 
Fleiss’s kappa inter-rater agreement for grading heart rejection using the ISHLT 2005 
guidelines (Angelini et al. 2011). Together, these data suggest that deep learning can be 
used in conjunction with digitized pathology images of endomyocardial biopsies to 
predict cardiac failure. This is particularly relevant in light of the recent FDA approval of 
whole imaging systems for primary diagnosis using digital slides (Caccomo 2017). 
 
A review of the misclassified non-failing patients where the CNN gave a high likelihood 
of heart failure led to the discovery of severe tissue pathology in two patients. 
Unsupervised clustering reproducibly grouped these patients away from the non-failing 
class and into the failing class or a third, intermediate cluster. Thus, the CNN identified 
tissue pathology in patients without pre-existing heart failure, suggesting these patients 
may represent cases of occult cardiomyopathy. An important area of research moving 
157 
forward is whether CNNs or other models can use EMBs to predict the future onset of 
heart failure or the rate of decline in patients with mild or moderate heart failure. 
Our study did have its limitations. We assessed our classifier on the extremes of heart 
disease: patients with severe heart failure requiring advanced therapies (e.g. cardiac 
transplant or mechanical circulatory devices) versus patients without a history of clinical 
heart failure. One may argue that comparing extremes exaggerates classifier 
performance. However, the identification of tissue pathology in a small subset of patients 
without a definitive clinical diagnosis suggests these algorithms are very sensitive to 
pathological features of myocardial disease. Future research will need to evaluate the 
ability of CNNs to detect pre-clinical disease. 
 
In summary, we develop a CNN classifier to detect heart failure and show that cardiac 
histopathology is sufficient to identify patients with clinical heart failure accurately. We 
also find that these algorithms are sensitive to detect tissue pathology, and may aid in 
the detection of disease prior to definitive clinical diagnosis. These data lend support for 
the incorporation of computer-assisted diagnostic workflows in cardiology and adds to 
the burgeoning literature that digital pathology adds diagnostic and prognostic utility. 
Future work will focus on predictive modeling in heart failure and post-transplant 
surveillance for rejection, etiologic discrimination of cardiomyopathy etiologies, and risk 
stratification studies which correlate digital histopathology with disease progression, 
survival and treatment responses.  
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6.5. Materials and Methods 
Human tissue research 
Human heart tissue was procured from two separate groups of subjects: heart transplant 
or LVAD recipients with severe heart failure (Fal), and brain dead, organ donors with no 
history of heart failure (non-failing, NF). No organs or tissue were procured from 
prisoners. Prospective informed consent for research use of heart tissue was obtained 
from all transplant or LVAD recipients and next-of-kin in the case of organ donors. All 
patient data and images were de-identified, and all protocols were performed in 
accordance with relevant guidelines for research involving tissue from human subjects. 
Tissue used in this study was collected and processed at the Cardiovascular Research 
Institute and the Department of Pathology and Laboratory Medicine at the University of 
Pennsylvania between 2008 and 2013. All patients were from the same institutional 
cohort. All study procedures were approved or waived by the University of Pennsylvania 
Institutional Review Board. 
 
Dataset collection and histological processing 
Both failing and non-failing hearts received in situ cold cardioplegia in the operating 
room and were immediately placed on wet ice in 4°C Krebs-Henseleit buffer. Within 4 
hours of cardiectomy, transmural biopsies from the left ventricular free wall were fixed in 
4% paraformaldehyde and later processed, embedded in paraffin, sectioned and stained 
with hematoxylin and eosin (H&E) for morphologic analysis. Whole-slide images were 
acquired at 20x magnification using an Aperio ScanScope slide scanner. Images were 
down-sampled to 5x magnification for image analysis, a magnification sufficient for 
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expert assessment of gross tissue pathology. The allocation to the training and held-out 
test cohort was random and performed prior to image analysis. 
Image analysis and machine learning 
 
All image processing and analysis were performed in in MATLAB R2016a, Python, or 
Caffe (Jia et al. 2014).The CNN uses a modified version of the AlexNet architecture 
(Krizhevsky 2009; Krizhevsky and Hinton 2010; Krizhevsky et al. 2012). The network 
accepts 64x 64 pixel RGB image patches (128µm2) with a label corresponding to the 
cohort to which the patient belongs (failing or non-failing). The CNN classifier was 
trained using 100 patches per ROI, per patient, and the training set was augmented 
rotating each patch by 90 degrees. The output of the CNN is a pixel-level probability of 
whether ROIs belong to the failing class. The pixels in a single image were averaged to 
obtain the image-level probability. Each fold of the three-fold cross validation was trained 
using NVIDIA DIGITS for 30 epochs on a Titan X GPU with CUDA7.5 and cuDNN 
optimized by Stochastic Gradient Descent built into Caffe and a fixed batch size of 64. 
 
The comparative approach used WND-CHARM (Orlov et al. 2008) to extract 4059 
engineered features from each ROI, including color, pixel statistics, polynomial 
decompositions, and texture features among others. This rich feature set has shown to 
perform as well or better as other feature extraction algorithms on a diverse range of 
biomedical image (Orlov et al. 2008). The top 20 features were selected using the 
minimal Redundancy Maximal Relevance algorithm (Peng et al. 2005). Alternative 
feature selection methods, such as the Wilcoxon Rank-Sum test and the Fischer score, 
did not show improved performance. These features were used to train a 1000 tree 
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Breiman-style random decision forest (Breiman 2001) using the TreeBagger function in 
MATLAB. The output of the random decision forest was an image-level probability of 
whether an ROI belongs to the failing class. 
 
Evaluation metrics 
The performance of the heart failure classifiers was evaluated using traditional metrics 
derived from a confusion matrix including accuracy, sensitivity, specificity, and the 
positive predictive value (Powers 2011). The area under the ROC curve was computed 
over the three-fold cross-validated models. 
 
The human-level detection of heart failure was performed independently by two 
pathologists experienced in cardiac histopathology. In order to train the pathologists for 
the task, they were given access to the 104 patients in the training dataset, grouped by 
patient, with their images and ground truth labels. To evaluate their performance on the 
test set, each pathologist was blinded to all patient information in the test set. For each 
patient in the test set, they were asked to provide a binary prediction of whether the set 
of images were from a patient with clinical heart failure or not. The pathologists were 
given unlimited time to complete the task. The inter-rater agreement was measured 
using Cohen’s kappa statistic (Cohen 1960). 
 
Code and data availability 
WND-CHARM is open-source and hosted at https://github.com/wnd-charm/wnd-charm. 
The deep learning procedure used here follows the method described in Janowczyk and 
Madabhushi 2016 (Janowczyk and Madabhushi 2016); a deep learning tutorial with 
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source code is hosted at http://www.andrewjanowczyk.com/deep-learning. The data that 
support the findings of this study will be made publicly available through the Image Data 




Statistical tests were performed in MATLAB R2016a. An unpaired, two-sample t-test was 
used to compare two sample means. A one sample t-test was used to compare the CNN 
to the best human performance value for each evaluation metric. A two-sample 
Kolmogorov-Smirnov test was used to compare two distributions. Unsupervised 
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7. CHAPTER 7: Discussion7 
  
                                                
7 This chapter contains sections that were adapted from: 
Nirschl JJ*, Ghiretti AE*, & Holzbaur ELF. (2017). The impact of cytoskeletal 
organization on the local regulation of neuronal transport. Nature Reviews 
Neuroscience, 18(10), 585–597. http://doi.org/10.1038/nrn.2017.100 
*Denotes equal contribution 
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This thesis has interrogated biological questions at the level of single-molecules, cells, 
and tissues using recent advances in computer vision, machine learning, and 
microscopy. We used state of the art microscopy and single-particle tracking algorithms 
to delineate the mechanisms regulating dynein-dynactin loading in a minimal in vitro 
system as well as in primary neurons. We developed a Python toolbox and trained 
neural networks in order to extract high-level image features from microscopic images in 
biological screens. Finally, we developed CNNs to segment histologic structures and 
detect clinical heart failure from whole-slide images of cardiac histopathology. 
 
7.1. Axon transport 
7.1.1. Processes regulating retrograde axonal transport  
In chapter three, we provide evidence for multiple mechanisms regulating retrograde 
transport initiation in neurons. First, there is a spatial gradient of microtubule post-
translational modifications that enhance the affinity of the dynein-dynactin complex, as 
well as other cytoplasmic organelle linker proteins, for microtubules. Second, 
phosphorylation of CLIP-170 in the third serine-rich domain regulates whether CLIP-170 
is active and able to facilitate the transport initiation process. Third, CLIP-170 may act to 
increase the effective search radius of the microtubule, linking the microtubule with 
cargo up to 135nm away, in order to allow efficient cargo capture in the sparse 
microtubule cytoskeleton of the distal axon. Thus, multiple mechanisms converge on the 
transport initiation machinery to provide a robust and highly modular system of 
regulation for a process that is essential to molecular recycling and retrograde signaling.  
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Even these mechanisms only describe a fraction of the processes that could regulate 
retrograde transport. In this work, we considered the regulation of CLIP-170 by 
phosphorylation, but p150Glued (DCTN1) is also subject to phosphorylation at serine 
residues that may play a role in intracellular trafficking (Farshori and Holzbaur 1997). 
Two known examples of the phosphoregulation of p150Glued include phosphorylation at 
Ser-19 by PKA to regulate microtubule binding in non-polarized cells (Vaughan et al. 
2002) and at Ser-179 by Polo-like kinase 1 during mitosis (Li et al. 2010). However, the 
role of p150Glued phosphorylation in axonal transport has not been examined. 
 
A natural question is whether there is any evidence of p150Glued phosphorylation in the 
nervous system. Since, there are no formal studies on this subject, information was 
mined through public phosphor-proteomic databases to address this challenge. Table 
7.1 shows brain-specific phosphorylation sites in p150Glued. The sites mentioned in the 
paragraph above are also identified but are not brain-specific (Huttlin et al. 2010). 













Table 7.1 Brain-specific phosphorylation sites in p150Glued. 
Table of brain-specific phosphorylation sites compiled from a mouse tissue atlas of 
protein phosphorylation (Huttlin et al. 2010) and cultured primary neurons (Liao et al. 
2012). The phosphorylated residue is the amino acid immediately following p. The 
Ascore is the probability of the correct phosphorylation site localization in the peptide 
fragment based on the MS/MS spectra (Beausoleil et al. 2006).  
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This table provides several avenues for future research. An obvious first step involves 
developing phosphor-specific antibodies to recognize these sites and directly assessing 
endogenous phosphorylation in vivo and in primary neurons using immunofluorescence 
or Western blotting. One benefit of the immunofluorescence approach is that it would 
allow visualization of neuronal morphology to address both the absence/ presence of the 
phosphor-protein as well as potential domain-specific localization. 
 
If the endogenous phosphorylation results are promising, a candidate approach would 
be an efficient way to address the potential kinases involved. The P-Ser 105 peptide 
sequence is a predicted site for Casein Kinase 1. This site is not only ranked highly by 
prediction engines but a related kinase family member, Casein Kinase 2, can bind to and 
phosphorylate cytoplasmic dynein (Karki et al. 1997). Since dynein and dynactin are in a 
complex, one possible mechanism of regulating transport is that a Casein Kinase family 
member could act on both components simultaneously to coordinate motility or motor-
adaptor assembly. A straightforward biochemical test would involve 32-P labeling of 
purified, recombinant N-terminal fragments of p150Glued and Casein Kinase 1 or 2. 
 
At least three other kinases deserve mention here. CDK5 and CDKL5 are both predicted 
kinases for sites 105 and 108. CDK5 is known to play a role in the cellular stress 
response and also has a role in regulating axonal transport via phosphorylating Ndel1, 
which regulates dynein via the Lis1/ Ndel1 complex (Klinman and Holzbaur 2015; 
Pandey and Smith 2011). Much less is known about CDKL5 in intracellular trafficking, 
but it does interact with cytoskeletal proteins, and mutations in CDKL5 are linked to 
defects in neuronal architecture as well as the neurodevelopmental disorder Rhett 
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syndrome (Kilstrup-Nielsen et al. 2012). Finally, the NEK kinase family member, NEK1, 
has been implicated in amyotrophic lateral sclerosis (ALS) (Kenna et al. 2016), a fatal 
motor neuron degenerative disease. Mutations in DCTN1 are also linked to motor 
neuron disease (Puls et al. 2003) and ALS (Munch et al. 2004), though previous ALS-
associated DCTN1 mutations did not show robust phenotypes in cells (Dixit et al. 2008). 
 
Assessing the regulation of transport via p150Glued phosphorylation represents an 
exciting future direction; not only because of the bioinformatics results above, but also in 
vitro experimental work in neurons.  In neurons, the CAP-Gly domain of p150Glued is not 
required for efficient mid-axonal retrograde transport (Moughamian and Holzbaur 2012). 
In vitro, the CAP-Gly domain of p150Glued can act as a brake to reduce processive 
dynein-driven transport (Ayloo et al. 2014). Perhaps there is a phosphorylation-
dependent switch that reduces p150Glued microtubule affinity after transport initiation? 
Another possibility is that motility or motor adaptors cause a structural rearrangement of 
the dynactin complex which disengages the p150Glued CAP-Gly domain. Recent 
structural work may support this idea because the structure from a subset of dynactin 
particles show the Coiled-Coil domain of p150Glued can fold back to a position where the 
CAP-Gly domain is likely inaccessible to the microtubule (Urnavicius et al. 2015). 
 
Finally, the future directions listed above may not only provide insight into the regulation 
of transport but also disease processes in neurodegeneration. A recent study applied 
amyloid-β aggregates, a pathological hallmark of Alzheimer’s disease, to cultured 
neurons and reported that amyloid-β treatment reduced DCTN1 phosphorylation levels 
(Henriques et al. 2016). However, the raw phosphorylation peptides not reported, so we 
cannot confirm which of the phosphorylation sites in DCTN1 were affected.  
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Up to this point, we have considered the regulation of retrograde transport by the 
microtubule cytoskeleton and a subset of microtubule-associated proteins, but we know 
the distal axon is enriched with actin and actin-binding proteins (Cingolani and Goda 
2008). Investigating the role of actin in retrograde transport initiation will be an exciting 
line of research. The neurotrophic factor literature has started to shed light on the role of 
actin in retrograde transport. Harrington et al. (2011) show that actin depolymerization is 
required for Quantum-dot labeled NGF to reach the soma after uptake in the distal axon. 
However, the precise mechanisms involved in actin depolymerization, such as where 
and when it is required, as well as how organelles transition from actin to microtubule-
based transport are unclear. 
 
A direct follow-up to the neuronal work in chapter 3 could use cultured neurons in 
microfluidic chambers and apply actin stabilizing (e.g., jasplakinolide) or destabilizing 
(e.g., latrunculin B, cytochalasin D) compounds selectively to the mid or distal axon. 
Live-cell imaging of retrograde flux in these conditions would provide insight into when 
and where actin dynamics are required for efficient, processive transport. However, 
disrupting actin dynamics in neurons may prove challenging. Actin in dendritic spines is 
known to be resistant to the depolymerization compound cytochalasin D, suggesting a 
population of stable, depolymerization resistant F-actin in neurons (Allison et al. 1998). 
Further, a recent study found evidence for continued neurite outgrowth and intact F-actin 
in the distal axon in neurons treated with latrunculin B or cytochalasin D for 24 hours at 
all tested concentrations of (1-10µM) (Chia et al. 2016). 
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This presents a challenge for experimental work, but raises a separate set of intriguing 
questions regarding the neuronal cytoskeleton such as: What confers resistance to F-
actin depolymerization in the axon terminal and dendritic spines? How do stable actin 
filaments develop in the neuron and does it occur via time-dependent maturation or 
specific targeting of a subset of actin filaments by post-translational modifications and 
actin-binding proteins or both? And what role, if any, does this stable population of F-
actin in the distal axon have to do with maintaining the distal enrichment of dynein or 
dynactin (Moughamian and Holzbaur 2012; Twelvetrees et al. 2016). With respect to the 
final question, it is clear that kinesin-driven slow anterograde transport of dynein, and 
likely dynactin, are essential to transport dynein distally (Twelvetrees et al. 2016). 
Intuitively, the dynein and dynactin must be sequestered or inactivated until needed to 
preserve the gradient; however, this needs to be tested. 
 
Returning the question of the retrograde transport, cytoplasmic linker proteins (CLIPS 
and CLASPS) may be critical bridges for more than just dynein-dynactin loading. For 
example, in addition to binding to DCTN1 and microtubules, CLIP-170 can also bind to 
actin binding proteins such as mDia1 (Lewkowicz et al. 2008). In the distal axon, CLIP-
170 localizes to F-actin patches in the growth cone (Beaven et al. 2015). The finding that 
CLIP-170 is phosphorylated in brain tissue suggests (Huttlin et al. 2010) that inactive 
CLIP-170 may localize to actin in the distal axon until required for transport. However, 
we know that CLIP-170 has roles outside of axonal transport, including regulating actin 
and microtubule dynamics as well as axon formation and outgrowth (Bearce et al. 2015; 
Galjart 2005; Neukirchen and Bradke 2011). A thorough understanding of CLIP-170 in 
the distal axon will require integrating its many functions into a coherent framework.  
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The actin-CLIP-170 interaction may also be relevant to our in vitro studies of CLIP-170 
and dynein-dynactin transport initiation. Surprisingly, CLIP-170 and mDia1 were recently 
shown to promote ultra-fast actin polymerization from growing microtubule plus-ends in 
vitro (Henty-Ridilla et al. 2016). This suggests a possible mechanism for organelle 
capture by CLIP-170 ‘riding’ on polymerizing actin. Our in vitro reconstitution assay 
would be an excellent system to test this hypothesis. However, reconstituting actin and 
microtubule dynamics with purified CLIP-170 and a functional dynein-dynactin complex 
is a very technically challenging project. Another mechanism through which CLIP-170-
mediated actin polymerization could be relevant for transport initiation is via generating 
actin-microtubule intersections. Recent work has shown that actin-microtubule 
intersections can facilitate the initiation or termination of cargo driven by multiple motors 
(McIntosh et al. 2015) and this could provide yet another layer of regulation. 
 
7.1.2. Translating molecular insights into therapeutic strategies 
In the process of dissecting the mechanisms that regulate retrograde transport initiation, 
we can learn information relevant to potential therapeutic strategies. The fatal 
neurodegenerative disease Perry syndrome is caused by point mutations in the p150Glued 
subunit of dynactin (Farrer et al. 2009). The primary phenotype in cultured mammalian 
neurons and Drosophila in vivo is a specific reduction in retrograde transport initiation 
from the distal axon (Lloyd et al. 2012; Moughamian and Holzbaur 2012). Our results 
suggest that therapies which improve the efficiency of loading dynein-dynactin cargo 
onto microtubule, such as modulating CLIP-170 dependent recruitment, may mitigate 
defects transport initiation. However, the transport initiation process is complicated and 
developing therapies may not be straightforward.  
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For example, over-expression of active, de-phosphorylated CLIP-170 (CLIP-A) can 
rescue the siRNA knockdown of CLIP-170, but it did not produce noticeably increased 
rates of lysosomal transport initiation compared to wild-type (Figure 3.3). Perhaps 
lysosomes are not the best cargo for testing therapeutic strategies for transport initiation. 
Other cargoes, such as autophagosomes or neurotrophic factor signaling endosomes 
may be more appropriate since they represent organelles enriched in the distal axon that 
depend on retrograde transport to reach the soma and fulfill their cellular function. 
Alternatively, there may be a ceiling to rates of transport initiation due to the density of 
cargo, microtubules, and motors in the distal axon; or that CLIP-170 is not the rate-
determining step in transport initiation. There are no therapies to modulate axonal 
transport, but continued basic research, such as the work described here, will help focus 
the lines of investigation to critical proteins and pathways. 
7.1.3. Local regulation of transport in other neuronal compartments 
Retrograde transport initiation in the distal axon is just one example of the local 
regulation of transport in a single neuronal compartment. However, the mature neuron is 
composed of many subdomains, each with a distinctive cytoskeletal organization. This 
local structure creates unique transport challenges and requirements within each region. 
The dynamic interplay between the local cytoskeleton, motors, and gradients of 
regulatory elements within each subdomain makes it clear that neuronal trafficking must 
be understood in a subcellular context. Although each subdomain faces different 
challenges and needs, local regulation is achieved using a core set of cytoskeletal and 
molecular tools. We are only beginning to discover how these tools are differentially 
employed and executed to allow the precise navigation of the neuronal cytoskeletal 
architecture, and many critical questions lie ahead.  
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7.2. Data science in biomedical research 
“Data science also holds tremendous potential, not only for enhancing the 
efficiency of the conduct of science, but also for increasing the impact of 
fundamental science, along with many other areas of biomedical 
research.” NIH-Wide Strategic Plan 2016 – 2020, p16 (Collins 2016) 
 
Biology and medicine are now firmly embedded in the age of algorithms, information, 
and data science. There is a need for advanced computational tools in biomedical 
research, especially image analysis, in order to automate quantification and extract 
information from large, high-dimensional image datasets. The NIH has recognized this 
need and highlighted data science in their recent fiscal plan and strategic outlook; in 
addition to sponsoring “big data” and “data science” initiatives (Collins 2016) 
 
7.2.1. Biomedical research in the 21st century 
Immediate applications of artificial intelligence (AI) in basic research and medical image 
analysis will likely focus on automating repetitive tasks and improving existing workflows. 
Indeed, applications already include automating or improving segmentation, image 
classification, and feature extraction (Carpenter et al. 2006; Jones et al. 2008; Litjens et 
al. 2016; Sommer and Gerlich 2013; Sommer et al. 2011). These are important lines of 
research and will advance research and medicine, automating routine tasks, allowing a 
more granular assessment of image data, and improving reproducibility (discussed in 
section 7.2.4). However, it would be a shame to relegate artificial intelligence to routine 
tasks deemed too tedious for human attention (Granter et al. 2017). 
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Henry Ford is often misquoted as having said the following regarding the invention of the 
automobile: “If I had asked people what they wanted, they would have said faster 
horses.” (Vlaskovits 2011). Regardless of the quote origin, we can interpret the content 
in light of developing new and innovative AI applications in biomedical research. 
Engineers looking to develop the “killer app” for cell biologists or pathologists may 
appropriately focus on the current needs of basic researchers and pathologists, which 
include automated segmentation and classification to improve existing workflows. These 
are useful applications that are urgently needed, but we should bear in mind that the 
next most important application of AI in biomedical imaging, or society in general, likely 
hasn’t even entered the public consciousness because it fills a need we do not know 
exists or it is so fundamentally different from the current system of thought or practice. 
 
7.2.2. Phenotypic profiling 
In Chapter 4, we challenge the traditional approach of feature extraction and profiling in 
high-content screening by posing the questions: “What if the features aren’t known or 
what if the transforms are too difficult to formulate?” We attempt to address these 
questions by developing and applying trained CNNs as deep feature extractors. We 
show that deep features trained on one dataset encode image phenotypes sufficient to 
cluster subcellular structures by type and separate drug compounds by the mechanism 
of action. In the process, we develop Cell DECODER, a neural network toolbox for deep 
feature extraction and phenotypic profiling using CNNs. Our hope is that this work will 
enable more biologists to access the power of deep learning and that it will empower 
basic researchers to develop computational skills, which are needed, now more than 
ever, in scientific research.  
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The field of computer vision in cell biology is an exciting and fast-paced field. Recently, 
groups have started to apply CNNs for cell classification in flow cytometry (Eulenberg et 
al. 2017), improved segmentation in high-throughput microscopy (Van Valen et al. 
2016), and prediction of hematopoiesis lineage specification (Buggenthin et al. 2017). 
Our work represents an early attempt to use the deep features or hidden-layer 
representations in trained networks for phenotypic profiling on new datasets. Developing 
and applying new neural network architectures, such as deep metric networks, are one 
future direction for phenotypic profiling in high-throughput microscopy (Ando et al. 2017). 
 
Another area of future research involves improving transparency in neural networks. 
Deep learning is typically described as a ‘black box’ approach where the learned 
representations and decision-making process of the network are difficult to interpret. 
However, recent work has attempted to demystify the ‘black box’ using deconvolution 
networks (Zeiler et al. 2010), synthesizing image patterns that maximally activate 
‘neurons’ or sets of ‘neurons’ in the network (Mordvintsev et al. 2015; Yosinski et al. 
2015), or generating saliency maps that highlight the regions of the image important for 
classification (Simonyan et al. 2013). Applying these techniques to CNNs used in 
phenotypic profiling will allow biologists to evaluate the learned image phenotypes and 
may reveal novel image features. 
 
Finally, another exciting future direction involves unsupervised learning or learning 
without labels. There are numerous cellular images without labeled phenotypes. One 
solution is to use active learning approaches in fluorescence microscopy (Jones et al. 
2009; Naik et al. 2016), where a small set of images are labeled, and unlabeled images 
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are clustered into existing labels by a similarity metric. Another solution involves 
unsupervised deep learning, where data without human labels are input to the neural 
network, and the network attempts to model the underlying data structure. This has the 
potential to make use of large unlabeled datasets, but there are significant theoretical 
and engineering challenges to overcome before unsupervised learning can reach the 
performance of current supervised deep learning methods. 
7.2.3. Digital pathology 
In chapter five, we develop CNNs for automated tissue segmentation in cardiac 
histopathology. This application involves the automation and improvement of traditional 
tasks in pathology, such as annotation or quantification of histologic features. One future 
direction is to bring this technology to the clinic. The recent FDA approval of imaging 
systems for digital pathology is an esential first step in this process (Caccomo 2017). 
 
In chapter six, we show that a CNN can be trained to classify clinical heart failure from 
cardiac histopathology. Importantly, the deep learning approach outperformed a 
traditional machine learning algorithm, a random decision forest, and two pathologists. 
We acknowledge that the machine-human comparison was contrived because 
pathologists usually interpret histopathological findings given a diagnosis of heart failure 
and not the other way around. However, we felt that a fair comparison gives all agents 
(algorithm or human) access to the same data. Our algorithms were trained on a subset 
of regions of interest (ROIs) randomly sampled from the tissue, so we provided the 
pathologists with the same data. We did group ROIs by patients for pathologists though, 
as described in the methods. Thus, pathologists had the context of multiple samples 
grouped by patient whereas the machine did not have this benefit.  
177 
The fact that a deep learning classifier can outperform a random decision forest 
classifier using traditional image features is not surprising in itself. Deep learning has 
shown remarkable progress in medical imaging and can use images to classify diabetic 
retinopathy (Gulshan et al. 2016), skin cancer (Esteva et al. 2017), and lung cancer 
(Wang et al. 2017) to name a few recent applications. However, the relevance of 
comparing the CNN to the random decision forest is that it demonstrates that the CNN 
was able to learn representations that were not captured by a library of nearly 4000 
image features (Orlov et al. 2008). One future application of CNNs in medical imaging is 
to reverse-engineer the image features and decision-making process of the neural 
network, using the methods described in section 7.2.2. If we are able to do this, we could 
re-train pathologists to recognize subtle image features that were previously unidentified 
or update diagnostic and grading criteria to include new decision rules. 
 
Finally, a critical future direction for biomedical imaging involves integrating discoveries 
at all scales of investigation from molecules to cells, tissues, and patients. For example, 
recent work has shown that changes in microtubule detyrosination are a molecular 
feature of heart disease that correlates with contractility and disease progression 
(Robison et al. 2016). In the clinic, pathologists could use immunohistochemical or 
immunofluorescence to highlight additional disease features, such as microtubule 
detyrosination, which are not captured by routine hematoxylin and eosin staining.  
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7.2.4. Methods reproducibility: An argument for computational image analysis  
Reproducibility is one of the many arguments given in favor of computational image 
analysis in biomedical research. However, we must first define our terms, because 
reproducibility is referenced in many different contexts. Dr. Ioannidis, a leader in the field 
of scientific reproducibility, has parsed the traditional terms of reproducibility and/or 
replicability into three terms to describe the most common usages; the terms include 
methods reproducibility, results reproducibility, and inferential reproducibility as shown in 
Table 7.2 (Goodman et al. 2016). 
Type of Reproducibility Former term Definition (Goodman et al. 2016) 
Methods reproducibility Reproducibility “…the ability to implement, as exactly as 
possible, the experimental and comput-
ational procedures, with the same data 
and tools, to obtain the same results.” 
Results reproducibility Replicability “…the production of corroborating results 
in a new study, having followed the same 
experimental methods.” 
Inferential reproducibility  “…making of knowledge claims of similar 
strength from a study replication or 
reanalysis.” 
Table 7.2 Types of reproducibility in scientific research, per Goodman et al. (2016). 
 
Advances in data science and image analysis software will enable scientists, even 
without programming experience, to more accurately describe and quantify images. 
Improved metrics will allow researchers to characterize cellular processes in more detail. 
For example, we used our single-molecule image analysis pipeline in chapter 3 to show 
that both alpha-tubulin tyrosination and active CLIP-170 increase landing rates without 
affecting vesicle dwell time. This provided evidence that these regulatory mechanisms 
increase on-rates without substantially affecting off-rates, a finding that reveals important 
details about the molecular processes. An analysis with lower sensitivity could have 
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missed this point. Another example includes the sub-classification of TDP-43 RNA 
granules by morphology, which independently correlates with the granule biophysical 
properties, although the area distributions are similar (Gopal et al. 2017). 
 
The ability to extract more, high-quality information from image data is a reward in itself. 
However, computational image analysis will also improve methods reproducibility in 
biomedical imaging. A program, by definition, is an explicit sequence of instructions for 
performing a task. Thus, image analysis pipelines partially fulfill methods reproducibility 
because they are the tools and contain the computations to transform image data into 
results. They are more than that though because software can also be executed, which 
allows anyone to run the same data, computations, and tools to reproduce the results. 
 
Most scientists agree this is good, but an argument for manual analysis may appeal to 
the fact that a scientific finding is more convincing when a reanalysis observes findings 
of similar magnitude, using different human interpretations of images and/or analysis 
criteria. This is where defining terms is essential, because methods reproducibility, as 
defined above, involves implementing the experimental and computational process “as 
exactly as possible” using the “same data and tools.” In the case of manual analysis, 
tools not only refer to software but also the human interpretation, which include the 
domain expertise of an individual. Using the definitions in Table 7.2, this argument 
seems to fit inferential reproducibility, where observations or findings of similar strength 
are found on reanalysis. Nevertheless, an executable for precise methods reproducibility 
does not prohibit reanalysis, manual or computational, for any other type of 
reproducibility and science will benefit from as many forms of reproducibility as possible.  
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7.2.5. Garbage In, Garbage Out: The GIGO principle in biomedical imaging 
On two occasions I have been asked, "Pray, Mr. Babbage, if you put 
into the machine wrong figures, will the right answer come out?”…  
I am not able rightly to apprehend the kind of confusion of ideas that 
could provoke such a question. Passages of a Philosopher, p67 
(Babbage 1864) 
 
Garbage In, Garbage Out (GIGO) refers to the principle in computing and mathematics 
that the output quality is determined by the input quality. The concept underlying the 
GIGO principle has been around since Charles Babbage’s first mechanical computer 
(Babbage 1864) and the recent use in the 1950’s can either be attributed to an army 
specialist, William Mellin, or an IBM programmer, George Fuechsel. Regardless, the 
GIGO principle could not be more relevant in the current scientific environment. 
 
7.2.5.1. Respecting the GIGO principle 
The massive growth in the scale of data collected in biology and medicine is both a 
blessing and a curse. Is it possible to build a model from noisy or incorrect data? Yes, 
according to the GIGO principle, but the output will reflect the quality. For the sake of 
argument, a purely data-driven scientist might counter that informative patterns with 
sufficient signal will emerge in a large enough dataset (Halevy et al. 2009). I believe 
there is truth to this argument and in the future it will be critical to leverage the power of 
very large, imperfect datasets using unsupervised learning or active learning 
approaches. However, there are problems with naively accepting this approach in 
biomedical imaging, since the size of public biomedical image datasets are orders of 
magnitude smaller than existing collections of web images, such as ImageNet (Deng et 
al. 2009). Another problem is that we do not know the amount of data required to 
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overcome given levels of input noise. In natural language processing, experts posit that 
a hundred to a million-fold increase in dataset size is likely sufficient for complex 
linguistic patterns to emerge in noisy and incompletely labeled datasets (Halevy et al. 
2009). This provides an estimate, but the amount of data required will likely depend on 
the problem domain, the type and magnitude of input errors, and the learning algorithm. 
 
In smaller datasets, the added noise may reduce one significant advantage of large, 
computational approaches, which is the power to identify and discriminate complex or 
subtle phenotypes. To further complicate the matter, training models using noisy data 
assumes stochastic stability of the underlying noise or error-generating function over 
time. Thus, future predictions may depend on an out-of-date noise or error model, which 
is not unlikely given the rapid advances in imaging technology or improvements in data 
standardization and data labeling, not to mention the multitude and variety of factors 
beyond human control. Thus, it behooves researchers to respect GIGO principle. 
 
At the individual level, experimentalists should adhere to guidelines for image 
acquisition, annotation, and data analysis and sharing (Caicedo et al. 2017). At the 
community level, there is the need to organize the rapidly accumulating data into large-
scale, standardized biological image databases with verified labels, similar to what 
ImageNet did for the Google Image Search database (Deng et al. 2009). There are 
already efforts underway to standardize image metadata, including the Open Microscopy 
Environment (OME) file format (Linkert et al. 2010) and the Image Data Resource 
(Williams et al. 2017).  
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The development of large image databases that are easily accessible, publicly available, 
and centralized or linked with other databases is another challenge. Currently, there are 
many excellent public image databases including: The Cancer Imaging Archive (Clark et 
al. 2013), The Human Protein Atlas (Thul et al. 2017; Uhlen et al. 2015; Uhlen et al. 
2017), and the Image Data Resource (Williams et al. 2017) among others. However, 
each database has its own set of licenses, restrictions, and methods for accessing 
image data. Moreover, the image phenotypes or labels in each database may not be 
complete or congruent with labels in other databases. Thus, phenotypes would ideally 
be mapped to a common ontology, which—in information science—refers to the formal 
representation of categories, concepts, and properties of entities as well as their 
interrelationships. The Cellular Microscopy Phenotype Ontology (Jupp et al. 2016) is one 
effort to provide a species-neutral ontology for cellular and sub-cellular phenotypes. 
However, it would be useful to link this ontology with the existing gene, tissue, and 
clinical ontologies to efficiently map phenotypes across multiple scales and systems. 
 
Clearly, this is a herculean task meant for multiple groups, institutes, and the community 
at large over the next decade or more. However, a large-scale image databases linked 
to an ontology of biological phenotypes would be a boon to artificial intelligence and 
bioimage informatics researchers attempting to parse relationships among genes, 
cellular, and tissue level phenotypes expressed as images. The Image Data Resource, 
an open-source platform for storing and annotating data from high content screens, 
multidimensional microscopy images, and digital pathology is taking steps in the right 
direction, and it is already integrated with the Cellular Microscopy Phenotype Ontology 
project, but it needs to be adopted by the community in order to be successful.  
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7.2.5.2. Bias In, Bias Out 
It is easy to dismiss the GIGO principle as simple to follow and only likely to be violated 
in poorly constructed experiments or databases. It is also easy to fall into the trap of 
believing that computational analysis is completely unbiased and objective. While 
algorithms do not have irrational human biases or other subjective human traits, bias can 
be introduced at multiple levels during computer analysis. We will focus our discussion 
below on bias introduced at the level of the training dataset. 
 
Training datasets that are imbalanced or do not accurately represent the population can 
bias the model and ultimately predictions or inferences based on the model. One recent 
and embarrassing example in popular culture were the results from the first Beauty.AI 
contest, reported in The Guardian (Levin 2016). This was a beauty contest judged only 
by deep learning algorithms trained on a database of headshots, and it was supposedly 
trained to determine facial symmetry, wrinkles, etc. Although nearly 6,000 people 
worldwide entered the contest, the majority of winners were white, and only one out of 
the 44 winners had a dark complexion. As reported by The Guardian, Alex 
Zharvoronkov, who is Beauty.AI’s chief scientific officer, admitted that the training 
dataset likely did not include enough minorities (Levin 2016). 
 
Let this be a cautionary tale for biomedical image databases. As an exercise, we can 
ask how the frequency of cell lines referenced in biomedical research articles compares 
to the frequency of images per cell line in The Human Protein Atlas. I performed a 
Google Scholar search for articles mentioning one of 22 different human cell lines and 
compared the search results to the image frequency in The Human Protein Atlas. 
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The results are shown in Figure 7.1. It is no surprise that the HeLa cell line, broadly 
defined, represents 41% of all search results. However, images of HeLa cells account 
for less than 1% of images in the cell atlas. The imbalance is also apparent when we 
examine the three cell lines that were initially used to establish The Human Protein Atlas 
(A431, U251-MG, U2-OS). These cells lines account for nearly 73% of the Human 
Protein Atlas cell images, but references to these cells are only found in 4% of search 
results that mention any cell line in the Google Scholar database. 
 
This is not to argue that we need more HeLa images in public databases or that A431 
cells should be used in more research studies. Instead, as 21st-century scientists, in an 
algorithm and data-driven world, we should ask ourselves the following questions: 
What bias could result from our data or models built using this data, and how can we 
mitigate this bias? How can we take advantage of existing data while developing 
forward-compatible models that remain effective on different distributions of classes or 
error-properties? Most importantly, are our datasets and models adequately 
representing the population of interest or the fundamental biology, physiology, or 




Figure 7.1 Frequency of cell lines referenced in biomedical research. 
The fraction of images for each cell line in The Human Protein Atlas was recorded, after 
downloading the dataset as described in chapter four. The number of results was 
obtained by querying the database for articles with any mention of a cell line in the 
abstract, keywords, title, or associated full text; the search terms included all 
abbreviations, names, and synonyms recognized in the Cellosaurus database (Bairoch 
2017). The search for each cell line was performed independently to allow articles that 
used multiple cell lines to count toward more than one group. The total number of results 
was obtained by searching for all cell lines. The Google Scholar database was accessed 
on September 21st, 2017. 
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7.3. Concluding remarks 
“…the question of whether machines can think …is about as relevant as 
the question of whether submarines can swim.” Edsger W.Dijkstra (1984) 
 
AI will play an increasing role in medicine, science, and society at large, without a doubt. 
It will disrupt disciplines and conventional ways of thinking through a process that has 
been aptly referred to as the “information revolution.” In the process, it will reduce 
demand for specific jobs or technology, or make them altogether obsolete. At the same 
time, it will propel new industries and jobs as well as new medical and scientific 
discoveries. There will be anxiety and uncertainty, but also awe, excitement, and 
remarkable progress in many disciplines. A challenge for 21st-century scientists will be 
leveraging new technology in creative applications that transcend current limitations 
while integrating these techniques with the strengths of traditional approaches. 
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APPENDIX I 
Supplemental figures for chapter 3 
 
Figure S 1, related to Figure 3.1 
Supplementary data for Figure 3.1. (A) Deconvolved max projection confocal images of 
COS-7 cells transfected with HaloTag (HT) CLIP-170 (WT, A, E) and stained for the HT 
epitope. Phosphodeficient CLIP-A comets are significantly longer than phosphomimetic 
CLIP-E as shown previously (Lee et al. 2010); this comparison shows the dynamic range 
of CLIP-170 phosphorylation (B) Bootstrapped mean and 95% confidence intervals (CI) 
for line scans of CLIP-170 comets (n > 60 comets per condition from 4 cells, N = 2). (C) 
Mean p150Glued intensity per cell for p150Glued WT or G71R shows similar levels of 
recombinant protein expression (n > 40 cells, N=2). (D) Representative dSTORM image 
of HT-CLIP-A comets decorated with myc-p150Glued WT. 
  
188 
Figure S 2, related to Figure 3.2 and Figure 3.5 
Western blot characterization of neuronal vesicles, related to Figure 3.2 and Figure 3.5. 
Western blot of isolated neuronal vesicles shows a robust population of vesicles similar 
to (Hendricks et al. 2010). Fractions were blotted for antibodies to dynein heavy chain 
(DHC), dynein intermediate chain (DIC), p150Glued, p50-GFP, Lis1, kinesin-1 heavy chain 
(KHC), kinesin-2, LAMP-1, synaptotagmin, beta-tubulin, and GAPDH. Cytosolic marker 




Figure S 3, related to Figure 3.2 
Supplementary data for Figure 3.2. (A) Standard curve of the absorbance (555nm) of 
tetramethylrhodamine (TMR) in lysis buffer (mean + SD; n = 10, N = 3). (B) Spectrum 
sweep showing the absorbance of TMR standard in lysis buffer vs mock-transfected cell 
lysates at different wavelengths. At 555nm, cytosolic proteins in cell lysates have very 
low absorbance and thus minimally interfere with TMR measurements used in the assay 
to determine relative concentration of TMR-labeled proteins in cell lysates. (C) Western 
blot of cell extract HSS for TMR labeled CLIP-WT, CLIP-A, and CLIP-E. Densitometry 
analysis, normalized to WT condition, shows similar levels of HT-CLIP protein in cell 
lysates (mean +SD). (D) Western blot of cell extract HSS shows similar levels of 
expression of EB1, Lis1, and p150Glued regardless of the recombinant CLIP-170 
construct. (E) Above, the still images from TIRF movies with 100nM unlabeled EB1 + 
~100nM CLIP in the lysate HSS. CLIP-E shows very little microtubule decoration 
whereas CLIP-A robustly decorates GMPCPP microtubules. Below, the still images from 
TIRF show 100nM Rhodamine labeled EB1 decorating GMPCPP microtubules. (F) 
Schematic of computational image analysis workflow. Additional details provided in the 
Supplemental Experimental Procedures. (G) Parameter sweep of uTrack thresholds for 
local maxima detection show a stable number of particles is detected with a local 
maxima threshold of 0.01 for a single frame or 0.005 for over a window of 3 frames 
(green line). At this threshold, the median SNR for detected particles is 4.1, which is 






Figure S 4, related to Figure 3.3 
Supplementary data for Figure 3.3. Quantification of the median normalized intensity per 
neuron for the Oregon Green-labeled CLIP rescue constructs. These data are from the 
same neurons used for measuring retrograde flux in Figure 3.3B, C and demonstrate 
that all rescue constructs expressed to similar levels. Intensity was normalized to the 




Figure S 5, related to Figure 3.5 
Supplementary data for Figure 3.5. (A) Histogram of the microtubule lengths for 
GMPCPP microtubules polymerized with purified Tyr-/Detyr-tubulin. Each dataset was 
normalized to its Probability Density Function (PDF); distributions were compared with a 
two-sample KS test (p = 0.11; n > 1400 microtubules per condition total; N = 3). (B) 
Quantification of landing rate for Tyr-/ Detyr microtubules, separated by the fluorescently 
labeled tubulin used, shows a significant increase in landing rate on Tyr microtubules 
regardless of labeled tubulin (n > 30 movies per condition, each movie with > 500 
events; N = 3 independent vesicle isolations; Kruskal-Wallis one way ANOVA with 
Tukey-Kramer post-tests). (C) Histogram of the normalized PDF of dwell times on TRITC 
or AF647 labeled Detyr-microtubules show overlap of the distributions. (D) Histogram of 
the normalized PDF of dwell times on TRITC or AF647 labeled Tyr-microtubules show 




Figure S 6, related to Figure 3.6 
Supplementary data for Figure 3.6. Coomassie stained gel of purified proteins, including 
EB1, CLIP-170-H2-GFP, p150Glued [1-210]-GFP, p150Glued ∆Basic [1-210]-GFP, p150Glued 




Figure S 7, related to Figure 3.7 
Supplementary data for Figure 3.7. (A) Pseudocode for Monte Carlo simulation of 2D 
vesicle diffusion and microtubule capture. Parameters: timeStep = 0.1s, D = 0.006µm2/s, 
D_Std= sqrt(2*D*timeStep), Prob(Tyr) = 1, Prob(Detyr) = 0.25, MaxDuration = 1200 s. 
(B) Quantification of the median time to MT capture with Tyr probabilities and CLIP-E or 
CLIP-A at diffusion coefficients 0.05 – 1.0µm2/s . (C) Scatter plot of the time to MT 
capture given the initial starting distance from the microtubule with Tyr probabilities and 
CLIP-E or CLIP-A at a diffusion constant 0.006µm2/s. There was a 2.4 fold increase in 
the number of CLIP-E (red arrowhead) particles that never reach the microtubule within 
a 20 minute simulation with as compared to CLIP-A (blue arrowhead). (D) The 
bootstrapped mean and 95% confidence intervals for the time to MT at each starting 
distance are plotted below. The two lines overlap and the time to capture in these 
simulations is determined by the initial distance. Thus, the effect of CLIP-A is due to a 
shift in the distribution of starting positions such that they are, on average, closer to the 





Supplemental tables for chapter 3 
Table S 1, related to Figure 3.3 
Kruskal-Wallis one-way ANOVA and Tukey-Kramer post-hoc tests between groups for 
data in Figure 3C. 
Kruskal-Wallis one-way analysis of variance 
  Chi-sq:  29.4 
    df: 4 
    p: 6.50x10-6 
    
      Tukey-Kramer post-hoc test between groups 
  Groups being compared: p value 
 
Number Condition 
1 2 0.002107 
 
1 Mock siRNA 
1 3 0.999890 
 
2 siRNA + Vector 
1 4 0.997870 
 
3 siRNA + CLIP-WT 
1 5 0.216500 
 
4 siRNA + CLIP-A 
2 3 0.000094 
 
5 siRNA + CLIP-E 
2 4 0.000204 
   2 5 0.271370 
   3 4 0.999570 
   3 5 0.100470 
   4 5 0.155260 
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Table S 2, related to Figure 3.6 
Kruskal-Wallis one-way ANOVA and Tukey-Kramer post-hoc tests between groups for 
data in Figure 6B. 
Kruskal-Wallis one-way analysis of variance 
   Chi-sq:  137.87 
     df: 7 
     p: 1.42x10-26 
     
       Tukey-Kramer post-hoc test between groups 
   
Groups being compared: p value 
 
Numbe
r Protein Tyr/ Detyr 
1 2 6.0033x10-8 
 
1 CLIP-WT  Detyr 
1 3 0.99998 
 
2 CLIP-WT Tyr 
1 4 5.9893x10-8 
 
3 CLIP-A  Detyr 
1 5 0.99996 
 
4 CLIP-A Tyr 
1 6 0.08692 
 
5 CLIP-E  Detyr 
1 7 0.00001 
 
6 CLIP-E Tyr 
1 8 0.00034 
 
7 CA-Kinesin-1[560]  Detyr 
2 3 6.0433x10-8 
 
8 CA-Kinesin-1[560] Tyr 
2 4 1.00000 
    2 5 5.9882x10-8 
    2 6 0.00040 
    2 7 0.56326 
    2 8 0.16285 
    3 4 5.9927x10-8 
    3 5 0.99633 
    3 6 0.17335 
    3 7 0.00003 
    3 8 0.00095 
    4 5 5.9881x10-8 
    4 6 0.00010 
    4 7 0.40957 
    4 8 0.08941 
    5 6 0.01853 
    5 7 4.8394x10-7 
    5 8 0.00002 
    6 7 0.23258 
    6 8 0.69481 
    7 8 0.99683 
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Supplemental movies for chapter 3 
Movie S 1, related to Figure 3.1 
http://www.cell.com/cms/attachment/2079983007/2071442196/mmc2.mp4 
STORM 3D reconstruction of WT p150Glued puncta associated with a CLIP-A comet at 
the microtubule plus end, related to Figure 1. This represents a cropped view of a single 
microtubule plus end (unlabeled) in COS-7 cells expressing myc-p150Glued WT and HT-
CLIP-A. CLIP-A decorates the microtubule plus end as long comets, which is shown in 
magenta. Wild type p150Glued forms either discrete clusters of p150Glued that dock on the 
CLIP-A comet and correspond to the p150Glued-positive puncta identified by confocal 
microscopy. In addition, a soluble pool of point-localized p150Glued also localize to the 
CLIP-A comet. 
 
Movie S 2, related to Figure 3.5 
http://www.cell.com/cms/attachment/2079983007/2071442197/mmc3.mp4 
Robust p50-GFP-vesicle recruitment to Tyr microtubules. Alexa647-labeled Tyr 
microtubules are shown in magenta, related to Figure 5. TRITC-labeled Detyr 
microtubules are shown in red. The Green-Fire-Blue lookup table was applied to GFP-
vesicles for better visualization. Playback is 2x real time (20fps). 
 
Movie S 3, related to Figure 3.5 and S5 
http://www.cell.com/cms/attachment/2079983007/2071442198/mmc4.mp4 
p50-GFP-vesicle recruitment to Tyr microtubules is independent of the fluorescent 
tubulin label, related to Figures 5 and S5. TRITC-labeled Tyr microtubules are shown in 
red. Alexa647-labeled Detyr microtubules are shown in blue. The Green-Fire-Blue 
lookup table was applied to p50-GFP-vesicles for better visualization. Playback is 2x real 
time (20fps). 
 
Movie S 4, related to Figure 3.6 
http://www.cell.com/cms/attachment/2079983007/2071442199/mmc5.mp4 
Representative movies for CLIP-WT/ -A/ -E recruitment to Tyr or Detyr-microtubules. 
TMR-HaloTag-CLIP-170 is shown in red; Alexa488 Tyr-microtubules in green; and 
Alexa647 Detyr-microtubules in blue. The Alexa labeled tubulin used for Tyr/ Detyr-
microtubules was reversed for half of the experimental repeats with similar results. 
Playback is 2x real time (20fps). 
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Supplemental experimental procedures for chapter 3 
Microscopy 
Single-molecule imaging was performed on an inverted Nikon Ti Eclipse equipped for 
total internal fluorescence (TIRF) microscope with a cooled Hamamatsu ImagEM 
charge-coupled device (CCD) camera C9100-13 using a 1.45 N.A. x100 oil immersion 
objective with an effective pixel size of 159nm. Single molecule imaging acquired the 
channel of interest at a rate of 10 frames per second for 2 minutes, with still images of 
microtubule captured at 0 and 2 minutes. Exposure times were 75ms and laser 
intensities were kept constant whenever conditions were compared. Spinning disk 
confocal microscopy was performed on an inverted Nikon Ti Eclipse with a Perkin-Elmer 
Ultra VIEW Vox spinning disk confocal module and a PhotoKinesis accessory for 
photobleaching. Images were acquired with a Hamamatsu ImagEM CCD camera 
E9100-50 using a 1.45 N.A. x100 oil immersion objective with an effective pixel size of 
71.5nm. STED microscopy was performed on a Leica DMI 6000 inverted microscope 
equipped with 592nm and 660nm STED depletion lasers. Direct STORM was performed 
on a Nikon STORM system. 
 
Reagents 
Antibodies: CLIP-170, rabbit polyclonal (CST #8977); anti-HaloTag, rabbit polyclonal 
(Promega #G9281); anti-GAPDH, mouse monoclonal (Abcam ab9484); anti-Tyr-alpha-
tubulin YL1/2, rat monoclonal (Milipore #1864); anti-Detyr-alpha-tubulin, rabbit polyclonal 
(Milipore #AB3201); anti-beta-tubulin mouse monoclonal clone TUB2.1 (Sigma T5201); 
anti-synaptotagmin, mouse monoclonal (StressGen SYA-130); anti-Rab7, mouse 
monoclonal (Abcam ab50533); anti-LAMP-1, rabbit polyclonal (Abcam ab24170); GFP-
Booster (Chromotek gba488); anti-p150Glued CAP-Gly, mouse monoclonal (BD 
Transduction 610474); anti-dynein heavy chain, rabbit polyclonal (sc-9115); anti-DIC 
(Milipore #1618); anti-KIF5B, mouse monoclonal (Milipore #1614); anti-KIF3A (Abcam 
ab24626); anti-GFP, chicken (Clontech JL-8); anti-Lis1, mouse (Sigma #L7391); anti-
EB1, mouse (BD Transduction 610534). 
siRNA: Mouse CLIP1 siRNA (Dharmacon: J-054772-10, CUUCAAAGCUAACGAGGAA; 
and J-054772-11 GCAGAAGAGUAUUGGCGAA). Control non-targeting siRNA pool 
(Dharmacon: D001810-01-05). 
DNA Constructs: LAMP-1-RFP (Addgene #1817). Rat CLIP-170 (AJ237670.1) was used 
to generate a wild-type CLIP-1 construct fused to HaloTag® at the N terminus. Serine 
residues (309, 311, 313, 319, 320) of this CLIP-170 construct were mutated to glutamate 
(phosphomimetic, CLIP-E) or alanine (phosphodeficient, CLIP-A). Human p150Glued 
(NM_004082.4) fused to an N-terminal myc tag. Human KIF5C amino acids 1-560 fused 




Cell culture and live-cell imaging 
DRG neurons were transfected with LAMP-1-RFP (0.3ug), siRNA resistant rat HT-CLIP-
170 or HT-vector (0.5ug), Mouse CLIP-1 siRNA (20pmol) and then cultured for 4DIV. 
The distal axon of DRG neurons were imaged in a temperature-controlled chamber at 
37C. After identifying the distal axon, a 40µm region of axon that is 10µm proximal to the 
growth cone tip was photobleached a 561nm laser at 100%, allowing measurement of 
retrograde flux through a pre-defined region 3.5µm proximal to the distal edge of the 
bleached region. Movies were acquired at 200ms per frame for 2fps for 5s pre-bleach 
and 2fps for 120s post-bleach. 
 
Protein biochemistry 
Unlabeled tubulin was purified from bovine brain through two cycles of polymerization 
and depolymerization in high-molarity PIPES buffer as described (Castoldi and Popov 
2003). EB1, CLIP-170-H2, and GFP-p150Glued constructs were purified as described 
(Lazarus et al. 2013).  Protein concentrations were determined using BCA or A280nm 
(tubulin). 
 
Tyrosinated tubulin was obtained from Hela S3 cells (ATCC® CCL-2.2™) according to 
the protocol adapted from (Barisic et al. 2015; Castoldi and Popov 2003). Cells were 
grown in the spinner bottles for 1 week, then spun down and lysed in BRB80 (80 mM K-
PIPES pH 6.8, 1 mM MgCl2, 1 mM EGTA) supplemented with 1 mM β-
mercapthoethanol, 1 mM PMSF and protease inhibitors using a French Press at 4°C. 
The soluble fraction was obtained after ultracentrifugation and the first tubulin 
polymerization step was performed at 30°C for 30 min by adding 1 mM GTP and 30% 
glycerol. Microtubules were pelleted by ultracentrifugation at 30°C, and then re-
suspended in BRB80 at 4°C; soluble tubulin was clarified by ultracentrifugation at 4°C. 
Carboxypeptidase A (CPA, Sigma C9268, app 6U/mg of tubulin) was added to the 
soluble tubulin for 5 min at 30°C to produce detyrosinated tubulin. The second 
polymerization, this time in presence of high molarity PIPES, was performed for 30 min 
at 30°C and the microtubule pellet was sedimented by ultracentrifugation. Microtubules 
were then depolymerized in BRB80 at 4°C, and soluble tubulin clarified and snap frozen. 
The tyrosination status of the tubulin was verified by Western blot using the antibodies 
against tyrosinated (YL1/2) and detyrosinated (Millipore, AB3201) tubulin. 
 
In vitro reconstitution of microtubule recruitment 
Briefly, adult mouse brains were homogenized in ice-cold MAB with 1mM dithiothreitol 
(DTT) and protease inhibitors. The homogenate was centrifuged first at 17K x g for 30 
minutes, and then at 133K x g for 20min to pellet the lower density membrane fraction. 
The membrane pellet was loaded onto the bottom of a sucrose step gradient (2.5M, 




Image analysis and machine learning classification of fixed particles 
Our unbiased multi-particle tracking approach provides a robust, automated method to 
determine landing rates while correcting for the background rate of particles randomly 
entering the TIRF field. Particle tracking was performed in uTrack (v.2.1.3). The median 
particle SNR was 4.1, which is within acceptable limits for most single-particle tracking 
algorithms (Chenouard et al. 2014). Microtubule (MT) masks were generated by 
applying a pixel classifier in ilastik (Sommer et al. 2011) to create a probability map, 
which was further processed using custom MATLAB scripts to segment individual MT 
from the background. Unambiguous labeling of events in the MT or background was 
ensured by creating a buffer region of 10 pixels surrounding each MT; particles landing 
in this region were excluded from analysis. Overlapping MTs were excluded from 
analysis. Particle trajectories were mapped onto their positions within MT or background 
masks to determine the landing rate, per square micron per minute. This gave one MT 
landing rate and one background landing rate per movie and allowed the subtraction of 
the background landing rate to obtain the normalized landing rate per square micron. 
Since the microtubule has a fixed intensity profile width of ~3 pixels in our images, we 
used a conversion factor to transform the landing rate per square micron to the landing 
rate per micron length. Calculating the whole-field landing rate per movie gave more 
precise values than calculating a per microtubule landing rate, which were subject to 
extreme values. However, neither method of calculating landing rate significantly 
changed the results. To minimize the contribution of random landing events on our 
measurements we used a low density of microtubules in our flow chambers. On 
average, less than 10% of the image field contained microtubules. Assuming that non-
specific landing events have a uniform random probability of landing at any given pixel, 
this reduced the number of non-specific events relative to the total number of events 
observed. 
 
There was a class of particles landing in the background with long dwell times and little 
displacement, which we label as particles fixed to the coverslip. These particles had the 
potential to skew our dwell time analysis, and to correct for this we used a machine 
learning approach to detect and exclude these fixed particles from analysis. In brief, we 
used a Random Forest (Breiman 2001)classifier in MATLAB consisting of 2000 trees 
and trained on 898 trajectories manually labeled as fixed to the coverslip (0) or not-fixed 
(1) with 22 features derived from the XY coordinates and intensity for each trajectory. 
The generalization error from held-out examples in the training set was ~ 5% and the 
classifier had a 95.5% AUC on a held-out test set of 100 examples. 
 
Stochastic simulation of 2D organelle diffusion and microtubule capture 
Immunofluorescence images of tyrosinated microtubules and a cytosol-filling marker 
were used to create the experimental space for simulated trajectories. Briefly, an ilastik 
pixel-level classifier on the MT intensity image was used to segment microtubules in the 
growth cone, which was manually refined for a best-fit segmentation. Similarly, ilastik 
was used on the combined MT and GFP-LC3 intensity image to segment the neuron 
outline. These two masks formed the experimental space for simulated vesicle diffusion 
and microtubule capture. For each neuronal growth cone, 1000 trajectories were 
generated and seeded at random starting indices. Each trajectory underwent simulated 
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2D Brownian diffusion with a time interval of 0.1s for 1200 seconds simulated time. At 
each time step, the current position of the trajectory in simulation space was evaluated 
accordingly: cytosol = continue simulation; MT = end simulation for current trajectory; 
plasma membrane = pause for 0.1s and then move away from PM in the next step. To 
simulate the diffusion of a large organelle in the heterogeneous viscoelastic environment 
of the cytoplasm, we used a diffusion constant, D = 0.006 µm2/s, taken from empirical 
measurements of the diffusion of EGF-quantum-dot labeled endosomes in the Arpe-19 
cell cytoplasm (Zajac et al. 2013). This value is similar to the diffusion of non-microtubule 
bound melanosomes (D = 0.003 µm2/sec) in Xenopus melanophores (Semenova et al. 
2008). We also simulated a range of diffusion constants from 0.001 to 1.0µm2/s (Figure 
S7). 
 
To simulate retrograde flux for comparison with our experimental observations, we first 
measured the number of LAMP-1-RFP vesicles within of the 10µm distal axon growth 
cone of WT DRG neurons expressing LAMP-1-RFP at low levels. The empirical 
distribution of LAMP-1-RFP vesicles had a mean of 12 and SD of 6 and approximated a 
normal distribution (n = 30 neurons; p > 0.1, one-sample KS test). We randomly sampled 
this distribution to determine the random number of vesicles (nVesicles) we may expect 
to find in any given growth cone. Next we sampled nVesicles, with replacement, from a 
pool of 5,000 simulated vesicles per neuron and calculated the number of vesicles that 
reach the microtubule within the duration of our neuronal live cell imaging experiment 
(120 sec). Since we measure retrograde flux 3.5µm proximal to the bleached region, a 
vesicle only counted toward retrograde flux if it reached the microtubule within 120 sec – 
(3.5µm * 0.5µm/sec), or 113 sec, which assumes cargo undergoes continuous, 
processive dynein driven transport at a velocity of 0.5µm/sec following microtubule 
capture. As biological cargo may not capture with 100% efficiency or may exhibit 
directional changes, these simulations may slightly overestimate retrograde flux. The 
simulation for each neuron growth cone was repeated 5000 times per condition. 
 
Statistics 
Statistical tests and distribution fitting were performed in MATLAB R2015a. A Wilcoxon 
Rank-Sum test was used to compare two sample medians and the Kruskal-Wallis one-
way ANOVA with a Tukey-Kramer post-test was used to correct for multiple comparisons 
between sample medians. A two sample Kolmogorov-Smirnov test was used to compare 
two distributions, with Bonferroni correction for pairwise comparison of multiple 
distributions. The 95% confidence intervals (CI) were calculated from 1000 bootstrapped 
resamplings. Maximum likelihood estimation with 100 bootstrapped fits was used to fit 
dwell times with a double exponential curve and obtain 95% CI on the curve parameters 
amplitude, k1, and k2 (Woody et al. 2016). Box and whisker plots show the median (red 
bar) and interquartile range (IQR, blue box) with the whiskers extending to the upper and 
lower adjacent values. Statistical outliers, defined as data greater than median +/- 
1.5*IQR, were included in all analysis, but are not shown in boxplots so that the outliers 
do not compress the visualization of the majority of data. 
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APPENDIX II 
Supplemental movies for Chapter 4 
Movie S 5. Phenotypic profiling of the IICBU 2008 binucleate dataset. 
https://www.dropbox.com/s/qy7j70jgzopbwwi/binucleate_profiling_legend.avi?dl=0 
 





Supplemental information for Chapter 6 
 
Figure S 8 Example of normal and abnormal cardiac histopathology. 
(a) Normal cardiac tissue shows regular, dense arrays of cardiomyocytes (green) with 
stroma limited to perivascular regions (orange). (b) Patients with heart failure have an 
expansion of the cellular and acellular stromal tissue (orange) that disrupts 
cardiomyocyte arrays (green). Other features seen in heart failure include large 
myocytes with enlarged, hyperchromatic, “boxcar” nuclei (arrowhead, enlarged 200µm 
region shown in the inset). Images are 5x magnification and the scale bar is 1mm.  
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Table S 3. Top 20 features in the training dataset identified by mRMR feature 
selection 
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